PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
2544604-8	1989	We show here that capacitated mouse sperm, incubated with ZP glycopeptides, displayed ARs when incubated subsequently with anti-ZP3 IgG; ARs did not occur when parallel sperm samples were incubated with anti-ZP2 IgG or with anti-ZP3 Fab fragments.	Glycopeptides	61-74	zona pellucida glycoprotein 3	Mus musculus	128-131
2777373-0	1989	Differences in adhesion of Pseudomonas aeruginosa to mucin glycopeptides from sputa of patients with cystic fibrosis and chronic bronchitis.	Glycopeptides	59-72	LOC100508689	Homo sapiens	53-58
2589897-9	1989	The TNF activity was always higher when LPS in an amount of 10 ng/ml was added to the glycopeptides.	Glycopeptides	86-99	tumor necrosis factor	Mus musculus	4-7
2507289-9	1989	TRH administration in vivo normalized the Concanavalin-A binding pattern of secreted TSH glycopeptides in the PVN lesioned group but had no significant effect in the sham lesioned group.	Glycopeptides	89-102	thyrotropin releasing hormone	Rattus norvegicus	0-3
2552998-1	1989	Herpes simplex virus type-1 glycoprotein C (gC1) contains several O-linked oligosaccharides clustered near N-linked chains, and Pronase digestion produces glycopeptides carrying both oligosaccharide types.	Glycopeptides	155-168	solute carrier family 25 member 22	Homo sapiens	44-47
2552998-3	1989	gC1 was isolated from herpes-simplex-virus-infected BHK (baby-hamster kidney) cells after short labelling periods with [3H]glucosamine, and the labelled Pronase-cleaved glycopeptides fractionated on concanavalin A-Sepharose.	Glycopeptides	169-182	solute carrier family 25 member 22	Homo sapiens	0-3
2775488-0	1989	Isolation and structural characterization of sialic-acid-containing glycopeptides of the O-glycosidic type from the urine of two patients with an hereditary deficiency in alpha-N-acetylgalactosaminidase activity.	Glycopeptides	68-81	alpha-N-acetylgalactosaminidase	Homo sapiens	171-202
2775488-1	1989	Glycopeptides have been isolated from the urine of two patients, aged 5 and 6, with a new lysosomal storage disease characterized by a deficiency in alpha-N-acetylgalactosaminidase activity.	Glycopeptides	0-13	alpha-N-acetylgalactosaminidase	Homo sapiens	149-180
2544604-8	1989	We show here that capacitated mouse sperm, incubated with ZP glycopeptides, displayed ARs when incubated subsequently with anti-ZP3 IgG; ARs did not occur when parallel sperm samples were incubated with anti-ZP2 IgG or with anti-ZP3 Fab fragments.	Glycopeptides	61-74	zona pellucida glycoprotein 2	Mus musculus	208-211
2544604-8	1989	We show here that capacitated mouse sperm, incubated with ZP glycopeptides, displayed ARs when incubated subsequently with anti-ZP3 IgG; ARs did not occur when parallel sperm samples were incubated with anti-ZP2 IgG or with anti-ZP3 Fab fragments.	Glycopeptides	61-74	zona pellucida glycoprotein 3	Mus musculus	229-232
2544604-13	1989	Together, these findings are consistent with the hypothesis under examination, and suggest that the aggregation of sperm molecules recognized by ZP3 glycopeptides or by TPA-treated ZP is sufficient to trigger the events that occur during acrosomal exocytosis.	Glycopeptides	149-162	zona pellucida glycoprotein 3	Mus musculus	145-148
2470404-2	1989	After conversion to acyl azide, the reagent reacts with the amino group of a glycopeptide, and the modified glycopeptide is deacetalized with a weak acid to unmask the aldehydo group, which is then conjugated to bovine serum albumin (BSA) by reductive alkylation with pyridine-borane.	Glycopeptides	77-89	albumin	Homo sapiens	219-232
2653823-5	1989	(formula; see text) This structure was verified by binding to the immobilized alpha-Gal-specific lectin, Griffonia simplicifolia I and leukoagglutinating phytohemagglutinin from Phaseolus vulgaris (L-PHA), which binds certain tri- or tetraantennary glycopeptides.	Glycopeptides	249-262	glycoprotein galactosyltransferase alpha 1, 3	Mus musculus	78-87
2495036-4	1989	Fast-atom bombardment mass spectrometry analysis of G.K."s erythrocyte glycopeptides detected a series of high mannose-type oligosaccharides, which were not detected in erythrocyte N-glycans of normal cells or of other HEMPAS cases: The former contains polylactosaminoglycans and the latter contains hybrid-type oligosaccharides.	Glycopeptides	71-84	SEC23 homolog B, COPII coat complex component	Homo sapiens	219-225
2492959-5	1989	Proteolysis occurs near the amino- or carboxy-terminus of ZP2, producing a 23,000 Mr glycopeptide(s) that remains attached to ZP2 by intramolecular disulfide bonds.	Glycopeptides	85-97	zona pellucida glycoprotein 2	Mus musculus	58-61
2492959-5	1989	Proteolysis occurs near the amino- or carboxy-terminus of ZP2, producing a 23,000 Mr glycopeptide(s) that remains attached to ZP2 by intramolecular disulfide bonds.	Glycopeptides	85-97	zona pellucida glycoprotein 2	Mus musculus	126-129
2470404-2	1989	After conversion to acyl azide, the reagent reacts with the amino group of a glycopeptide, and the modified glycopeptide is deacetalized with a weak acid to unmask the aldehydo group, which is then conjugated to bovine serum albumin (BSA) by reductive alkylation with pyridine-borane.	Glycopeptides	108-120	albumin	Homo sapiens	219-232
2912731-7	1989	Two mechanisms of binding at the primary sites of oligomannose-type glycopeptides have been identified which account for the 3000-fold increase in affinity of a Man9 glycopeptide relative to that of methyl alpha-D-mannopyranoside.	Glycopeptides	68-81	mannosidase alpha class 1A member 1	Homo sapiens	161-165
2912731-7	1989	Two mechanisms of binding at the primary sites of oligomannose-type glycopeptides have been identified which account for the 3000-fold increase in affinity of a Man9 glycopeptide relative to that of methyl alpha-D-mannopyranoside.	Glycopeptides	68-80	mannosidase alpha class 1A member 1	Homo sapiens	161-165
2535484-1	1989	The N-linked oligosaccharides of cell-CAM 105, a glycoprotein involved in the intercellular adhesion between rat hepatocytes, were studied by sequential lectin-agarose affinity chromatography of desialylated, [14C]-labelled glycopeptides.	Glycopeptides	224-237	CEA cell adhesion molecule 1	Rattus norvegicus	33-45
2523868-6	1989	Amino acid sequencing of glycopeptides prepared from the largest forms of L-CA indicated extensive O-linked glycosylation in at least one of the extra segments.	Glycopeptides	25-38	protein tyrosine phosphatase, receptor type, C	Rattus norvegicus	74-78
2562506-3	1989	The results obtained indicate that ovalbumin glycopeptides containing four to seven mannose residues and bovine lactotransferrin glycopeptides containing four to nine mannose residues were completely hydrolyzed by the enzyme.	Glycopeptides	45-58	ovalbumin	Bos taurus	35-44
2562506-3	1989	The results obtained indicate that ovalbumin glycopeptides containing four to seven mannose residues and bovine lactotransferrin glycopeptides containing four to nine mannose residues were completely hydrolyzed by the enzyme.	Glycopeptides	129-142	lactotransferrin	Bos taurus	112-128
2491877-1	1989	Antisera raised against a major 78 kD glycopeptide from pig epidermis were used to identify desmoglein II-derived glycopeptides in the conA-binding material isolated from human epidermis.	Glycopeptides	38-50	CONA	Sus scrofa	135-139
2491877-1	1989	Antisera raised against a major 78 kD glycopeptide from pig epidermis were used to identify desmoglein II-derived glycopeptides in the conA-binding material isolated from human epidermis.	Glycopeptides	114-127	CONA	Sus scrofa	135-139
3253057-8	1988	Taken together, these results demonstrate that the cloned cDNA sequence encodes a lipid-linked, PI-specific phospholipase C releasable surface isoform of N-CAM with core glycopeptide molecular weight corresponding to the authentic muscle 125 x 10(3) Mr N-CAM isoform.	Glycopeptides	170-182	neural cell adhesion molecule 1	Homo sapiens	154-159
2701484-1	1989	Bronchial mucin peptide chains were obtained by performing a two-step chemical deglycosylation of the highly glycosylated regions (or glycopeptides) which are the most characteristic part of bronchial mucins.	Glycopeptides	134-147	LOC100508689	Homo sapiens	10-15
2971654-3	1988	Fractionation of 32P-labeled glycopeptides followed by amino acid sequence analysis indicated that greater than 95% of the label was incorporated into two out of three glycosylation sites at Asn-82 and Asn-136 of the TGF-beta 1 precursor.	Glycopeptides	29-42	transforming growth factor beta-1 proprotein	Cricetulus griseus	217-227
3170547-3	1988	Upon hydrazine/nitrous acid fragmentation and radiolabeling with NaB3H4, all human unit B DEAE-resolved glycopeptide fractions yielded an acidic disaccharide which was characterized as Gal-3-SO4 beta 1----4-anhydromannitol.	Glycopeptides	104-116	galectin 3	Homo sapiens	185-201
3170547-4	1988	Studies on glycopeptides modified by desialylation, desulfation, and beta-galactosidase treatment indicated that the majority (approximately 70%) of the complex carbohydrate units contain sulfate groups and that Gal-3-SO4 and sialic acid residues can coexist in terminal positions on the same N-linked oligosaccharide.	Glycopeptides	11-24	galactosidase beta 1	Homo sapiens	69-87
3170547-4	1988	Studies on glycopeptides modified by desialylation, desulfation, and beta-galactosidase treatment indicated that the majority (approximately 70%) of the complex carbohydrate units contain sulfate groups and that Gal-3-SO4 and sialic acid residues can coexist in terminal positions on the same N-linked oligosaccharide.	Glycopeptides	11-24	galectin 3	Homo sapiens	212-217
3211159-8	1988	The binding of SAP to ligand(s) in zymosan extract or ovalbumin was inhibited by the preincubation of SAP with either zymosan extract or ovalbumin glycopeptides, both of which share similar mannose oligosaccharide sequences.	Glycopeptides	147-160	amyloid P component, serum	Homo sapiens	15-18
3211159-8	1988	The binding of SAP to ligand(s) in zymosan extract or ovalbumin was inhibited by the preincubation of SAP with either zymosan extract or ovalbumin glycopeptides, both of which share similar mannose oligosaccharide sequences.	Glycopeptides	147-160	amyloid P component, serum	Homo sapiens	102-105
3377767-5	1988	In the present study, equimolar mixtures of two oligomannose type glycopeptides, a Man-6 and a Man-9 glycopeptide, gives a quantitative precipitation profile which shows two protein peaks.	Glycopeptides	66-79	mannosidase alpha class 1A member 1	Homo sapiens	95-100
2971395-0	1988	Oligosaccharide structure and amino acid sequence of the major glycopeptides of mature human beta-hexosaminidase.	Glycopeptides	63-76	O-GlcNAcase	Homo sapiens	93-112
3402460-6	1988	The glycopeptides of AGP-A did not bind to ConA-Sepharose whereas for AGP-B and AGP-C 18% and 44%, respectively, of the glycopeptides were bound as diantennary structures.	Glycopeptides	4-17	orosomucoid 1	Homo sapiens	21-26
2453314-3	1988	Reduction of the mucin decreased the reactivity by only 14% indicating that the assay reacts almost as well with mucin glycopeptides as with native mucin.	Glycopeptides	119-132	LOC100508689	Homo sapiens	17-22
2453314-3	1988	Reduction of the mucin decreased the reactivity by only 14% indicating that the assay reacts almost as well with mucin glycopeptides as with native mucin.	Glycopeptides	119-132	LOC100508689	Homo sapiens	113-118
2453314-3	1988	Reduction of the mucin decreased the reactivity by only 14% indicating that the assay reacts almost as well with mucin glycopeptides as with native mucin.	Glycopeptides	119-132	LOC100508689	Homo sapiens	113-118
3298096-1	1987	Two glycopeptides associating the aminoacid sequence of LH-RH with MDP were prepared, using a Lys residue as a linker.	Glycopeptides	4-17	gonadotropin releasing hormone 1	Homo sapiens	56-61
3367907-3	1988	Selection of this carbohydrate-containing form of NB with Datura stramonium lectin, its susceptibility to digestion by endo-beta-galactosidase, and determination of the size of NBp glycopeptides by gel filtration chromatography suggested that the increase in molecular weight is due to processing to polylactosaminoglycan.	Glycopeptides	181-194	NUBP iron-sulfur cluster assembly factor 1, cytosolic	Homo sapiens	177-180
3365364-1	1988	We have recently demonstrated that certain oligomannose and bisected hybrid type glycopeptides and bisected complex type oligosaccharides are bivalent for binding to concanavalin A and can precipitate the lectin [Bhattacharyya, L., Ceccarini, C., Lorenzoni, P., & Brewer, C.F.	Glycopeptides	81-94	LOW QUALITY PROTEIN: lectin	Glycine max	205-211
2825412-9	1987	In addition to these disaccharides, Pronase-resistant PNA-binding glycopeptides of gC-1 also contained neutral trisaccharides.	Glycopeptides	66-79	solute carrier family 25 member 22	Homo sapiens	83-87
3117549-8	1987	259, 6586-6592], the endo-beta-galactosidase of Bacteroides fragilis cannot hydrolyse branch-point beta-galactosidic linkages on erythrocyte membrane glycopeptides.	Glycopeptides	150-163	galactosidase beta 1	Homo sapiens	26-44
2444130-8	1987	Glycoasparagine, lacking all amino acids except the carbohydrate-linking asparagine, inhibits IgE-binding to glycopeptide discs up to 100%.	Glycopeptides	109-121	immunoglobulin heavy constant epsilon	Homo sapiens	94-97
3620357-0	1987	Glycolipids and glycopeptides of red cell membranes in congenital dyserythropoietic anaemia type II (CDA II).	Glycopeptides	16-29	SEC23 homolog B, COPII coat complex component	Homo sapiens	55-99
3597368-1	1987	Immobilized tomato lectin interacts with high affinity with glycopeptides containing long poly-N-acetyllactosamine chains.	Glycopeptides	60-73	LTL	Solanum lycopersicum	19-25
3311021-13	1987	Thus the 118,000-Mr component is an integral part of the mucin and, although linked to large glycopeptides by disulphide bonds, this component also has proteinase-sensitive peptide bonds, presumably at terminal locations such that brief treatment with proteinases releases the molecule in a reasonably intact form.	Glycopeptides	93-106	solute carrier family 13 member 2	Rattus norvegicus	57-62
3104329-8	1987	TRH caused a 2-fold increase in secretion of [3H]mannose-labeled TSH glycopeptides due almost exclusively to a specific increase in structures that bound to ConA-Sepharose and eluted with 10mM alpha-methylglucoside, corresponding to biantennary complex or unusual hybrid species.	Glycopeptides	69-82	thyrotropin releasing hormone	Mus musculus	0-3
3104329-11	1987	Moreover, ConA-Sepharose chromatography of secreted [3H]glucosamine- and [3H]fucose-labeled TSH glycopeptides showed similar increases in ConA-Sepharose binding with TRH as noted with [3H]mannose labeling.	Glycopeptides	96-109	thyrotropin releasing hormone	Mus musculus	166-169
3128279-1	1988	of oligosaccharides of N-acetyl-lactosamine-type released from human erythrocyte glycopeptides by endo-beta-galactosidase.	Glycopeptides	81-94	galactosidase beta 1	Homo sapiens	103-121
2453447-7	1988	The hemagglutinating activity of antibody 177.1 is inhibited by purified glycophorin A and its chymotryptic glycopeptides CH1 (amino acid residues 1-64) and CH3 (amino acid residues 35-64), whereas the hemagglutinating activity of 179.3 is inhibited weakly by glycophorin A but not by chymotryptic peptides.	Glycopeptides	108-121	SUN domain containing ossification factor	Homo sapiens	122-125
2453447-7	1988	The hemagglutinating activity of antibody 177.1 is inhibited by purified glycophorin A and its chymotryptic glycopeptides CH1 (amino acid residues 1-64) and CH3 (amino acid residues 35-64), whereas the hemagglutinating activity of 179.3 is inhibited weakly by glycophorin A but not by chymotryptic peptides.	Glycopeptides	108-121	glycophorin A (MNS blood group)	Homo sapiens	260-273
3055253-14	1988	High-performance ion exchange chromatography revealed mucin glycopeptides to constitute a very heterogeneous population.	Glycopeptides	60-73	LOC100508689	Homo sapiens	54-59
3426806-5	1987	The Ge2 epitopes were found to be located on a tryptic glycopeptide from glycophorin D comprising about 20-30 amino-acid residues.	Glycopeptides	55-67	glycophorin C (Gerbich blood group)	Homo sapiens	73-86
3435657-8	1987	Some of the changes in glycopeptides were interpreted in terms of the levels of the major components of the matrix such as the interstitial procollagens and fibronectin.	Glycopeptides	23-36	fibronectin 1	Bos taurus	157-168
3621238-0	1987	Application of the trichloroacetimidate method to the synthesis of glycopeptides of the mucin type containing a beta-D-Galp-(1----3)-D-GalpNAc unit.	Glycopeptides	67-80	LOC100508689	Homo sapiens	88-93
3621238-0	1987	Application of the trichloroacetimidate method to the synthesis of glycopeptides of the mucin type containing a beta-D-Galp-(1----3)-D-GalpNAc unit.	Glycopeptides	67-80	galanin like peptide	Homo sapiens	119-123
3789744-1	1986	Mannose-labeled epiglycanin was prepared by incubation of TA3-Ha ascites cells with [2-3H]mannose, removal of the epiglycanin by incubation of viable cells with L-1-p-tosylamino-2-phenylethyl chloromethyl ketone-trypsin, and isolation of the large epiglycanin glycopeptides by gel filtration.	Glycopeptides	260-273	mucin 21	Mus musculus	16-27
3593280-5	1987	Lectin-binding glycopeptides were eluted with appropriate competing sugars and further analysed by gel filtration, base/borohydride elimination and susceptibility to degradation by glycosidases including endo-beta-galactosidase.	Glycopeptides	15-28	galactosidase, beta 1	Mus musculus	209-227
3593280-6	1987	Abundant quantities of N-linked polylactosamine-type glycopeptides, which bound only to the WGA columns, were identified on mature granulocytes but the molecules were highly-branched (i.e. resistant to endo-beta-galactosidase).	Glycopeptides	53-66	galactosidase, beta 1	Mus musculus	207-225
3566706-1	1987	The four major isoelectric forms of human liver neuraminidase (with pI values between 3.4 and 4.8) have been isolated by preparative isoelectric focusing and characterized with regard to their substrate specificity using glycoprotein, glycopeptide, oligosaccharide and ganglioside natural substrates.	Glycopeptides	235-247	neuraminidase 1	Homo sapiens	48-61
3789744-2	1986	Purification of epiglycanin glycopeptides was performed by wheat germ agglutinin affinity chromatography.	Glycopeptides	28-41	mucin 21	Mus musculus	16-27
2428831-5	1986	Glycopeptides bearing the antigenic determinant were identified by their ability to block binding of M-proteins and HNK-1 antibodies to MAG-coated microwells by enzyme-linked immunosorbent assay (ELISA).	Glycopeptides	0-13	beta-1,3-glucuronyltransferase 1	Homo sapiens	116-121
2944883-1	1986	The fibronectin receptor is a complex of two cell surface glycopeptides that mediate the binding of cells to fibronectin substrata.	Glycopeptides	58-71	fibronectin 1	Homo sapiens	4-15
2944883-1	1986	The fibronectin receptor is a complex of two cell surface glycopeptides that mediate the binding of cells to fibronectin substrata.	Glycopeptides	58-71	fibronectin 1	Homo sapiens	109-120
2428831-5	1986	Glycopeptides bearing the antigenic determinant were identified by their ability to block binding of M-proteins and HNK-1 antibodies to MAG-coated microwells by enzyme-linked immunosorbent assay (ELISA).	Glycopeptides	0-13	myelin associated glycoprotein	Homo sapiens	136-139
2578862-3	1985	alpha 2 M is bound to a low molecular weight glycopeptide, which is released during trypsinization of alpha 2 M.	Glycopeptides	45-57	alpha-2-macroglobulin	Rattus norvegicus	0-9
3709931-2	1986	Nearly 90% of glycopeptides released from amniotic fluid fibronectin was not bound by concanavalin A-Sepharose, whereas 75% of glycopeptides from plasma fibronectin was bound.	Glycopeptides	14-27	fibronectin 1	Homo sapiens	57-68
4043085-3	1985	Glycopeptides liberated from apolipoprotein-B by pronase were fractionated by affinity chromatography on concanavalin-A--Sepharose.	Glycopeptides	0-13	apolipoprotein B	Homo sapiens	29-45
3920213-8	1985	Removal of polylactosamine sequences from the former glycopeptide by endo-beta-galactosidase digestion caused the elution peak for this fraction to change from 2.0 to 2.5 M, the same as for the complex N-linked carbohydrate-containing glycopeptide.	Glycopeptides	53-65	galactosidase beta 1	Homo sapiens	74-92
16664119-13	1985	The smaller glycopeptides (IV, V, VI) were partially susceptible to alpha-mannosidase digestion, but this enzyme did not release any radioactive mannose from the larger-sized glycopeptides.	Glycopeptides	12-25	alpha-mannosidase At3g26720	Glycine max	68-85
3967951-4	1985	Neuraminidase treatment of the glycopeptides indicates that only gp87 contains accessible sialic acid moieties.	Glycopeptides	31-44	neuraminidase 1	Homo sapiens	0-13
3749029-4	1986	In addition, a quantitative reduction of glycopeptides was observed in mutant livers, when the radioactive peaks from the Bio-Gel P-6 fractionation were pooled and analyzed on a Dowex 50 column, followed by separation on DE-52 columns.	Glycopeptides	41-54	exosome component 9	Mus musculus	130-133
3768895-8	1986	Unlike the biantennary glycopeptides of human plasma fibronectin, those from skin fibroblast fibronectin were core-fucosylated and less highly sialylated.	Glycopeptides	23-36	fibronectin 1	Homo sapiens	53-64
3755358-1	1986	Endo-beta-galactosidase treatment of glycopeptides derived from the trypsinate and membranes of PC12 pheochromocytoma cells and cultured sympathetic neurons demonstrated the presence of poly(N-acetyllactosaminyl) units on tri- and tetraantennary oligosaccharides, some of which have a core fucose residue and a 2,6-substituted alpha-linked mannose residue.	Glycopeptides	37-50	galactosidase, beta 1	Rattus norvegicus	5-23
3514617-12	1986	In contrast, the N Sta glycophorin yielded two CNBr glycopeptides B; both contained fewer amino acid residues and virtually lacked Man and GlcNAc, indicating the absence of the Asn-linked carbohydrate.	Glycopeptides	52-65	GCY	Homo sapiens	19-22
3088498-7	1986	Treatment with exo-beta-galactosidase transformed the trisaccharide OS II into the disaccharide OS I, indicating that the deficiency of beta-galactosidase in GM1 gangliosidosis type I, but not in type II, also affects glycoprotein catabolism, leading to the accumulation of glycopeptides containing terminal beta-galactosyl residues and N-acetyllactosamine repeating units.	Glycopeptides	274-287	galactosidase beta 1	Homo sapiens	19-37
3527818-3	1986	Muramyl peptides (MDP) are synthetic glycopeptides which can substitute mycobacteria in FCA and are also adjuvant-active in saline.	Glycopeptides	37-50	dipeptidase 1	Homo sapiens	18-21
3972840-11	1985	Uptake was inhibited by yeast mannan and by glycopeptides isolated from either ovalbumin or uteroferrin.	Glycopeptides	44-57	acid phosphatase 5, tartrate resistant	Sus scrofa	92-103
2859851-3	1985	Glycopeptides were prepared from Thy-1 obtained from cells labelled by periodate/boro[3H]hydride treatment.	Glycopeptides	0-13	thymus cell antigen 1, theta	Mus musculus	33-38
3966805-1	1985	Using Sephadex G-75 and DEAE-cellulose column chromatography, an 8270-Da glycopeptide (designated Fragment II) has been isolated from a cyanogen bromide-formic acid digest of a heat-stable factor from Gaucher spleen which activates a lipid-depleted preparation of lysosomal glucocerebrosidase from human liver.	Glycopeptides	73-85	glucosylceramidase beta	Rattus norvegicus	274-292
2578862-3	1985	alpha 2 M is bound to a low molecular weight glycopeptide, which is released during trypsinization of alpha 2 M.	Glycopeptides	45-57	alpha-2-macroglobulin	Rattus norvegicus	102-111
6332144-1	1984	In the present study, well-defined immunomodulatory synthetic glycopeptides were used to investigate putative regulatory mechanisms of in vitro IL 2 production by normal human peripheral blood mononuclear cells.	Glycopeptides	62-75	interleukin 2	Homo sapiens	144-148
2412908-1	1985	Trypsin digestion of haptoglobin beta (heavy) chain resulted in five glycopeptides.	Glycopeptides	69-82	haptoglobin	Homo sapiens	21-32
6529554-1	1984	Sialylated biantennary glycopeptides from human fibrinogen were analyzed with fast atom bombardment mass spectrometry.	Glycopeptides	23-36	fibrinogen beta chain	Homo sapiens	48-58
3968538-6	1985	GP59(E1) contained glycopeptides in two size classes, designated R1.5 and R2.1; E1 contained these and an additional size class, R2.7.	Glycopeptides	19-32	small nucleolar RNA, H/ACA box 73A	Homo sapiens	0-8
3968538-7	1985	GP43(E2) contained glycopeptides in three size classes, R1.5, R2.1 and R2.7; E2 contained these and size class R3.3.	Glycopeptides	19-32	cystatin 12, pseudogene	Homo sapiens	0-8
3931095-3	1985	A minimum of four (possibly five) concanavalin A-binding glycopeptides was generated by cyanogen bromide cleavage of IRBP.	Glycopeptides	57-70	retinol binding protein 3	Bos taurus	117-121
6433980-5	1984	Glycopeptides from fetal plasma fibronectin contained a population of glycopeptides which bound to both lectin gels.	Glycopeptides	70-83	fibronectin 1	Homo sapiens	32-43
6433980-7	1984	In contrast, glycopeptides from adult plasma fibronectin practically lacked such glycopeptides.	Glycopeptides	13-26	fibronectin 1	Homo sapiens	45-56
6433980-8	1984	Another difference observed was that fetal plasma fibronectin had a larger amount of concanavalin A-unbound glycopeptides than did adult plasma fibronectin.	Glycopeptides	108-121	fibronectin 1	Homo sapiens	50-61
6436230-4	1984	The non- or low-reactivity of placenta fibronectin with this lectin was also demonstrated by affinity chromatography with concanavalin A-agarose, in which more than 90% of the radiolabeled glycopeptides derived from placenta fibronectin was not retained on the gel.	Glycopeptides	189-202	fibronectin 1	Homo sapiens	39-50
6094178-7	1984	A proportion of [3H]fucose-labelled glycopeptides was susceptible to endo-beta-galactosidase, confirming the immunoblotting experiment using antibodies against the Lea and the difucosylated Type 2 antigenic determinants.	Glycopeptides	36-49	galactosidase beta 1	Homo sapiens	74-92
6736034-2	1984	The glycopeptides were digested by endo-beta-galactosidase under various conditions and oligosaccharides and core glycopeptides thus obtained and intact glycopeptides were analyzed by methylation, exoglycosidase digestion, and fast atom bombardment mass spectrometry.	Glycopeptides	4-17	galactosidase beta 1	Homo sapiens	40-58
6203920-3	1984	The chemically defined immunoadjuvant glycopeptide, N-acetyl-muramyl-L-alanyl-D-isoglutamine (MDPL) also promoted an increase in ODC activity at 2 hours that was maximal after 4 hours, while little or no effect was observed with the D-alanyl analog (MDPD) that is devoid of adjuvant activity.	Glycopeptides	38-50	ornithine decarboxylase, structural 1	Mus musculus	129-132
6610106-4	1984	The results show that the three disulfide-linked polypeptides of Lyt-2/3 molecules are all surface-expressed glycopeptides possessing hydrophobic regions residing within the lipid bilayer.	Glycopeptides	109-122	CD8 antigen, alpha chain	Mus musculus	65-72
6725252-3	1984	As described in this report, the latter lectin binds glycopeptides that contain either the repeating N-acetyllactosamine sequence or an outer mannose residue substituted at C-2 and C-6 by N-acetyllactosamine.	Glycopeptides	53-66	complement component 2 (within H-2S)	Mus musculus	173-176
6725252-3	1984	As described in this report, the latter lectin binds glycopeptides that contain either the repeating N-acetyllactosamine sequence or an outer mannose residue substituted at C-2 and C-6 by N-acetyllactosamine.	Glycopeptides	53-66	complement component 6	Mus musculus	181-184
6230110-3	1984	The N-acetylglucosaminyltransferases I and II (enzymes which attach N-acetylglucosamine to either the 3" or 6" core mannose, respectively) were assayed with structurally-defined glycopeptides as specific acceptors and galactosyltransferase was assayed with asialo, agalactosylfetuin (galactose is attached to exposed N-acetylglucosamine termini).	Glycopeptides	178-191	alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase	Rattus norvegicus	4-45
6704415-8	1984	These high molecular weight 3H-labeled glycopeptides were degraded with endo-beta-galactosidase but not with testicular hyaluronidase.	Glycopeptides	39-52	galactosidase beta 1	Homo sapiens	77-95
6199836-0	1984	A common epitope identified by a monoclonal antibody, MID 2, present on all leucocytes and associated with a group of high molecular weight glycopeptides.	Glycopeptides	140-153	midline 2	Homo sapiens	54-59
6199017-9	1984	Therefore the antibody to human small-intestinal mucin appears to recognize a "naked" (non-glycosylated and Pronase-susceptible) peptide region(s) of mucin glycopeptides.	Glycopeptides	156-169	LOC100508689	Homo sapiens	49-54
6199017-9	1984	Therefore the antibody to human small-intestinal mucin appears to recognize a "naked" (non-glycosylated and Pronase-susceptible) peptide region(s) of mucin glycopeptides.	Glycopeptides	156-169	LOC100508689	Homo sapiens	150-155
6232267-4	1984	Linkage region-enriched glycopeptides, prepared by endo-beta-galactosidase digestion of the peptidokeratan sulfates, behaved similarly to the peptidokeratan sulfates on the same affinity chromatography.	Glycopeptides	24-37	galactosidase beta 1	Bos taurus	56-74
6086072-1	1984	The specificity of a human anti-Mg antibody has been evaluated by agglutination-inhibition assays using several peptides and glycopeptides structurally related to the N-terminal end of glycophorin A, which were obtained by chemical synthesis.	Glycopeptides	125-138	glycophorin A (MNS blood group)	Homo sapiens	185-198
6626573-2	1983	The 1H-NMR chemical shifts of the previously assigned anomeric and H-2 protons from the peripheral residues of the glycopeptide are identical to the corresponding values for the reduced oligosaccharide.	Glycopeptides	115-127	relaxin 2	Homo sapiens	67-70
6667476-0	1983	13C-N.m.r.-spectral study of the mode of binding of Gd3+ to various glycopeptides.	Glycopeptides	68-81	GRDX	Homo sapiens	52-55
6667476-4	1983	When the amino and carboxyl groups of the amino acid are blocked, noticeable interaction of Gd3+ with the glycosidic oxygen atom (O-3) and O-2" for the glycopeptide containing alpha-D-Galp, and with O-3 and N-2" for the glycopeptide containing alpha-D-GalpNAc, is observed.	Glycopeptides	152-164	GRDX	Homo sapiens	92-95
6667476-4	1983	When the amino and carboxyl groups of the amino acid are blocked, noticeable interaction of Gd3+ with the glycosidic oxygen atom (O-3) and O-2" for the glycopeptide containing alpha-D-Galp, and with O-3 and N-2" for the glycopeptide containing alpha-D-GalpNAc, is observed.	Glycopeptides	220-232	GRDX	Homo sapiens	92-95
6418744-3	1983	The first mentioned oligosaccharide, which was released in a steady and slow process unaffected by the addition of EDTA, appeared to be primarily the product of endo-beta-N-acetylglucosaminidase action on newly synthesized glycoprotein and such an enzyme with a neutral pH optimum capable of hydrolyzing exogenous glycopeptides and oligosaccharides (Km = 18 microM) was found in the thyroid microsomal fraction.	Glycopeptides	314-327	O-GlcNAcase	Homo sapiens	166-194
6225773-5	1983	GP-A was then serially digested with exoglycosidases, and the released sugars and the composition of the residual glycopeptides isolated by gel filtration were analyzed by gas-liquid chromatography.	Glycopeptides	114-127	glycophorin-A	Bos taurus	0-4
6870863-3	1983	Simultaneously, there occur increases in the bindings of 125I-labeled soybean lectin and 125I-Ricinus communis toxin to unsubstituted sites in glycopeptides.	Glycopeptides	143-156	LOW QUALITY PROTEIN: lectin	Glycine max	78-84
6629141-0	1983	Dermatan sulphate and mucin glycopeptides from the human uterine cervix.	Glycopeptides	28-41	LOC100508689	Homo sapiens	22-27
6831431-2	1983	When mouse LM-22 cells (nonmalignant and devoid of gangliosides) were preincubated with GM1 ganglioside (3.0 micrograms/ml), the cell surface glycopeptide inhibitor effectively arrested cell division.	Glycopeptides	142-154	coenzyme Q10A	Mus musculus	88-91
6870830-7	1983	When the bound glycopeptides were chromatographed on Bio-Gel P-6, it was found that confluent cells contained a larger proportion of lower-molecular-weight glycopeptides than subconfluent cells.	Glycopeptides	15-28	S100 calcium binding protein A12	Homo sapiens	61-64
6229300-4	1983	GPI consists of two glycopeptides, an alpha and a beta chain connected by a disulphide bridge.	Glycopeptides	20-33	glucose-6-phosphate isomerase	Homo sapiens	0-3
6345185-3	1983	The carbohydrate groups present in the glycopeptide cleaved from purified [3H]-GlcNAc-rhodopsin by an enzyme from the retinal pigment epithelium were analyzed in terms of the size of the oligosaccharide chains, the sequence of the sugars and their anomeric linkages.	Glycopeptides	39-51	rhodopsin	Homo sapiens	86-95
6174521-2	1982	Glycopeptides and oligosaccharides were prepared from alpha-fetoprotein by protease treatment and hydrazinolysis, respectively, and subjected to carbohydrate and amino acid analysis.	Glycopeptides	0-13	alpha fetoprotein	Homo sapiens	54-71
6832456-4	1983	Addition of soybean trypsin inhibitor (SbTI) blocks almost completely the release of glycopeptides but not the vesiculation.	Glycopeptides	85-98	kunitz trypsin protease inhibitor	Glycine max	20-37
6284780-10	1982	Paper electrophoresis of [3H]glucosamine-labeled tryptic glycopeptides reveals at least three radioactive peaks, suggesting that the two known glycosylation sites in human POMC may be variably glycosylated.	Glycopeptides	57-70	proopiomelanocortin	Homo sapiens	172-176
7107587-12	1982	Affinity chromatography of the glycopeptides on concanavalin A-Sepharose also showed that the glycopeptides from fibrinogen are greater than 95% biantennary oligosaccharide chains.	Glycopeptides	31-44	fibrinogen beta chain	Homo sapiens	113-123
7107587-12	1982	Affinity chromatography of the glycopeptides on concanavalin A-Sepharose also showed that the glycopeptides from fibrinogen are greater than 95% biantennary oligosaccharide chains.	Glycopeptides	94-107	fibrinogen beta chain	Homo sapiens	113-123
7115737-1	1982	Pronase digestion of human transcortin yielded two major glycopeptides (GID3 and G2D2, in a molar ratio of approx.	Glycopeptides	57-70	serpin family A member 6	Homo sapiens	27-38
7093235-2	1982	The array of glycopeptides from cellular E1 and E2 appeared similar to the glycopeptides (S1, S2, S3, and S4) found in mature virus glycoproteins described previously [Hakimi, J., & Atkinson, P. H. (1980) Biochemistry 19, 5619].	Glycopeptides	13-26	small nucleolar RNA, H/ACA box 73A	Homo sapiens	41-50
7093235-6	1982	By contrast, the products of PE2 cleavage (E2 and E3) contained sialyl glycopeptides similar to those found in mature virus (S1, S2, and S3).	Glycopeptides	71-84	ETS2 repressor factor	Homo sapiens	29-32
7093235-6	1982	By contrast, the products of PE2 cleavage (E2 and E3) contained sialyl glycopeptides similar to those found in mature virus (S1, S2, and S3).	Glycopeptides	71-84	cystatin 12, pseudogene	Homo sapiens	43-52
6948606-8	1982	High-molecular-weight glycopeptides predominated on another human myeloid leukemia cell line KG1, but they were expressed at low levels on both a human monocytic leukemia cel line (THP-1) and a human T-lymphoblastoid cell line (Jurkat).	Glycopeptides	22-35	GLI family zinc finger 2	Homo sapiens	181-186
6896906-5	1982	Zn-alpha2-glycoprotein is the only plasma protein which has a common determinant with nephritogenic urinary glycoprotein or glycopeptides.	Glycopeptides	124-137	alpha-2-glycoprotein 1, zinc-binding	Homo sapiens	0-22
6184028-5	1982	Antigens of H-2 system were detected in fraction IV, which contained three glycopeptides of molecular weights 18000, 37000 and 48000 and isoelectric points 6.0, 5.8, and 6.7 respectively.	Glycopeptides	75-88	relaxin 2	Homo sapiens	12-15
7325959-6	1981	Glycopeptides from soya-bean (Glycine max) lectin and fetuin are also strong inhibitors of Datura lectin, indicating that it interacts with internal N-acetylglucosamine residues.	Glycopeptides	0-13	LOW QUALITY PROTEIN: lectin	Glycine max	43-49
7317384-5	1981	Spectra of two endo-beta-N-acetylglucosaminidase products of the S4 glycopeptides are reported.	Glycopeptides	68-81	O-GlcNAcase	Homo sapiens	20-48
7325959-6	1981	Glycopeptides from soya-bean (Glycine max) lectin and fetuin are also strong inhibitors of Datura lectin, indicating that it interacts with internal N-acetylglucosamine residues.	Glycopeptides	0-13	LOW QUALITY PROTEIN: lectin	Glycine max	98-104
7325959-8	1981	After prolonged proteolytic digestion of reduced and S-carboxymethylated or S-aminoethylated derivatives of the lectin, glycopeptides of mol.wt.	Glycopeptides	120-133	LOW QUALITY PROTEIN: lectin	Glycine max	112-118
7284304-0	1981	Demonstration of heterogeneity of chick ovalbumin glycopeptides using 360-MHz proton magnetic resonance spectroscopy.	Glycopeptides	50-63	ovalbumin (SERPINB14)	Gallus gallus	40-49
7407676-4	1980	The PA 1 cells contained also oligomannosyl type glycans, presumably linked to asparagine (fraction C glycopeptides).	Glycopeptides	102-115	PAXIP1 associated glutamate rich protein 1	Homo sapiens	4-8
6158338-1	1980	Human follicle-stimulating hormone (human FSH), dansylated human FSH, human FSH-alpha and human FSH-beta subunits were individually conjugated by photoactivation to an azidobenzoyl derivative of a glycopeptide isolated from fetuin.	Glycopeptides	197-209	glycoprotein hormones, alpha polypeptide	Homo sapiens	76-85
6158338-1	1980	Human follicle-stimulating hormone (human FSH), dansylated human FSH, human FSH-alpha and human FSH-beta subunits were individually conjugated by photoactivation to an azidobenzoyl derivative of a glycopeptide isolated from fetuin.	Glycopeptides	197-209	follicle stimulating hormone subunit beta	Homo sapiens	96-104
6771264-3	1980	Fibronectin isolated from chick embryo fibroblasts binds both hyaluronic acid and heparin; heparan sulfate is bound less efficiently, and chondroitin sulfate and glycopeptides are bound minimally.	Glycopeptides	162-175	fibronectin 1	Gallus gallus	0-11
7358339-3	1980	The Ss blood group antigen determinants were found to be associated with the N-terminal tryptic and chymotryptic glycopeptides (residues 1--35 or 1--32) of the Ss sialoglycoprotein from human erythrocyte membranes.	Glycopeptides	113-126	glycophorin B (MNS blood group)	Homo sapiens	4-18
7378456-0	1980	Amino acid sequence, location and phylogenetic aspects of the glycopeptides of human lactotransferrin.	Glycopeptides	62-75	lactotransferrin	Homo sapiens	85-101
6772538-1	1980	The N-terminal amino acid sequence (residues 1--35) of the Ss sialoglycoprotein (or glycophorin B) from human erythrocyte membranes of defined Ss blood group activity was determined by manual sequencing methods, using N-terminal tryptic or chymotryptic glycopeptides and various secondary peptides.	Glycopeptides	253-266	glycophorin B (MNS blood group)	Homo sapiens	84-97
379005-4	1979	Cyanogen bromide cleavage of glycophorin A from red cells and the K562 cell protein gives apparently identical fragments, and the glycopeptides and oligosaccharides obtained after Pronase and mild alkaline treatment are closely similar.	Glycopeptides	130-143	glycophorin A (MNS blood group)	Homo sapiens	29-42
518544-0	1979	Bi-and tri-antennary human transferrin glycopeptides and their affinities for the hepatic lectin specific for asialo-glycoproteins.	Glycopeptides	39-52	transferrin	Homo sapiens	27-38
220199-6	1979	It proved possible to distinguish several categories of hematopoietic cell lines due to the effect that pretreatment of the glycopeptides with neuraminidase or mild acid exerted on their subsequent chromatographic behavior.	Glycopeptides	124-137	neuraminidase 1	Homo sapiens	143-156
227363-0	1979	Neuraminidase inhibition by chemically sulphated glycopeptides.	Glycopeptides	49-62	neuraminidase 1	Bos taurus	0-13
227363-1	1979	Chemically sulphated glycopeptides (derived from pig duodenal mucosa) inhibited Clostridium perfringens neuraminidase (EC 3.2.1.18) activity in a pH-dependent manner.	Glycopeptides	21-34	neuraminidase 1	Bos taurus	104-117
438217-3	1979	One of the prominent features common to all these glycopeptides was that they all contain 1 fucosyl residue at either C-3 or C-6 position of the N-acetylglucosamine which is linked to asparagine.	Glycopeptides	50-63	complement C3	Homo sapiens	118-121
438217-3	1979	One of the prominent features common to all these glycopeptides was that they all contain 1 fucosyl residue at either C-3 or C-6 position of the N-acetylglucosamine which is linked to asparagine.	Glycopeptides	50-63	complement C6	Homo sapiens	125-128
99447-0	1978	Preparation of glycopeptides and oligosaccharides from thyroxine-binding globulin.	Glycopeptides	15-28	serpin family A member 7	Homo sapiens	55-81
668697-3	1978	By correlation of these spectra and comparison with spectra of reference glycopeptides and sialyl-lactose isomers it was possible to assign all signals belonging to anomeric, mannose H-2, sialic acid H-3 and N-acetyl protons.	Glycopeptides	73-86	H3 clustered histone 14	Homo sapiens	200-203
99447-10	1978	We propose that TBG contains four oligosaccharide chains as calculated from the molecular weights of the glycopeptides and from compositional data assuming 1 asparagine residue/glycopeptide.	Glycopeptides	105-117	serpin family A member 7	Homo sapiens	16-19
99447-11	1978	The carbohydrate structures of the glycopeptides and relative affinities of TBG, glycopeptides and oligosaccharides for hepatocyte plasma membrane binding are presented in the accompanying paper (Zinn, A.B., Marshall, J.S., and Carlson, D.M.	Glycopeptides	35-48	serpin family A member 7	Homo sapiens	76-79
308510-0	1978	Studies on the attachment of N-acetylneuraminic acid to glycopeptides from alpha-1-antitrypsin.	Glycopeptides	56-69	serpin family A member 1	Homo sapiens	75-94
687592-0	1978	Structural studies on rabbit transferrin: isolation and characterization of the glycopeptides.	Glycopeptides	80-93	serotransferrin	Oryctolagus cuniculus	29-40
687592-2	1978	The composition and molecular weight of the Pronase glycopeptides revealed that rabbit transferrin contains two heteropolysaccharide units, each composed of 2 sialic acid residues, 2 galactose residues, 3 mannose residues, and 4-N-acetylglucosamine residues.	Glycopeptides	52-65	serotransferrin	Oryctolagus cuniculus	87-98
668707-6	1978	Treatment with neuraminidase or acetylation of amino groups destroyed the M and N blood-group activity and increased the activity towards Vicia graminea anti-N lectin of all glycopeptides studied.	Glycopeptides	174-187	neuraminidase 1	Homo sapiens	15-28
75805-3	1977	Glycopeptides, obtained by excessive pronase treatment of fetuin were partially capable of replacing the nonhydrolyzed fetuin.	Glycopeptides	0-13	alpha-2-HS-glycoprotein	Ovis aries	58-64
659387-0	1978	Glycopeptides isolated from ovine submaxillary mucin.	Glycopeptides	0-13	LOC100508689	Homo sapiens	47-52
620075-1	1978	The carbohydrate-binding specificity of two pokeweed (Phytolacca americana) mitogens (Pa-1 and Pa-2) was investigated by means of hemagglutination inhibition assays and the quantitative inhibition of the binding of 125I-labeled lectins to human erythrocytes using various oligosaccharides, glycopeptides and glycoproteins as hapten inhibitors.	Glycopeptides	290-303	PAXIP1 associated glutamate rich protein 1	Homo sapiens	86-99
75805-3	1977	Glycopeptides, obtained by excessive pronase treatment of fetuin were partially capable of replacing the nonhydrolyzed fetuin.	Glycopeptides	0-13	alpha-2-HS-glycoprotein	Ovis aries	119-125
852928-1	1977	A relatively easy synthetic method is reported for the production of the immunoadjuvant glycopeptide, N-acetyl-muramy-L-alanyl-D-isoglutamine (MDP).	Glycopeptides	88-100	dipeptidase 1	Homo sapiens	143-146
849453-3	1977	The glycopeptide fraction from alpha1-acid glycoprotein is complex (i.e., the carbohydrate moiety contains mannose, galactose, N-acetylglucosamine, and sailic acid), as is one of the glycopeptide fractions from thyroglobulin (type I).	Glycopeptides	4-16	thyroglobulin	Homo sapiens	211-224
986187-1	1976	Approximately 70% of fucose-labeled glycopeptides from the cell surface and cellular material of rat fibroblasts (3Y1B cells) were hydrolyzed by endo-beta-N-acetylglucosaminidase D in the presence of neuraminidase, beta-galactosidase and beta-N-acetylglucosaminidase.	Glycopeptides	36-49	galactosidase, beta 1	Rattus norvegicus	215-233
795426-2	1976	The relevant glycopeptides were isolated from tryptic hydrolysates of the glycosylated ribonuclease and analysed.	Glycopeptides	13-26	ribonuclease	Saccharomyces cerevisiae S288C	87-99
978772-5	1976	Based on analogy with other cell membranes, a schema is given for the structure of the membrane glycopeptides on the neuroblastoma cell.	Glycopeptides	96-109	Rho guanine nucleotide exchange factor (GEF) 16	Mus musculus	117-130
986187-2	1976	Structure of the susceptible glycopeptides were found to be very similar to non-membrane glycopeptides of the complex heteropolysaccharide unit, such as the sialylated glycopeptides of thyroglobulin.	Glycopeptides	29-42	thyroglobulin	Rattus norvegicus	185-198
986187-2	1976	Structure of the susceptible glycopeptides were found to be very similar to non-membrane glycopeptides of the complex heteropolysaccharide unit, such as the sialylated glycopeptides of thyroglobulin.	Glycopeptides	89-102	thyroglobulin	Rattus norvegicus	185-198
986187-2	1976	Structure of the susceptible glycopeptides were found to be very similar to non-membrane glycopeptides of the complex heteropolysaccharide unit, such as the sialylated glycopeptides of thyroglobulin.	Glycopeptides	89-102	thyroglobulin	Rattus norvegicus	185-198
821753-7	1976	Although alpha-lactalbumin can switch the specificity of A protein from N-acetyl-D-glucosamine to D-glucose resulting in the production of lactose, no transfer of galactose was observed to beta(1 leads to 4)-linked glycose oligomers or to a collagen glycopeptide, D-glycopyranosyl-alpha(1 leads to 2)-D-galactopyranosyloxy-beta(1 leads to 5)-lysine.	Glycopeptides	250-262	lactalbumin alpha	Homo sapiens	9-26
59739-12	1976	Studies of the binding of [3H] fetuin glycopeptide to normal lymphocytes demonstrate 7.5 x 10(6) saturable binding sites per cell.	Glycopeptides	38-50	alpha-2-HS-glycoprotein	Ovis aries	31-37
1170888-4	1975	Further study on the non-calcium-binding peptides from the tryptic digest of fragment 1 revealed the presence of two low molecular weight glycopeptides, GP-1 and GP-2.	Glycopeptides	138-151	glycoprotein 2	Bos taurus	153-166
1247569-8	1976	The glycoproteins E1 and E3 revealed glycopeptides of A-type.	Glycopeptides	37-50	small nucleolar RNA, H/ACA box 73A	Homo sapiens	18-26
389-0	1975	Structural studies of two ovalbumin glycopeptides in relation to the endo-beta-N-acetylglucosaminidase specificity.	Glycopeptides	36-49	O-GlcNAcase	Homo sapiens	74-102
819146-1	1975	Endo beta-N-acetylglucosaminidase activity was found in a alpha-L-fucosidase preparation purified from human liver homogenates, using glycopeptides from human parotid glycoprotein as a substrate.	Glycopeptides	134-147	O-GlcNAcase	Homo sapiens	5-33
1170888-17	1975	The glycopeptides, GP-1 and GP-2, were distinguished from each other by differences in their behavior on ion exchange chromatography and in their amino acid composition, and from CBF by their inability to bind calcium under any conditions.	Glycopeptides	4-17	glycoprotein 2	Bos taurus	19-32
1156360-9	1975	Cattle transferrin is exceptional in having two glycopeptides in which this position is occupied by serine.	Glycopeptides	48-61	serotransferrin	Bos taurus	7-18
5690539-8	1968	The amino acid sequences of the glycopeptides carrying these different oligosaccharides are the same in ovotransferrin and serum transferrin, showing that the carbohydrate groups are attached to the same site on the protein molecule.	Glycopeptides	32-45	transferrin	Homo sapiens	107-118
5101853-0	1971	Glycopeptides isolated from bovine submaxillary mucin.	Glycopeptides	0-13	mucin 1, cell surface associated	Bos taurus	48-53
5357018-7	1969	In ovalbumin glycopeptides with approximate mannose/hexosamine ratios 5:3 and 5:4, one and two N-acetylglucosamine residues respectively were accessible to the action of beta-N-acetylglucosaminidase.	Glycopeptides	13-26	O-GlcNAcase	Homo sapiens	170-198
5357018-9	1969	A mixture of alpha-mannosidase and beta-N-acetylglucosaminidase, acting on an ovalbumin glycopeptide with mannose/hexosamine ratio 5:3.7, removed nearly 4moles of mannose and 1.5moles of N-acetylglucosamine.	Glycopeptides	88-100	O-GlcNAcase	Homo sapiens	35-63
33848722-1	2021	A focused library of water soluble 1,2,3-triazole tethered glycopeptide conjugates derived from variety of azido-monosaccharides and aliphatic azido-alcohols were synthesized through manipulation at the C-terminus of Pam3CAG and screened for their potential as TLR2 agonistic adjuvants against HBsAg antigen.	Glycopeptides	59-71	toll like receptor 2	Homo sapiens	261-265
5637058-2	1968	Preparation and properties of glycopeptides isolated from an enzymatic hydrolyzate of alpha-2-M].	Glycopeptides	30-43	alpha-2-macroglobulin	Homo sapiens	86-95
33979146-4	2021	Our studies demonstrated the possibility of using synthetic glycopeptides as the adiponectin downsized mimetic for the development of novel therapeutics to treat diseases associated with deficient adiponectin.	Glycopeptides	60-73	adiponectin, C1Q and collagen domain containing	Mus musculus	81-92
33979146-4	2021	Our studies demonstrated the possibility of using synthetic glycopeptides as the adiponectin downsized mimetic for the development of novel therapeutics to treat diseases associated with deficient adiponectin.	Glycopeptides	60-73	adiponectin, C1Q and collagen domain containing	Mus musculus	197-208
33676668-5	2021	Thirty-two glycopeptides from human serum immunoglobulin G (IgG) tryptic digests were observed with a greatly improved signal-to-noise ratio (S/N) and also presented high performance in anti-interfering enrichment of glycopeptides from complex samples containing 100-fold bovine serum albumin tryptic digests.	Glycopeptides	11-24	albumin	Homo sapiens	279-292
33676668-5	2021	Thirty-two glycopeptides from human serum immunoglobulin G (IgG) tryptic digests were observed with a greatly improved signal-to-noise ratio (S/N) and also presented high performance in anti-interfering enrichment of glycopeptides from complex samples containing 100-fold bovine serum albumin tryptic digests.	Glycopeptides	217-230	albumin	Homo sapiens	279-292
33929864-6	2021	When combining results of these 2 glycopeptides with AFP, the ROC curve analysis demonstrated the AUC value increased to 0.834 (95% CI, 0.748-0.921) and 0.847 (95% CI, 0.766-0.932), respectively, as compared to that of AFP alone (AUC = 0.791, 95% CI, 0.690-0.892).	Glycopeptides	34-47	alpha fetoprotein	Homo sapiens	219-222
33645601-2	2021	One potential drawback in using the native MUC1 glycopeptide for vaccine design is the instability of the O-glycosyl linkage between the glycan and the peptide backbone to glycosidase.	Glycopeptides	48-60	mucin 1, cell surface associated	Homo sapiens	43-47
33899899-5	2021	Furthermore, an unnatural sugar, i.e., 6-azidoglucose can be transferred by XT-I introducing a reactive handle onto the glycopeptide for selective functionalization.	Glycopeptides	120-132	xylosyltransferase 1	Homo sapiens	76-80
33899899-6	2021	XT-I can be coupled with beta-4-galactosyl transferase-7 for one pot synthesis of glycopeptides bearing galactose-xylose disaccharide, paving the way toward efficient chemoenzymatic synthesis of PG glycopeptides and glycoproteins.	Glycopeptides	82-95	xylosyltransferase 1	Homo sapiens	0-4
33787236-11	2021	The method was employed to characterize sialylated glycopeptides derived from bovine fetuin, human alpha-1 acid glycoprotein (AGP), and human erythropoietin (EPO).	Glycopeptides	51-64	erythropoietin	Homo sapiens	142-156
33787236-11	2021	The method was employed to characterize sialylated glycopeptides derived from bovine fetuin, human alpha-1 acid glycoprotein (AGP), and human erythropoietin (EPO).	Glycopeptides	51-64	erythropoietin	Homo sapiens	158-161
33889548-8	2021	Among them, glycopeptides from APOH, HPT/HPTR, and PON1 were significantly changed in AFP-negative HCC as compared to LC.	Glycopeptides	12-25	apolipoprotein H	Homo sapiens	31-35
33889548-8	2021	Among them, glycopeptides from APOH, HPT/HPTR, and PON1 were significantly changed in AFP-negative HCC as compared to LC.	Glycopeptides	12-25	alpha fetoprotein	Homo sapiens	86-89
33889548-10	2021	The two glycopeptides HAN253WTLTPLK (H5N4S2) and (H5N4S1) corresponding to PON1 were significantly increased in AFP-negative HCC patients, as compared with LC patients.	Glycopeptides	8-21	paraoxonase 1	Homo sapiens	75-79
33889548-10	2021	The two glycopeptides HAN253WTLTPLK (H5N4S2) and (H5N4S1) corresponding to PON1 were significantly increased in AFP-negative HCC patients, as compared with LC patients.	Glycopeptides	8-21	alpha fetoprotein	Homo sapiens	112-115
33316563-9	2021	Finally, the MOF packed in pipette tip was applied to selectively capture the N-linked endogenous glycopeptides from a healthy saliva sample and 64 unique endogenous glycopeptides were identified.	Glycopeptides	98-111	lysine acetyltransferase 8	Homo sapiens	13-16
33576634-3	2021	The xylosylated glycopeptides were synthesized via solid phase synthesis, which was followed by the addition of the galactose unit by the galactosyl transferase beta4GalT7.	Glycopeptides	16-29	beta-1,4-galactosyltransferase 7	Homo sapiens	161-171
33167210-0	2021	High-throughput glycopeptide profiling of prostate-specific antigen from seminal plasma by MALDI-MS. An altered total seminal plasma glycosylation has been associated with male infertility, and the highly abundant seminal plasma glycoprotein prostate-specific antigen (PSA) plays an important role in fertilization.	Glycopeptides	16-28	kallikrein related peptidase 3	Homo sapiens	42-67
33167210-3	2021	In this study, we developed a novel, high-throughput PSA glycopeptide workflow, based on matrix-assisted laser desorption/ionization-mass spectrometry, allowing the discrimination of sialic acid linkage isomers via the derivatization of glycopeptides.	Glycopeptides	237-250	kallikrein related peptidase 3	Homo sapiens	53-56
33167210-8	2021	Next to seminal plasma, the method is also expected to be of use for studying PSA glycopeptides derived from other biofluids and/or in other disease contexts.	Glycopeptides	82-95	kallikrein related peptidase 3	Homo sapiens	78-81
33469292-5	2021	Methods: An antitumor vaccine was developed, in which MUC1 glycopeptide was used as tumor-associated antigen, alpha-GalCer served as an immune adjuvant and AuNPs was a multivalent carrier.	Glycopeptides	59-71	mucin 1, cell surface associated	Homo sapiens	54-58
33560106-0	2021	Calorimetric Analysis of the Interplay between Synthetic Tn Antigen-Presenting MUC1 Glycopeptides and Human Macrophage Galactose-Type Lectin.	Glycopeptides	84-97	mucin 1, cell surface associated	Homo sapiens	79-83
33560106-4	2021	Isothermal titration calorimetry (ITC) analysis of the binding of hMGL to this library of MUC1 glycopeptides revealed an enthalpy-driven process and an affinity enhancement of an order of magnitude with an increasing glycan count from 6-8 muM for monoglycosylated peptides to 0.6 muM for triglycosylated peptide.	Glycopeptides	95-108	C-type lectin domain containing 10A	Homo sapiens	66-70
33560106-4	2021	Isothermal titration calorimetry (ITC) analysis of the binding of hMGL to this library of MUC1 glycopeptides revealed an enthalpy-driven process and an affinity enhancement of an order of magnitude with an increasing glycan count from 6-8 muM for monoglycosylated peptides to 0.6 muM for triglycosylated peptide.	Glycopeptides	95-108	mucin 1, cell surface associated	Homo sapiens	90-94
33406838-7	2021	Our recently developed liquid chromatography-mass spectrometry methodology allowed us to identify LacdiNAc structural motifs on all occupied N-glycopeptides and polyLacNAc structures on six glycopeptides of the spike protein.	Glycopeptides	143-156	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	211-216
33316563-9	2021	Finally, the MOF packed in pipette tip was applied to selectively capture the N-linked endogenous glycopeptides from a healthy saliva sample and 64 unique endogenous glycopeptides were identified.	Glycopeptides	166-179	lysine acetyltransferase 8	Homo sapiens	13-16
33613735-3	2021	Glycopeptide-modified nanodisks (Gly-A7R-NDs), which demonstrated high capacity of brain targeting via GLUT-mediated transcytosis in our previous reports, were utilized to better understand the whole transcytosis process.	Glycopeptides	0-12	solute carrier family 2 member 1	Homo sapiens	103-107
32885544-4	2021	Although the initial yields of the EPO 1-28 glycopeptides were satisfactory, they could be markedly improved by increasing the purity of the peptide using a reversed-phase high-performance liquid chromatography (RP-HPLC) purification of the protected peptide.	Glycopeptides	44-57	erythropoietin	Homo sapiens	35-38
33001366-0	2020	TF-containing MUC1 glycopeptides fail to entice Galectin-1 recognition of tumor-associated Thomsen-Freidenreich (TF) antigen (CD176) in solution.	Glycopeptides	19-32	coagulation factor III, tissue factor	Homo sapiens	0-2
32239131-8	2020	Significant predictors for ARO colonization on NF admission included lower functional status (adjusted odds ratio [aOR]>1 for all four AROs) and recent exposure to glycopeptides (aOR>2 for VREfm, VREfc and MRSA) or 3rd/4th-generation cephalosporins (aOR>2 for MRSA and VREfm).	Glycopeptides	164-177	cytochrome P450 family 19 subfamily A member 1	Homo sapiens	27-30
32363391-7	2020	Our data on the N- and O-glycosylation are strengthened by extensive manual interpretation of each glycopeptide spectra in addition to using bioinformatics tools to confirm the complexity of glycosylation in the spike protein.	Glycopeptides	99-111	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	212-217
33010570-1	2020	The synthesis of MUC1 glycopeptides bearing modified tumor-associated carbohydrate antigens (TACAs) represents an effective strategy to develop potential antitumor vaccines that trigger strong immune response.	Glycopeptides	22-35	mucin 1, cell surface associated	Homo sapiens	17-21
33001366-0	2020	TF-containing MUC1 glycopeptides fail to entice Galectin-1 recognition of tumor-associated Thomsen-Freidenreich (TF) antigen (CD176) in solution.	Glycopeptides	19-32	mucin 1, cell surface associated	Homo sapiens	14-18
32615213-0	2020	The reorganization of conformations, stability and aggregation of serum albumin isomers through the interaction of glycopeptide antibiotic teicoplanin: A thermodynamic and spectroscopy study.	Glycopeptides	115-127	albumin	Homo sapiens	66-79
32615213-2	2020	In this work, we study the binding of teicoplanin (TPN), a glycopeptide antibiotic, with bovine serum albumin (BSA) in its neutral (N), physiological (P) and basic (B) forms, which exist at pH 6, pH 7.4 and pH 9, respectively.	Glycopeptides	59-71	albumin	Homo sapiens	96-109
33182731-5	2020	Further, utilizing enhanced intact glycopeptide identification afforded by the NGAG workflow, we found that the sugar analog 1,3,4-O-Bu3ManNAc, a "high flux" metabolic precursor for sialic acid biosynthesis, increased sialylation of secreted proteins including recombinant human erythropoietin (rhEPO).	Glycopeptides	35-47	erythropoietin	Homo sapiens	279-293
33073321-4	2020	Benefitting from the merits of Zr-MOF and glucose-6-phosphate, the as-designed composite exhibits good selectivity (the mass ratio of HRP digests to BSA digests was up to1:200) and low limit of detection (0.1 fmol muL-1) towards the recognition of glycopeptides from standard samples.	Glycopeptides	248-261	mitochondrial E3 ubiquitin protein ligase 1	Homo sapiens	214-219
32786366-5	2020	Moreover, we found that the helicity of glycopeptides can affect its antitumor activity and proteolytic stability, and the alpha-linked D-monosaccharides can effectively improve the anti-tumor activity of HYL.	Glycopeptides	40-53	megakaryocyte-associated tyrosine kinase	Homo sapiens	205-208
33073321-6	2020	Further gene ontology analysis of molecular function and biological process revealed that 13 original glycoproteins of the identified glycopeptides from urine of patients significantly participate in diverse cancer-associated events, including collagen binding, immunoglobulin receptor binding, antigen binding, and complement activation process.	Glycopeptides	134-147	megakaryocyte and platelet inhibitory receptor G6b	Homo sapiens	262-285
32752208-1	2020	Background: Sialidosis is a rare autosomal recessive disease caused by NEU1 mutations, leading to neuraminidase deficiency and accumulation of sialic acid-containing oligosaccharides and glycopeptides into the tissues.	Glycopeptides	187-200	neuraminidase 1	Homo sapiens	71-75
32610041-5	2020	We demonstrate the efficient utilization of such microscale glycopeptide libraries to determine the specificity of glycan-recognizing antibodies (e.g., CTD110.6) using microarrays, enzyme specificity on-array and in-solution (e.g., ST6GalNAc1, GCNT1, and T-synthase), and binding kinetics using fluorescence polarization.	Glycopeptides	60-72	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1	Homo sapiens	232-242
32610041-5	2020	We demonstrate the efficient utilization of such microscale glycopeptide libraries to determine the specificity of glycan-recognizing antibodies (e.g., CTD110.6) using microarrays, enzyme specificity on-array and in-solution (e.g., ST6GalNAc1, GCNT1, and T-synthase), and binding kinetics using fluorescence polarization.	Glycopeptides	60-72	glucosaminyl (N-acetyl) transferase 1	Homo sapiens	244-249
32610041-5	2020	We demonstrate the efficient utilization of such microscale glycopeptide libraries to determine the specificity of glycan-recognizing antibodies (e.g., CTD110.6) using microarrays, enzyme specificity on-array and in-solution (e.g., ST6GalNAc1, GCNT1, and T-synthase), and binding kinetics using fluorescence polarization.	Glycopeptides	60-72	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1	Homo sapiens	255-265
32669364-0	2020	Differential splicing of the lectin domain of an O-glycosyltransferase modulates both peptide and glycopeptide preferences.	Glycopeptides	98-110	super sex combs	Drosophila melanogaster	49-70
32786443-10	2020	To the best of our knowledge, this is the first report of the AQUA of N-glycosylated AFP in human sera using a stable isotope-labeled glycopeptide as an internal standard.	Glycopeptides	134-146	alpha fetoprotein	Homo sapiens	85-88
33026882-5	2020	Through systematic analysis, we found that herbal extracts combined with antibiotics, such as beta-lactams, quinolones, aminoglycosides, tetracyclines and glycopeptides, could greatly enhance the antibacterial effects of the antibiotics, reduce the dosage and toxic side effects, and reverse MRSA resistance.	Glycopeptides	155-168	solute carrier family 9 member A6	Homo sapiens	292-296
32672464-3	2020	In the present study, we focused on the MUC1 associated Tn antigen (alpha-O-GalNAc-Ser/Thr), and substituted the GalNAc monosaccharide by a glycomimic to identify MUC1 based glycopeptides with increased antigenicity.	Glycopeptides	174-187	mucin 1, cell surface associated	Homo sapiens	163-167
32672464-6	2020	The suitability of the sp2-iminosugar glycopeptides to detect anti-MUC1 antibodies was demonstrated and serological experiments showed stage I breast cancer autoantibodies binding with a specific unnatural glycopeptide with almost no healthy serum interaction.	Glycopeptides	38-51	mucin 1, cell surface associated	Homo sapiens	67-71
32672464-6	2020	The suitability of the sp2-iminosugar glycopeptides to detect anti-MUC1 antibodies was demonstrated and serological experiments showed stage I breast cancer autoantibodies binding with a specific unnatural glycopeptide with almost no healthy serum interaction.	Glycopeptides	38-50	mucin 1, cell surface associated	Homo sapiens	67-71
32617538-6	2020	Hydrophilic glycopeptides could be selectively enriched with an extremely low limit of detection (0.33 fmol per muL) and a high selectivity (1 : 100).	Glycopeptides	12-25	tripartite motif containing 37	Homo sapiens	112-115
32617538-7	2020	From 2 muL of human serum, 328 unique glycopeptides from 101 glycoproteins were identified.	Glycopeptides	38-51	tripartite motif containing 37	Homo sapiens	7-10
32883391-0	2020	Production of sialic acid rich glycopeptide from bovine kappa-casein glycomacropeptide by hydrolyzing with papain.	Glycopeptides	31-43	casein kappa	Bos taurus	56-68
32485649-2	2020	In this short communication, we studied the effect of an organic modifier in the sample solvent on the solubility of different tryptic glycopeptides of hemopexin and haptoglobin proteins.	Glycopeptides	135-148	hemopexin	Homo sapiens	152-161
32775865-0	2020	Human Serum Albumin-Inspired Glycopeptide-Based Multifunctional Inhibitor of Amyloid-beta Toxicity.	Glycopeptides	29-41	albumin	Homo sapiens	12-19
32728216-6	2020	These initial lysosome-targeting chimaeras, which we term LYTACs, consist of a small molecule or antibody fused to chemically synthesized glycopeptide ligands that are agonists of the cation-independent mannose-6-phosphate receptor (CI-M6PR).	Glycopeptides	138-150	insulin like growth factor 2 receptor	Homo sapiens	184-231
32340989-0	2020	Impact of vanA-positive Enterococcus faecium exhibiting diverse susceptibility phenotypes to glycopeptides on 30-day mortality of patients with a bloodstream infection.	Glycopeptides	93-106	Vancomycin Teicoplanin A-type resistance protein VanA / D-alanine--D-alanine ligase	Enterococcus faecium	10-14
32388223-2	2020	This compound is a semisynthetic glycopeptide antibiotic thought to be a mixture of five major compounds (named A2-1 through A2-5) and four minor ones (RS-1 to RS-4), all sharing the same glycopeptide core structure (dubbed A3-1) and differing only on the length of a hydrocarbon side chain.	Glycopeptides	33-45	retinoschisin 1	Homo sapiens	152-164
32340989-1	2020	Introduction: This study was performed to evaluate the impacts of vanA-positivity of Enterococcus faecium (EFM) exhibiting diverse susceptibility phenotypes to glycopeptides on clinical outcomes in patients with a bloodstream infection (BSI) through a prospective, multicenter, observational study.Methods: A total of 509 patients with an EFM BSI from eight sentinel hospitals in South Korea during a two-year period were enrolled in this study.	Glycopeptides	160-173	Vancomycin Teicoplanin A-type resistance protein VanA / D-alanine--D-alanine ligase	Enterococcus faecium	66-70
32220931-4	2020	Here, we describe several structures of mouse and human FUT8 in the apo state and in complex with guanosine diphosphate (GDP), a mimic of the donor substrate, and with a glycopeptide acceptor substrate at 1.80-2.50 A resolutions.	Glycopeptides	170-182	fucosyltransferase 8	Homo sapiens	56-60
32439962-4	2020	The glycopeptide specific CD4+ T cells display a prominent feature of Th2 and Th17 differentiation and exert high efficacy and potency to help Env trimer humoral immune responses.	Glycopeptides	4-16	CD4 molecule	Homo sapiens	26-29
32439962-4	2020	The glycopeptide specific CD4+ T cells display a prominent feature of Th2 and Th17 differentiation and exert high efficacy and potency to help Env trimer humoral immune responses.	Glycopeptides	4-16	endogenous retrovirus group K member 20	Homo sapiens	143-146
32439962-5	2020	Glycopeptide-induced CD4+ T cell response prior to Env trimer immunization elicits neutralizing antibody development and production of antibodies facilitating uptake of immunogens by antigen-presenting cells.	Glycopeptides	0-12	CD4 molecule	Homo sapiens	21-24
32439962-6	2020	Our identification of gp120 glycopeptide-induced, T cell-specific immune responses offers a foundation for developing future knowledge-based vaccines that elicit strong and long-lasting protective immune responses against HIV-1 infection.	Glycopeptides	28-40	inter-alpha-trypsin inhibitor heavy chain 4	Homo sapiens	22-27
32203567-8	2020	In order to discover which fucosylated glycan epitopes are involved in the observed effect, we performed in-depth characterization of multiply-fucosylated N-glycans via tandem mass spectrometry analysis of the EGFR tryptic glycopeptides.	Glycopeptides	223-236	epidermal growth factor receptor	Homo sapiens	210-214
32212632-6	2020	Then, combined with the quantitative analysis strategy of site-specific N-glycan heterogeneity based on the diagnostic MS2 ion (peptides+GlcNAc, Y1 ions) of glycopeptides, an integrated approach for the quantitation of site-specific N-glycan heterogeneities among charge isomers was established.	Glycopeptides	157-170	MS2	Homo sapiens	119-122
32370047-0	2020	Preparation and Evaluation of New Glycopeptides Obtained by Proteolysis from Corn Gluten Meal Followed by Transglutaminase-Induced Glycosylation with Glucosamine.	Glycopeptides	34-47	transglutaminase 1	Homo sapiens	106-122
32370047-1	2020	New glycopeptides were generated by proteolysis from corn gluten meal (CGM) followed by transglutaminase (TGase)-induced glycosylation with glucosamine (GlcN).	Glycopeptides	4-17	transglutaminase 1	Homo sapiens	88-104
32370047-1	2020	New glycopeptides were generated by proteolysis from corn gluten meal (CGM) followed by transglutaminase (TGase)-induced glycosylation with glucosamine (GlcN).	Glycopeptides	4-17	transglutaminase 1	Homo sapiens	106-111
32326261-8	2020	We describe the various types of glycopeptide hypersensitivity reactions associated with glycopeptides and lipoglycopeptides, including IgE-mediated reactions, RMS, and linear immunoglobulin A bullous dermatosis, as well as describe cross-reactivity with other glycopeptides.	Glycopeptides	33-45	immunoglobulin heavy constant epsilon	Homo sapiens	136-139
32109354-2	2020	In our previous efforts, vaccinating rabbits with evolved HMP mimic glycopeptides containing Man9 resulted in an overall antibody response targeting the glycan core and linker rather than the full glycan or Manalpha1 2Man tips of Man9 glycans.	Glycopeptides	68-81	mannosidase alpha class 1A member 1	Homo sapiens	93-97
32109354-2	2020	In our previous efforts, vaccinating rabbits with evolved HMP mimic glycopeptides containing Man9 resulted in an overall antibody response targeting the glycan core and linker rather than the full glycan or Manalpha1 2Man tips of Man9 glycans.	Glycopeptides	68-81	mannosidase alpha class 2C member 1	Homo sapiens	207-216
32109354-2	2020	In our previous efforts, vaccinating rabbits with evolved HMP mimic glycopeptides containing Man9 resulted in an overall antibody response targeting the glycan core and linker rather than the full glycan or Manalpha1 2Man tips of Man9 glycans.	Glycopeptides	68-81	mannosidase alpha class 1A member 1	Homo sapiens	230-234
32091889-9	2020	These glycopeptides were attributable to eleven different peptide backbones, derived from IgG1, IgG2/3, IgG4, IgA1, IgA2 and the joining chain from dimeric IgA.	Glycopeptides	6-19	immunoglobulin heavy constant gamma 3 (G3m marker)	Homo sapiens	96-102
32091889-9	2020	These glycopeptides were attributable to eleven different peptide backbones, derived from IgG1, IgG2/3, IgG4, IgA1, IgA2 and the joining chain from dimeric IgA.	Glycopeptides	6-19	immunoglobulin heavy constant alpha 1	Homo sapiens	110-114
31729101-8	2020	Molecular dynamics simulations of the MUC1 glycopeptide and peptide revealed distinguishing differences in their conformational preferences.	Glycopeptides	43-55	mucin 1, cell surface associated	Homo sapiens	38-42
31545160-1	2020	Aims: Heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) could be misinterpreted as "susceptible" with routine susceptibility testing procedures, and the subpopulations with reduced susceptibility to glycopeptides can lead to therapeutic failure.	Glycopeptides	217-230	mitochondrial antiviral signaling protein	Homo sapiens	67-72
31932717-2	2020	We explored the molecular mechanism for GalNAc-T3 glycosylation of FGF23 using engineered cell models and biophysical studies including kinetics, molecular dynamics and X-ray crystallography of GalNAc-T3 complexed to glycopeptide substrates.	Glycopeptides	217-229	polypeptide N-acetylgalactosaminyltransferase 3	Homo sapiens	40-49
31932717-2	2020	We explored the molecular mechanism for GalNAc-T3 glycosylation of FGF23 using engineered cell models and biophysical studies including kinetics, molecular dynamics and X-ray crystallography of GalNAc-T3 complexed to glycopeptide substrates.	Glycopeptides	217-229	fibroblast growth factor 23	Homo sapiens	67-72
31932717-2	2020	We explored the molecular mechanism for GalNAc-T3 glycosylation of FGF23 using engineered cell models and biophysical studies including kinetics, molecular dynamics and X-ray crystallography of GalNAc-T3 complexed to glycopeptide substrates.	Glycopeptides	217-229	polypeptide N-acetylgalactosaminyltransferase 3	Homo sapiens	194-203
31841011-7	2020	Thus, the insertion of alpha-GalCer significantly improved the immunogenicity of the MUC1 glycopeptide and induced strong antigen-specific antitumor responses, indicating that alpha-GalCer is an effective built-in adjuvant for constructing potent chemical synthetic antitumor vaccines.	Glycopeptides	90-102	mucin 1, transmembrane	Mus musculus	85-89
31103168-8	2019	Compared with the identification scheme using only MS2 spectra of intact glycopeptides or glycosites, this approach enabled quantitative analysis on two levels, i.e. glycosites and site-specific glycoforms, simultaneously.	Glycopeptides	73-86	minisatellites detected by probe MMS2	Mus musculus	51-54
31498587-5	2019	The conjugates of MUC1-Tf and -STn glycopeptides with Qbeta were utilized to immunize immune-tolerant human MUC1 transgenic (MUC1.Tg) mice, which elicited superior levels of anti-MUC1 IgG antibodies with titers reaching over 2 million units.	Glycopeptides	35-48	mucin 1, cell surface associated	Homo sapiens	108-112
31498587-5	2019	The conjugates of MUC1-Tf and -STn glycopeptides with Qbeta were utilized to immunize immune-tolerant human MUC1 transgenic (MUC1.Tg) mice, which elicited superior levels of anti-MUC1 IgG antibodies with titers reaching over 2 million units.	Glycopeptides	35-48	mucin 1, cell surface associated	Homo sapiens	108-112
31498587-5	2019	The conjugates of MUC1-Tf and -STn glycopeptides with Qbeta were utilized to immunize immune-tolerant human MUC1 transgenic (MUC1.Tg) mice, which elicited superior levels of anti-MUC1 IgG antibodies with titers reaching over 2 million units.	Glycopeptides	35-48	mucin 1, transmembrane	Mus musculus	108-112
31498587-6	2019	The IgG antibodies recognized a wide range of MUC1 glycopeptides bearing diverse glycans.	Glycopeptides	51-64	mucin 1, transmembrane	Mus musculus	46-50
31569686-5	2019	Here, serum levels of serotransferrin glycoforms at the glycopeptide level were measured in the sera of CCA (n = 100), PDF (n = 50), and healthy control (n = 100) subjects.	Glycopeptides	56-68	transferrin	Homo sapiens	22-37
31076819-9	2019	Finally, we confirmed that the area under the receiver operating characteristic curve (AUC = 0.944) for the combination of AFP and VTN increased more so than for a single glycopeptide (AUC = 0.889 for AFP and 0.792 for VTN) with respect to discriminating between HCC and cirrhosis serum.	Glycopeptides	171-183	vitronectin	Homo sapiens	131-134
31215694-0	2019	Glycopeptides by Linch-Pin C-H Activations for Peptide-Carbohydrate Conjugation by Manganese(I)-Catalysis.	Glycopeptides	0-13	dynein light chain LC8-type 1	Homo sapiens	23-26
31642255-5	2019	The retention of glycopeptides on Poly-Trp was investigated revealing that the retention ability decreased as the acetonitrile content of the mobile phase decreased and its acidity increased.	Glycopeptides	17-30	transient receptor potential cation channel subfamily C member 5	Bos taurus	39-42
31642255-6	2019	Poly-Trp exhibited higher enrichment selectivity for glycopeptides from bovine fetuin than the commercial material ZIC-HILIC, and aminated silica which could defect the interference of 100-fold amount of substance ratios of bovine serum albumin.	Glycopeptides	53-66	transient receptor potential cation channel subfamily C member 5	Bos taurus	5-8
31203640-1	2019	Progranulin is a recently recognized multifunctional glycopeptide shown to be related to obesity and diabetes mellitus.	Glycopeptides	53-65	granulin precursor	Homo sapiens	0-11
31588183-3	2019	Utilizing an anti-tumor vaccine based on a synthetically prepared glycopeptide, we generated a monoclonal antibody (mAb) GGSK-1/30, selectively recognizing human tumor-associated MUC1.	Glycopeptides	66-78	mucin 1, cell surface associated	Homo sapiens	179-183
31247730-0	2019	Glycopeptide Nanofiber Platform for Abeta-Sialic Acid Interaction Analysis and Highly Sensitive Detection of Abeta.	Glycopeptides	0-12	amyloid beta precursor protein	Homo sapiens	36-41
31247730-0	2019	Glycopeptide Nanofiber Platform for Abeta-Sialic Acid Interaction Analysis and Highly Sensitive Detection of Abeta.	Glycopeptides	0-12	amyloid beta precursor protein	Homo sapiens	109-114
31079966-0	2019	Synthetic glycopeptides reveal specific binding pattern and conformational change at O-mannosylated position of alpha-dystroglycan by POMGnT1 catalyzed GlcNAc modification.	Glycopeptides	10-23	protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)	Homo sapiens	134-141
30952968-1	2019	We have previously studied the generation of immune responses after vaccination with tumor-associated carbohydrate antigen (TACA)-containing glycopeptides from the tandem repeat (TR) sequence of MUC4, an aberrantly expressed mucin in pancreatic adenocarcinomas.	Glycopeptides	141-154	mucin-4	Oryctolagus cuniculus	195-199
30795648-5	2019	We demonstrate that SP2 can be applied to phosphopeptides and glycopeptides and that the approach is compatible with robotic liquid handling for automated sample processing.	Glycopeptides	62-75	Sp2 transcription factor	Homo sapiens	20-23
30952968-4	2019	Glycan microarray analysis showed an intriguing binding pattern where the antiserum showed near complete specificity for MUC4 TR glycopeptides and peptides, relative to all components on the array.	Glycopeptides	129-142	mucin-4	Oryctolagus cuniculus	121-125
30032777-5	2018	The enrichment efficiency of MAR@MOP to glycopeptides was demonstrated by trapping N-linked glycopeptides from tryptic digests of human immunoglobulin G (IgG), horseradish peroxidase (HRP) and bovine fetuin.	Glycopeptides	40-53	interferon regulatory factor 1	Homo sapiens	29-36
30827091-5	2019	This hydrophilic probe presents an extremely high performance in anti-interfering enrichment of glycopeptides from mimic complex samples, even when the molar ratio of immunoglobulin G versus bovine serum albumin was up to about 1:5000.	Glycopeptides	96-109	albumin	Homo sapiens	198-211
30504228-5	2019	As the MGLshort H259T variant could still bind a single GalNAc monosaccharide on this array, we next investigated its binding characteristics to Tn-containing glycopeptides derived from the MGL ligands mucin 1 (MUC1), MUC2, and CD45.	Glycopeptides	159-172	C-type lectin domain containing 10A	Homo sapiens	7-10
30504228-5	2019	As the MGLshort H259T variant could still bind a single GalNAc monosaccharide on this array, we next investigated its binding characteristics to Tn-containing glycopeptides derived from the MGL ligands mucin 1 (MUC1), MUC2, and CD45.	Glycopeptides	159-172	mucin 1, cell surface associated	Homo sapiens	202-209
31364056-2	2019	As the MHC processing pathways communicate cellular health to circulating CD8+ and CD4+ T-cells, MHC-associated glycopeptides are likely a source of neoantigens in cancer.	Glycopeptides	112-125	CD8a molecule	Homo sapiens	74-77
31364056-2	2019	As the MHC processing pathways communicate cellular health to circulating CD8+ and CD4+ T-cells, MHC-associated glycopeptides are likely a source of neoantigens in cancer.	Glycopeptides	112-125	CD4 molecule	Homo sapiens	83-86
30384610-3	2018	Here we report the chemoenzymatic synthesis, antigenicity, and immunogenicity of the V3 N334 glycopeptides from HIV-1 A244 gp120, a key component in the partially successful Thai clinical trials.	Glycopeptides	93-106	Envelope surface glycoprotein gp160, precursor	Human immunodeficiency virus 1	123-128
30794378-8	2019	In addition, GO-PEI-Carr exhibited a unique repeatability and stability even after enrichment of glycopeptides for 20 times.	Glycopeptides	97-110	arrestin 3, retinal	Mus musculus	20-24
30693278-4	2018	In this study, a set of glycopeptides with modifications on the GlcNAc residue, were prepared in a recombinant full-length human OGT-catalyzed reaction, using chemoenzymatically synthesized UDP-GlcNAc derivatives.	Glycopeptides	24-37	O-linked N-acetylglucosamine (GlcNAc) transferase	Homo sapiens	129-132
30344001-1	2018	We have employed genetically-encoded fragment-based discovery to identify novel glycopeptides with affinity for the dendritic cell receptor DC-SIGN.	Glycopeptides	80-93	CD209 molecule	Homo sapiens	140-147
30261726-7	2018	Moreover, without immunoprecipitation, this multilectin nanoprobe allows the sensitive identification of 51 glycopeptides from 10 of 12 reported sites from onco-protein EGFR.	Glycopeptides	108-121	epidermal growth factor receptor	Homo sapiens	169-173
30344001-2	2018	Starting from libraries of 108 mannose-conjugated peptides, we identified glycopeptides that exhibited up to a 650-fold increase in multivalent binding affinity for DC-SIGN, which is also preserved in cells.	Glycopeptides	74-87	CD209 molecule	Homo sapiens	165-172
30344001-5	2018	The natural framework of glycopeptide conjugates and the simplicity of orthogonal conjugation to make these glycopeptides anticipates a promising future for development of DC-SIGN-targeting moieties.	Glycopeptides	108-121	CD209 molecule	Homo sapiens	172-179
30001488-3	2018	Having a general architecture of N-terminal capping, glycosylation, and an integrin-binding sequence, the glycopeptides self-assemble to form a dynamic continuum of nanostructures (i.e., from nanoparticles to nanofibers) to affect the interactions of integrins, E-selectin, and cadherins with their natural ligands and to act adaptively according to the cellular environment.	Glycopeptides	106-119	selectin E	Homo sapiens	262-272
30115684-5	2018	Selective labeling of gp120 by N-azidoacetylmannosamine (ManNAz) and N-azidoacetylgalactosamine (GalNAz) incorporation into the gp120 glycan shield was characterized by MS of tryptic glycopeptides.	Glycopeptides	183-196	inter-alpha-trypsin inhibitor heavy chain 4	Homo sapiens	22-27
30115684-5	2018	Selective labeling of gp120 by N-azidoacetylmannosamine (ManNAz) and N-azidoacetylgalactosamine (GalNAz) incorporation into the gp120 glycan shield was characterized by MS of tryptic glycopeptides.	Glycopeptides	183-196	inter-alpha-trypsin inhibitor heavy chain 4	Homo sapiens	128-133
29885416-7	2018	Compared to non-glycosylated nanodisk, glycopeptide modification could significantly enhance the uptake of disks by brain capillary endothelial cells through glucose transporter 1 (GLUT1).	Glycopeptides	39-51	solute carrier family 2 member 1	Homo sapiens	158-179
29885416-7	2018	Compared to non-glycosylated nanodisk, glycopeptide modification could significantly enhance the uptake of disks by brain capillary endothelial cells through glucose transporter 1 (GLUT1).	Glycopeptides	39-51	solute carrier family 2 member 1	Homo sapiens	181-186
29784830-7	2018	We demonstrate that 14-3-3 proteins bind O-GlcNAc moieties in human cells, and we present the structures of 14-3-3beta/alpha and gamma bound to glycopeptides, providing biophysical insights into O-GlcNAc-mediated protein-protein interactions.	Glycopeptides	144-157	O-linked N-acetylglucosamine (GlcNAc) transferase	Homo sapiens	195-203
29972295-8	2018	In contrast, the alpha-2-6 sialylated glycoform of the O-glycopeptide of SHBG increases in liver cirrhosis, and a significant 2-fold further increase is observed in HCC.	Glycopeptides	57-69	immunoglobulin binding protein 1	Homo sapiens	17-26
29972295-8	2018	In contrast, the alpha-2-6 sialylated glycoform of the O-glycopeptide of SHBG increases in liver cirrhosis, and a significant 2-fold further increase is observed in HCC.	Glycopeptides	57-69	sex hormone binding globulin	Homo sapiens	73-77
29751197-0	2018	Investigating Cytochrome P450 specificity during glycopeptide antibiotic biosynthesis through a homologue hybridization approach.	Glycopeptides	49-61	cytochrome P450 family 4 subfamily F member 3	Homo sapiens	14-29
29185859-11	2018	In conclusion, this study investigated the nature of RIF-R in Italy among RIF-R-MRSA strains, finding a prevalence of ST228, strongly associated with reduced susceptibility to glycopeptides (hVISA).	Glycopeptides	176-189	mitochondrial antiviral signaling protein	Homo sapiens	191-196
29557479-7	2018	We found that boronic acid chemistry in this study preferred to capture glycopeptides with high mannose glycans, ZIC-HILIC enriched most N-glycopeptides and did not show significant preference during enrichment and PGC was not suitable for separating glycopeptides with a long amino acid sequence.	Glycopeptides	139-152	zinc finger protein of the cerebellum 1	Mus musculus	113-116
29644550-2	2018	However, aiming for resolving site-specific glycosylation of sulfated glycopeptides by direct LC-MS2 sequencing is technically most challenging.	Glycopeptides	70-83	MS2	Homo sapiens	97-100
30136494-0	2018	[Preparation of cobalt phthalocyanine functionalized polymer monolith and application to enrichment of transferrin glycopeptides].	Glycopeptides	115-128	transferrin	Homo sapiens	103-114
29642865-4	2018	RESULTS: Leucine-rich alpha-2-glycoprotein-1 with fucosylated triantennary N-glycan (LRG-FTG) was identified as CRC marker after evaluating 30,000 candidate glycopeptide peaks.	Glycopeptides	157-169	leucine rich alpha-2-glycoprotein 1	Homo sapiens	9-44
29642865-4	2018	RESULTS: Leucine-rich alpha-2-glycoprotein-1 with fucosylated triantennary N-glycan (LRG-FTG) was identified as CRC marker after evaluating 30,000 candidate glycopeptide peaks.	Glycopeptides	157-169	leucine rich alpha-2-glycoprotein 1	Homo sapiens	85-88
30136494-4	2018	After enrichment of transferrin through the functionalized monolith, 17 glycopeptides were identified by electrospray ionization quadrupole time-of-flight mass spectrometry.	Glycopeptides	72-85	transferrin	Homo sapiens	20-31
30136494-5	2018	When the concentration of transferrin was reduced to 8.8x10-10mol/L, three glycopeptides could still be obtained.	Glycopeptides	75-88	transferrin	Homo sapiens	26-37
29107699-6	2017	Rabbit immunization revealed that the synthetic self-adjuvant glycopeptide could elicit substantial glycan-dependent antibodies that exhibited broader recognition of HIV-1 gp120s than the non-glycosylated V3 peptide.	Glycopeptides	62-74	Envelope surface glycoprotein gp160, precursor	Human immunodeficiency virus 1	172-177
29285644-5	2018	Serum haptoglobin enriched by immunoaffinity chromatography was subjected to multispecific proteolysis to generate site-specific glycopeptides and to investigate the macroheterogeneity and microheterogeneity.	Glycopeptides	129-142	haptoglobin	Homo sapiens	6-17
29046357-8	2017	The crystal structures of PILRalpha complexed with these glycopeptides highlighted the importance of stereochemical positioning of the O4 atom of the sugar moiety.	Glycopeptides	57-70	paired immunoglobin like type 2 receptor alpha	Homo sapiens	26-35
29045792-0	2017	Glycopeptides as Targets for Dendritic Cells: Exploring MUC1 Glycopeptides Binding Profile toward Macrophage Galactose-Type Lectin (MGL) Orthologs.	Glycopeptides	0-13	mucin 1, transmembrane	Mus musculus	56-60
29166012-1	2017	A structure-based design of a new generation of tumor-associated glycopeptides with improved affinity against two anti-MUC1 antibodies is described.	Glycopeptides	65-78	mucin 1, cell surface associated	Homo sapiens	119-123
29022615-0	2017	Principles of mucin structure: implications for the rational design of cancer vaccines derived from MUC1-glycopeptides.	Glycopeptides	105-118	LOC100508689	Homo sapiens	14-19
29022615-0	2017	Principles of mucin structure: implications for the rational design of cancer vaccines derived from MUC1-glycopeptides.	Glycopeptides	105-118	mucin 1, cell surface associated	Homo sapiens	100-104
29045792-0	2017	Glycopeptides as Targets for Dendritic Cells: Exploring MUC1 Glycopeptides Binding Profile toward Macrophage Galactose-Type Lectin (MGL) Orthologs.	Glycopeptides	0-13	C-type lectin domain family 10, member A	Mus musculus	98-130
29045792-0	2017	Glycopeptides as Targets for Dendritic Cells: Exploring MUC1 Glycopeptides Binding Profile toward Macrophage Galactose-Type Lectin (MGL) Orthologs.	Glycopeptides	0-13	C-type lectin domain family 10, member A	Mus musculus	132-135
29016103-9	2017	In particular, isobaric tag labeled glycopeptides after C18 desalting could be readily enriched by SAX and RAX cartridges but not by HILIC to enable quantitative glycoproteomics.	Glycopeptides	36-49	Bardet-Biedl syndrome 9	Homo sapiens	56-59
29045792-0	2017	Glycopeptides as Targets for Dendritic Cells: Exploring MUC1 Glycopeptides Binding Profile toward Macrophage Galactose-Type Lectin (MGL) Orthologs.	Glycopeptides	61-74	mucin 1, transmembrane	Mus musculus	56-60
29045792-0	2017	Glycopeptides as Targets for Dendritic Cells: Exploring MUC1 Glycopeptides Binding Profile toward Macrophage Galactose-Type Lectin (MGL) Orthologs.	Glycopeptides	61-74	C-type lectin domain family 10, member A	Mus musculus	98-130
29045792-0	2017	Glycopeptides as Targets for Dendritic Cells: Exploring MUC1 Glycopeptides Binding Profile toward Macrophage Galactose-Type Lectin (MGL) Orthologs.	Glycopeptides	61-74	C-type lectin domain family 10, member A	Mus musculus	132-135
29045792-3	2017	To estimate the ability of distinct MGL orthologs to recognize aberrant glycan cores in mucins, we applied evanescent-field detection to a versatile MUC1-like glycopeptide microarray platform.	Glycopeptides	159-171	mucin 1, transmembrane	Mus musculus	149-153
28921955-4	2017	Three enzymes, trypsin, AspN, and pepsin, were used separately to generate suitable glycopeptides for online LC tandem MS analysis.	Glycopeptides	84-97	asporin	Homo sapiens	24-28
28675699-2	2017	We showed that vaccines containing tumor-associated human MUC1 glycopeptides induce strong humoral antitumor responses in mice.	Glycopeptides	63-76	mucin 1, cell surface associated	Homo sapiens	58-62
28678517-3	2017	Here, we examined the specificity and activity of human FUT8 toward tri- and tetra-antennary N-glycans in the forms of glycopeptides.	Glycopeptides	119-132	fucosyltransferase 8	Homo sapiens	56-60
28741944-2	2017	To analyze how UGGT recognizes non-native glycoproteins, we chemically synthesized site-specifically 15N-labeled interleukin 8 (IL-8) C-terminal (34-72) glycopeptides bearing a Man9GlcNAc2 (M9) oligosaccharide.	Glycopeptides	153-166	C-X-C motif chemokine ligand 8	Homo sapiens	113-126
28741944-2	2017	To analyze how UGGT recognizes non-native glycoproteins, we chemically synthesized site-specifically 15N-labeled interleukin 8 (IL-8) C-terminal (34-72) glycopeptides bearing a Man9GlcNAc2 (M9) oligosaccharide.	Glycopeptides	153-166	C-X-C motif chemokine ligand 8	Homo sapiens	128-132
28681051-5	2017	ENGase biocatalysts are now finding burgeoning application for the production of biologically active glycopeptides and glycoproteins, including therapeutic monoclonal antibodies (mAbs) for which the oligosaccharides have been remodelled to optimise effector functions.	Glycopeptides	101-114	endo-beta-N-acetylglucosaminidase	Homo sapiens	0-6
28514044-4	2017	Using synthetic glycopeptides with O-GalNAc (the Tn antigen) or O-GlcNAc, we demonstrated that the method is selective for glycopeptides with O-GalNAc and can distinguish between these two modifications.	Glycopeptides	16-29	O-linked N-acetylglucosamine (GlcNAc) transferase	Homo sapiens	35-72
29048831-4	2017	Thus, POP-1 was tried to be used for glycopeptides enrichment from tryptic digest of standard protein and complex biosamples in hydrophilic mode.	Glycopeptides	37-50	processing of precursor 1, ribonuclease P/MRP family, (S. cerevisiae)	Mus musculus	6-11
28685598-2	2017	MATERIALS & METHODS: Porcine cardiac tissue was analyzed for the presence of CgA-derived glycopeptides using a global O-glycoproteomic strategy.	Glycopeptides	93-106	chromogranin A	Homo sapiens	81-84
28685598-5	2017	RESULTS: We identified CgA-derived glycopeptides exclusively in the atrial tissue.	Glycopeptides	35-48	chromogranin A	Homo sapiens	23-26
28623326-7	2017	This approach was applied for the analysis of tryptic glycopeptides of prostate specific antigen, which shows highly complex and heterogeneous glycosylation.	Glycopeptides	54-67	kallikrein related peptidase 3	Homo sapiens	71-96
28514044-4	2017	Using synthetic glycopeptides with O-GalNAc (the Tn antigen) or O-GlcNAc, we demonstrated that the method is selective for glycopeptides with O-GalNAc and can distinguish between these two modifications.	Glycopeptides	123-136	O-linked N-acetylglucosamine (GlcNAc) transferase	Homo sapiens	35-72
28442774-2	2017	In this study, for the first time, a "one for two" hydrophilic magnetic amino-functionalized metal-organic framework (MOF) was designed and synthesized for selective enrichment of both glycopeptides and phosphopeptides.	Glycopeptides	185-198	lysine acetyltransferase 8	Homo sapiens	93-122
28440596-2	2017	However, tumor-associated aberrantly glycosylated MUC1 glycopeptides are endogenous structures, "self-antigens", that exhibit only low immunogenicity.	Glycopeptides	55-68	mucin 1, cell surface associated	Homo sapiens	50-54
28247191-8	2017	The results of PLS-DA showed that 167 glycopeptides were found to be significantly different between the naturally derived and recombinant hCG products.	Glycopeptides	38-51	chorionic gonadotropin subunit beta 5	Homo sapiens	139-142
28391691-0	2017	Both PepT1 and GLUT Intestinal Transporters Are Utilized by a Novel Glycopeptide Pro-Hyp-CONH-GlcN.	Glycopeptides	68-80	solute carrier family 15 member 1	Homo sapiens	5-10
28391691-0	2017	Both PepT1 and GLUT Intestinal Transporters Are Utilized by a Novel Glycopeptide Pro-Hyp-CONH-GlcN.	Glycopeptides	68-80	solute carrier family 2 member 1	Homo sapiens	15-19
27909778-3	2017	Here, we present a novel, simplified technique for HILIC enrichment termed "Drop-HILIC", which was applied to systematically evaluate the mobile phase effect on ZIC-HILIC (zwitterionic type of hydrophilic interaction chromatography) glycopeptide enrichment.	Glycopeptides	233-245	Zic family member 1	Homo sapiens	161-164
28251761-6	2017	Here, we report the crystal structures of the POMK catalytic domain in the absence and presence of an ATP analogue and O-mannosylated glycopeptide.	Glycopeptides	134-146	protein O-mannose kinase	Homo sapiens	46-50
28298421-5	2017	Fluorophore-labeled Man9-V3 glycopeptides bound to bnAb memory B cells and were able to be used to isolate a V3-glycan bnAb from an HIV-1-infected individual.	Glycopeptides	28-41	mannosidase alpha class 1A member 1	Homo sapiens	20-24
27966990-5	2017	The objectives of the present study were to characterize N-glycosylation sites in VEGFR-2 via enzymatic release of the glycans and concomitant incorporation of 18O into formerly N-glycosylated sites followed by tandem mass spectrometry (MS/MS) analysis to determine N-glycosylation site occupancy and the site-specific N-glycan heterogeneity of VEGFR-2 glycopeptides.	Glycopeptides	353-366	kinase insert domain receptor	Homo sapiens	82-89
28139739-0	2017	Combination of cephalosporins with vancomycin or teicoplanin enhances antibacterial effect of glycopeptides against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) and VISA.	Glycopeptides	94-107	mitochondrial antiviral signaling protein	Homo sapiens	177-182
28139739-0	2017	Combination of cephalosporins with vancomycin or teicoplanin enhances antibacterial effect of glycopeptides against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) and VISA.	Glycopeptides	94-107	mitochondrial antiviral signaling protein	Homo sapiens	178-182
27873468-0	2017	Synthetic Mucin-Like Glycopeptides as Versatile Tools to Measure Effects of Glycan Structure/Density/Position on the Interaction with Adhesion/Growth-Regulatory Galectins in Arrays.	Glycopeptides	21-34	LOC100508689	Homo sapiens	10-15
28323416-3	2017	As demonstrated on alpha-fetoprotein (AFP), a serum biomarker for hepatocellular carcinoma (HCC), the assay has high purification specificity (20 glycopeptides) with 2-fold and 10-fold superior total glycopeptide intensity compared to non-one-pot method (9 glycopeptides) or without enrichment (6 glycopeptides), respectively.	Glycopeptides	146-159	alpha fetoprotein	Homo sapiens	19-36
28323416-3	2017	As demonstrated on alpha-fetoprotein (AFP), a serum biomarker for hepatocellular carcinoma (HCC), the assay has high purification specificity (20 glycopeptides) with 2-fold and 10-fold superior total glycopeptide intensity compared to non-one-pot method (9 glycopeptides) or without enrichment (6 glycopeptides), respectively.	Glycopeptides	146-159	alpha fetoprotein	Homo sapiens	38-41
28323416-3	2017	As demonstrated on alpha-fetoprotein (AFP), a serum biomarker for hepatocellular carcinoma (HCC), the assay has high purification specificity (20 glycopeptides) with 2-fold and 10-fold superior total glycopeptide intensity compared to non-one-pot method (9 glycopeptides) or without enrichment (6 glycopeptides), respectively.	Glycopeptides	146-158	alpha fetoprotein	Homo sapiens	19-36
28323416-3	2017	As demonstrated on alpha-fetoprotein (AFP), a serum biomarker for hepatocellular carcinoma (HCC), the assay has high purification specificity (20 glycopeptides) with 2-fold and 10-fold superior total glycopeptide intensity compared to non-one-pot method (9 glycopeptides) or without enrichment (6 glycopeptides), respectively.	Glycopeptides	146-158	alpha fetoprotein	Homo sapiens	38-41
28323416-3	2017	As demonstrated on alpha-fetoprotein (AFP), a serum biomarker for hepatocellular carcinoma (HCC), the assay has high purification specificity (20 glycopeptides) with 2-fold and 10-fold superior total glycopeptide intensity compared to non-one-pot method (9 glycopeptides) or without enrichment (6 glycopeptides), respectively.	Glycopeptides	257-270	alpha fetoprotein	Homo sapiens	38-41
28323416-3	2017	As demonstrated on alpha-fetoprotein (AFP), a serum biomarker for hepatocellular carcinoma (HCC), the assay has high purification specificity (20 glycopeptides) with 2-fold and 10-fold superior total glycopeptide intensity compared to non-one-pot method (9 glycopeptides) or without enrichment (6 glycopeptides), respectively.	Glycopeptides	257-270	alpha fetoprotein	Homo sapiens	38-41
27957777-0	2017	Photoinduced Thiol-ene Chemistry Applied to the Synthesis of Self-Assembling Elastin-Inspired Glycopeptides.	Glycopeptides	94-107	elastin	Homo sapiens	77-84
27957777-2	2017	Herein, for the first time, taking advantage of thiol-ene chemistry coupled to solid-phase peptide synthesis, a self-assembling peptide inspired by elastin protein was bioconjugated to three carbohydrates in order to obtain the corresponding glycopeptides.	Glycopeptides	242-255	elastin	Homo sapiens	148-155
27810711-0	2016	Obstacles and solutions for chemical synthesis of syndecan-3 (53-62) glycopeptides with two heparan sulfate chains.	Glycopeptides	69-82	syndecan 3	Homo sapiens	50-60
27743362-5	2017	These glycopeptides are then separated and detected using an integrated C18-porous graphitized carbon-liquid chromatography (PGC-LC) setup online coupled to a high-resolution electrospray ionization (ESI)-quadrupole time-of-flight (QTOF)-mass spectrometer operated in a combined higher- and lower-energy CID (stepping-energy CID) mode.	Glycopeptides	6-19	Bardet-Biedl syndrome 9	Homo sapiens	72-75
27810711-4	2016	For assembly of glycans, a convergent 3+2+3 approach was developed producing two different octasaccharide amino acid cassettes, which were utilized towards syndecan-3 glycopeptides.	Glycopeptides	167-180	syndecan 3	Homo sapiens	156-166
27487254-2	2016	However, appropriate analytical tools to characterize acidic and high-molecular-weight (hMW) glycopeptides are still lacking.	Glycopeptides	93-106	cilia and flagella associated protein 97	Homo sapiens	88-91
27591639-3	2016	The functionalized magnetic nanoparticles exhibited superior performance in glycopeptide enrichment of HRP tryptic digest, demonstrating low detection limit (0.04ng/muL), high selectivity (a mixture of HRP and BSA at the mass ratio of 1:50) and reproducibility (5 repeating cycles).	Glycopeptides	76-88	tripartite motif containing 37	Homo sapiens	165-168
27591658-0	2016	Classification of congenital disorders of glycosylation based on analysis of transferrin glycopeptides by capillary liquid chromatography-mass spectrometry.	Glycopeptides	89-102	transferrin	Homo sapiens	77-88
27477788-1	2016	Glycopeptide antibiotic biosynthesis involves a complex cascade of reactions centred on a non-ribosomal peptide synthetase and modifiying proteins acting in trans, such as Cytochrome P450 enzymes.	Glycopeptides	0-12	cytochrome P450 family 2 subfamily B member 6	Homo sapiens	183-187
27752135-0	2016	F-O-G Ring Formation in Glycopeptide Antibiotic Biosynthesis is Catalysed by OxyE.	Glycopeptides	24-36	zinc finger protein, FOG family member 1	Homo sapiens	0-5
27487254-3	2016	In this study, we demonstrate that the addition of supercharging reagent, m-nitrobenzyl alcohol (m-NBA), into mobile phases greatly facilitates the analysis of acidic and hMW glycopeptides.	Glycopeptides	175-188	cilia and flagella associated protein 97	Homo sapiens	171-174
27487254-7	2016	Our results indicated that incorporation of m-NBA into reversed-phase liquid chromatography (LC) solvents improves sensitivity, charging, and chromatographic resolution for acidic and hMW glycopeptides.	Glycopeptides	188-201	cilia and flagella associated protein 97	Homo sapiens	184-187
26399494-3	2015	However, the enzymatic release of glycopeptides captured by hydrazide beads through direct incubation of the beads with PNGase F is not efficient due to the inherent steric hindrance effect.	Glycopeptides	34-47	N-glycanase 1	Homo sapiens	120-126
27380866-7	2016	Moreover, the elicited antisera reacted with the STn-MUC1 antigen-positive tumor cells, indicating that the carbohydrate antigen modification strategy may hold potential to overcome the weak immunogenicity of natural MUC1 glycopeptides.	Glycopeptides	222-235	mucin 1, transmembrane	Mus musculus	217-221
27340743-1	2016	Synthetic macromolecular MUC1 glycopeptides have been used to unravel molecular mechanisms in antibody recognition of disease-specific epitopes.	Glycopeptides	30-43	mucin 1, cell surface associated	Homo sapiens	25-29
27340743-3	2016	We have accomplished the synthesis of 77 amino acid MUC1 glycopeptides (MW = 12 759) having three major antigenic O-glycoforms [Tn, core 1 (T), and core 2 structures] at 10 designated positions out of 19 potential O-glycosylation sites.	Glycopeptides	57-70	mucin 1, cell surface associated	Homo sapiens	52-56
26858738-5	2016	Mass spectrometric analysis of IgA1 glycopeptides revealed the presence of complex biantennary N-glycans with terminal N-acetylglucosamine present on the N-glycosylation site of the CH2 domain in the IgA1 alpha chain.	Glycopeptides	36-49	immunoglobulin heavy constant alpha 1	Homo sapiens	31-35
26858738-5	2016	Mass spectrometric analysis of IgA1 glycopeptides revealed the presence of complex biantennary N-glycans with terminal N-acetylglucosamine present on the N-glycosylation site of the CH2 domain in the IgA1 alpha chain.	Glycopeptides	36-49	immunoglobulin heavy constant alpha 1	Homo sapiens	200-204
26824070-3	2016	A segment coupling strategy performed by native chemical ligation using six peptide segments including glycopeptides yielded homogeneous EPO glycopeptides, and folding experiments of these glycopeptides afforded the correctly folded EPO glycoforms.	Glycopeptides	103-116	erythropoietin	Homo sapiens	137-140
26582205-4	2016	Sequential digestion of TIB-141 with lysyl endopeptidase and trypsin resulted in the identification of a glycopeptide (H-Lys13-Try3; 48 amino acid residues) with a single N-linked oligosaccharide near the N terminus capable of neutralizing the effect of galectin-9 and another glycopeptide with two N-linked oligosaccharides (H-Lys13-Try1; 16 amino acid residues) having lower activity.	Glycopeptides	105-117	PRSS3 pseudogene 3	Homo sapiens	127-131
26582205-4	2016	Sequential digestion of TIB-141 with lysyl endopeptidase and trypsin resulted in the identification of a glycopeptide (H-Lys13-Try3; 48 amino acid residues) with a single N-linked oligosaccharide near the N terminus capable of neutralizing the effect of galectin-9 and another glycopeptide with two N-linked oligosaccharides (H-Lys13-Try1; 16 amino acid residues) having lower activity.	Glycopeptides	105-117	galectin 9	Homo sapiens	254-264
26582205-4	2016	Sequential digestion of TIB-141 with lysyl endopeptidase and trypsin resulted in the identification of a glycopeptide (H-Lys13-Try3; 48 amino acid residues) with a single N-linked oligosaccharide near the N terminus capable of neutralizing the effect of galectin-9 and another glycopeptide with two N-linked oligosaccharides (H-Lys13-Try1; 16 amino acid residues) having lower activity.	Glycopeptides	105-117	serine protease 1	Homo sapiens	334-338
26467158-7	2016	We purified BACE1 from Neuro2A cells and performed LC/ESI/MS analysis for BACE1-derived glycopeptides and mapped bisecting GlcNAc-modified sites on BACE1.	Glycopeptides	88-101	beta-site APP cleaving enzyme 1	Mus musculus	74-79
26467158-7	2016	We purified BACE1 from Neuro2A cells and performed LC/ESI/MS analysis for BACE1-derived glycopeptides and mapped bisecting GlcNAc-modified sites on BACE1.	Glycopeptides	88-101	beta-site APP cleaving enzyme 1	Mus musculus	74-79
26700048-0	2016	Characterization of Protein N-Glycosylation by Analysis of ZIC-HILIC-Enriched Intact Proteolytic Glycopeptides.	Glycopeptides	97-110	Zic family member 1	Homo sapiens	59-62
27472370-4	2016	A variety of adjuvants have been used with MUC1 glycopeptides to improve their immunogenicity.	Glycopeptides	48-61	mucin 1, transmembrane	Mus musculus	43-47
27139140-3	2016	Here we proposed pGlyco, a novel pipeline for the identification of intact glycopeptides by using complementary MS techniques: 1) HCD-MS/MS followed by product-dependent CID-MS/MS was used to provide complementary fragments to identify the glycans, and a novel target-decoy method was developed to estimate the false discovery rate of the glycan identification; 2) data-dependent acquisition of MS3 for some most intense peaks of HCD-MS/MS was used to provide fragments to identify the peptide backbones.	Glycopeptides	75-88	MS3	Homo sapiens	395-398
27139140-4	2016	By integrating HCD-MS/MS, CID-MS/MS and MS3, intact glycopeptides could be confidently identified.	Glycopeptides	52-65	MS3	Homo sapiens	40-43
26610890-6	2016	We now report on the glycopeptide substrate utilization of a series of glycopeptide (human-ppGalNAc-T4, T7, T10, T12 and fly PGANT7) and peptide-preferring transferases (T2, T3 and T5) by exploiting a series of random glycopeptide substrates designed to probe the functions of their catalytic and lectin domains.	Glycopeptides	21-33	Polypeptide N-Acetylgalactosaminyltransferase 7	Drosophila melanogaster	125-131
26820384-0	2016	Structure of OxyA tei: completing our picture of the glycopeptide antibiotic producing Cytochrome P450 cascade.	Glycopeptides	53-65	cytochrome P450 family 4 subfamily F member 3	Homo sapiens	87-102
26820384-1	2016	Cyclization of glycopeptide antibiotic precursors occurs in either three or four steps catalyzed by Cytochrome P450 enzymes.	Glycopeptides	15-27	cytochrome P450 family 4 subfamily F member 3	Homo sapiens	100-115
26692014-0	2016	Molecular basis of antibody binding to mucin glycopeptides in lung cancer.	Glycopeptides	45-58	LOC100508689	Homo sapiens	39-44
26692014-9	2016	These findings indicate that clusters of both TR backbones and sugars are essential for mAb binding to mucin glycopeptides.	Glycopeptides	109-122	LOC100508689	Homo sapiens	103-108
26831703-0	2016	Facile Synthetic Access to Glycopeptide Antibiotic Precursor Peptides for the Investigation of Cytochrome P450 Action in Glycopeptide Antibiotic Biosynthesis.	Glycopeptides	27-39	cytochrome P450 family 4 subfamily F member 3	Homo sapiens	95-110
26384718-5	2015	The utility of the methodology is demonstrated in the rapid synthesis of complex glycopeptide fragments of the epithelial glycoproteins MUC5AC and MUC4 and through the total synthesis of the structured, cysteine (Cys)-free protein eglin C.	Glycopeptides	81-93	mucin 5AC, oligomeric mucus/gel-forming	Homo sapiens	136-142
26399494-4	2015	In this study, we developed a hydroxylamine assisted PNGase F deglycosylation (HAPD) method using the hydroxylamine to release glycopeptides captured on the hydrazide beads through the cleavage of hydrazone bonds by transamination followed with the PNGase F deglycosylation of the released glycopeptides in the free solution.	Glycopeptides	127-140	N-glycanase 1	Homo sapiens	53-59
26384718-5	2015	The utility of the methodology is demonstrated in the rapid synthesis of complex glycopeptide fragments of the epithelial glycoproteins MUC5AC and MUC4 and through the total synthesis of the structured, cysteine (Cys)-free protein eglin C.	Glycopeptides	81-93	mucin 4, cell surface associated	Homo sapiens	147-151
26399494-4	2015	In this study, we developed a hydroxylamine assisted PNGase F deglycosylation (HAPD) method using the hydroxylamine to release glycopeptides captured on the hydrazide beads through the cleavage of hydrazone bonds by transamination followed with the PNGase F deglycosylation of the released glycopeptides in the free solution.	Glycopeptides	127-140	N-glycanase 1	Homo sapiens	249-255
26399494-4	2015	In this study, we developed a hydroxylamine assisted PNGase F deglycosylation (HAPD) method using the hydroxylamine to release glycopeptides captured on the hydrazide beads through the cleavage of hydrazone bonds by transamination followed with the PNGase F deglycosylation of the released glycopeptides in the free solution.	Glycopeptides	290-303	N-glycanase 1	Homo sapiens	53-59
26244810-6	2015	Glycopeptides carrying fucosylated glycans were collected by Aleuria aurantia lectin (AAL) affinity chromatography from kidney homogenates of wild-type and Fut9 knockout mice.	Glycopeptides	0-13	fucosyltransferase 9	Mus musculus	156-160
25776945-4	2015	Using the potent antiviral lectin griffithsin (GRFT) as a model, we identified by NMR spectroscopy, SPR, analytical ultracentrifugation, and microcalorimetry glycopeptides that fully recapitulate the specificity and kinetics of binding to Man9 GlcNAc2 Asn and a synthetic nonamannoside.	Glycopeptides	158-171	sepiapterin reductase	Homo sapiens	100-103
28717478-1	2015	The combination of solid phase peptide synthesis and endo-beta-N-acetylglucosaminidase (ENGase) catalysed glycosylation is a powerful convergent synthetic method allowing access to glycopeptides bearing full-length N-glycan structures.	Glycopeptides	181-194	O-GlcNAcase	Homo sapiens	58-86
28717478-1	2015	The combination of solid phase peptide synthesis and endo-beta-N-acetylglucosaminidase (ENGase) catalysed glycosylation is a powerful convergent synthetic method allowing access to glycopeptides bearing full-length N-glycan structures.	Glycopeptides	181-194	endo-beta-N-acetylglucosaminidase	Homo sapiens	88-94
25939779-3	2015	Here we present the first crystal structures of complexes of GalNAc-T2 with glycopeptides that together with enhanced sampling molecular dynamics simulations demonstrate a cooperative mechanism by which the lectin domain enables free acceptor sites binding of glycopeptides into the catalytic domain.	Glycopeptides	76-89	polypeptide N-acetylgalactosaminyltransferase 2	Homo sapiens	61-70
26129647-6	2015	The most notable feature of the binding of MUC1 glycopeptides to galectin-3 was a shift from a favorable enthalpy to an entropy-driven binding process.	Glycopeptides	48-61	mucin 1, cell surface associated	Homo sapiens	43-47
26129647-6	2015	The most notable feature of the binding of MUC1 glycopeptides to galectin-3 was a shift from a favorable enthalpy to an entropy-driven binding process.	Glycopeptides	48-61	galectin 3	Homo sapiens	65-75
25939779-3	2015	Here we present the first crystal structures of complexes of GalNAc-T2 with glycopeptides that together with enhanced sampling molecular dynamics simulations demonstrate a cooperative mechanism by which the lectin domain enables free acceptor sites binding of glycopeptides into the catalytic domain.	Glycopeptides	260-273	polypeptide N-acetylgalactosaminyltransferase 2	Homo sapiens	61-70
25776945-4	2015	Using the potent antiviral lectin griffithsin (GRFT) as a model, we identified by NMR spectroscopy, SPR, analytical ultracentrifugation, and microcalorimetry glycopeptides that fully recapitulate the specificity and kinetics of binding to Man9 GlcNAc2 Asn and a synthetic nonamannoside.	Glycopeptides	158-171	mannosidase alpha class 1A member 1	Homo sapiens	239-243
25548287-5	2015	The gC-1 O-glycosylation was regulated in an orderly manner initiated by synchronous addition of one GalNAc unit each to Thr-87 and Thr-91 and one GalNAc unit to either Thr-99 or Thr-101, forming a core glycopeptide for subsequent additions of in all 11 GalNAc residues to selected Ser and Thr residues of the Thr-76-Lys-107 stretch of the mucin domain.	Glycopeptides	203-215	olfactomedin 4	Homo sapiens	4-8
25755023-6	2015	In this study, MUC4 tandem-repeat glycopeptides were conjugated to the tetanus toxoid and used for vaccination of mice.	Glycopeptides	34-47	mucin 4	Mus musculus	15-19
25748228-2	2015	Herein, we report a suitable (18)F-labeled high-molecular-weight glycopeptide for imaging of peripheral neuropeptide Y (NPY) Y1 receptor (Y1R)-positive tumors by preclinical small-animal positron emission tomography (PET).	Glycopeptides	65-77	neuropeptide Y	Mus musculus	120-123
25748228-2	2015	Herein, we report a suitable (18)F-labeled high-molecular-weight glycopeptide for imaging of peripheral neuropeptide Y (NPY) Y1 receptor (Y1R)-positive tumors by preclinical small-animal positron emission tomography (PET).	Glycopeptides	65-77	neuropeptide Y receptor Y1	Mus musculus	138-141
25748228-2	2015	Herein, we report a suitable (18)F-labeled high-molecular-weight glycopeptide for imaging of peripheral neuropeptide Y (NPY) Y1 receptor (Y1R)-positive tumors by preclinical small-animal positron emission tomography (PET).	Glycopeptides	65-77	thyroid stimulating hormone receptor	Mus musculus	217-220
25748228-9	2015	In vitro autoradiography with Y1R-positive MCF-7 tumor tissue slices indicated high specific binding of the (18)F-labeled glycopeptide, when binding was reduced by 95% ([Pra(4),F(7),P(34)]NPY) and by 86% (BIBP3226 Y1R antagonist) in competition studies.	Glycopeptides	122-134	neuropeptide Y receptor Y1	Mus musculus	30-33
25748228-9	2015	In vitro autoradiography with Y1R-positive MCF-7 tumor tissue slices indicated high specific binding of the (18)F-labeled glycopeptide, when binding was reduced by 95% ([Pra(4),F(7),P(34)]NPY) and by 86% (BIBP3226 Y1R antagonist) in competition studies.	Glycopeptides	122-134	neuropeptide Y	Mus musculus	188-191
25748228-9	2015	In vitro autoradiography with Y1R-positive MCF-7 tumor tissue slices indicated high specific binding of the (18)F-labeled glycopeptide, when binding was reduced by 95% ([Pra(4),F(7),P(34)]NPY) and by 86% (BIBP3226 Y1R antagonist) in competition studies.	Glycopeptides	122-134	neuropeptide Y receptor Y1	Mus musculus	214-217
25748228-13	2015	PET imaging studies with MCF-7 tumor-bearing nude mice demonstrated uptake of the (18)F-labeled glycopeptide in the tumor region at 60 min p.i., whereas only negligible tumor uptake was observed in animals injected with a nonbinding (18)F-labeled glycopeptide pendant as a measure of nonspecific binding.	Glycopeptides	96-108	thyroid stimulating hormone receptor	Mus musculus	0-3
25824568-0	2015	Glycopeptide analogues of PSGL-1 inhibit P-selectin in vitro and in vivo.	Glycopeptides	0-12	selectin P ligand	Homo sapiens	26-32
25824568-0	2015	Glycopeptide analogues of PSGL-1 inhibit P-selectin in vitro and in vivo.	Glycopeptides	0-12	selectin P	Homo sapiens	41-51
25723283-0	2015	Characterization of monoclonal antibody LpMab-3 recognizing sialylated glycopeptide of podoplanin.	Glycopeptides	71-83	podoplanin	Homo sapiens	87-97
25723283-5	2015	In this study, we produced and characterized a novel anti-podoplanin monoclonal antibody, LpMab-3, the epitope of which is a sialylated glycopeptide of podoplanin.	Glycopeptides	136-148	podoplanin	Homo sapiens	58-68
25723283-5	2015	In this study, we produced and characterized a novel anti-podoplanin monoclonal antibody, LpMab-3, the epitope of which is a sialylated glycopeptide of podoplanin.	Glycopeptides	136-148	podoplanin	Homo sapiens	152-162
25750456-3	2015	Mass Spectrometry (MS) has evolved as one of the most powerful tools in glycomics and glycoproteomics and in combination with porous graphitized carbon-liquid chromatography (PGC-LC) it is a versatile and sensitive technique for the analysis of glycans and to some extent also glycopeptides.	Glycopeptides	277-290	progastricsin	Homo sapiens	175-178
25750456-8	2015	In addition, we will briefly review PGC analysis approaches for glycopeptides, glycosaminoglycans (GAGs) and human milk oligosaccharides (HMOs).	Glycopeptides	64-77	progastricsin	Homo sapiens	36-39
25265424-6	2014	Core fucosylation is detectable in only trace amounts in haptoglobin but with confidence on hemopexin and complement factor H, where core fucosylation of the bi-antennary glycans on select glycopeptides reaches 15-20% intensity.	Glycopeptides	189-202	complement factor H	Homo sapiens	106-125
25691903-13	2015	Sinus mucin fragmentation produced mucin subunits and glycopeptide units of smaller molecular sizes which are likely to have lower viscoelastic properties.	Glycopeptides	54-66	LOC100508689	Homo sapiens	6-11
25665441-8	2015	In addition, results on deglycosylation of metabolically labeled cathepsin Z are shown and the alterations in the apparent size of the glycopeptides are explained.	Glycopeptides	135-148	cathepsin Z	Homo sapiens	65-76
26156539-5	2015	Sulfated polysaccharides/glycopeptides and flavonoids may have synergistic effects with targeted anti-angiogenic drugs mainly targeting VEGF pathway by inhibiting bFGF and HIF-1alpha pathway, respectively.	Glycopeptides	25-38	vascular endothelial growth factor A	Homo sapiens	136-140
26156539-5	2015	Sulfated polysaccharides/glycopeptides and flavonoids may have synergistic effects with targeted anti-angiogenic drugs mainly targeting VEGF pathway by inhibiting bFGF and HIF-1alpha pathway, respectively.	Glycopeptides	25-38	fibroblast growth factor 2	Homo sapiens	163-167
26156539-5	2015	Sulfated polysaccharides/glycopeptides and flavonoids may have synergistic effects with targeted anti-angiogenic drugs mainly targeting VEGF pathway by inhibiting bFGF and HIF-1alpha pathway, respectively.	Glycopeptides	25-38	hypoxia inducible factor 1 subunit alpha	Homo sapiens	172-182
25329175-0	2014	Synthesis aided structural determination of amyloid-beta(1-15) glycopeptides, new biomarkers for Alzheimer"s disease.	Glycopeptides	63-76	amyloid beta precursor protein	Homo sapiens	44-56
25329175-2	2014	Aided by these glycopeptides and tandem mass spectrometry analysis, the naturally existing amyloid-beta glycopeptides, isolated from Alzheimer"s disease patients, were determined to contain an alpha-linked N-acetyl galactosamine at the modified tyrosine 10 residue.	Glycopeptides	15-28	amyloid beta precursor protein	Homo sapiens	91-103
24957836-1	2014	Glycopeptides are known to select for heterogeneous vancomycin-intermediate Staphylococcus aureus (h-VISA) from susceptible strains.	Glycopeptides	0-13	mitochondrial antiviral signaling protein	Homo sapiens	101-105
25324212-0	2014	Delineating binding modes of Gal/GalNAc and structural elements of the molecular recognition of tumor-associated mucin glycopeptides by the human macrophage galactose-type lectin.	Glycopeptides	119-132	LOC100508689	Homo sapiens	113-118
25324212-0	2014	Delineating binding modes of Gal/GalNAc and structural elements of the molecular recognition of tumor-associated mucin glycopeptides by the human macrophage galactose-type lectin.	Glycopeptides	119-132	C-type lectin domain containing 10A	Homo sapiens	146-178
25324212-2	2014	NMR and modeling-based data on the molecular recognition features of synthetic Tn-bearing glycopeptides by MGL are presented.	Glycopeptides	90-103	C-type lectin domain containing 10A	Homo sapiens	107-110
25303614-4	2014	We tested a small library consisting of 27 MUC1 glycopeptides with different O-glycosylations against anti-MUC1 mAb clone VU-3C6.	Glycopeptides	48-61	mucin 1, cell surface associated	Homo sapiens	43-47
25303614-4	2014	We tested a small library consisting of 27 MUC1 glycopeptides with different O-glycosylations against anti-MUC1 mAb clone VU-3C6.	Glycopeptides	48-61	mucin 1, cell surface associated	Homo sapiens	107-111
25092234-7	2014	Analysis of hFXI glycopeptides by LC-MS/MS enabled site-specific glycan profiling and occupancy.	Glycopeptides	17-30	coagulation factor XI	Homo sapiens	12-16
24957836-2	2014	In certain clinical situations, h-VISA strains have been isolated from patients without previous exposure to glycopeptides, such as cystic fibrosis patients, who frequently receive repeated treatments with beta-lactam antibiotics.	Glycopeptides	109-122	mitochondrial antiviral signaling protein	Homo sapiens	34-38
24884609-5	2014	First, we confirmed that the four ITIH4 N-X-S/T sequons (N81, N207, N517, and N577) were glycosylated by treating ITIH4 tryptic/GluC glycopeptides with PNGaseF in the presence of (18)O water.	Glycopeptides	133-146	inter-alpha-trypsin inhibitor heavy chain 4	Homo sapiens	34-39
24884609-5	2014	First, we confirmed that the four ITIH4 N-X-S/T sequons (N81, N207, N517, and N577) were glycosylated by treating ITIH4 tryptic/GluC glycopeptides with PNGaseF in the presence of (18)O water.	Glycopeptides	133-146	inter-alpha-trypsin inhibitor heavy chain 4	Homo sapiens	114-119
24884609-5	2014	First, we confirmed that the four ITIH4 N-X-S/T sequons (N81, N207, N517, and N577) were glycosylated by treating ITIH4 tryptic/GluC glycopeptides with PNGaseF in the presence of (18)O water.	Glycopeptides	133-146	glucosylceramidase beta 3 (gene/pseudogene)	Homo sapiens	128-132
24645849-3	2014	From libraries of ~10(13) glycopeptides containing multiple Man9 glycan(s), we selected variants that bind to HIV broadly neutralizing antibody 2G12 with picomolar to low nanomolar affinity.	Glycopeptides	26-39	mannosidase alpha class 1A member 1	Homo sapiens	60-64
24576160-0	2014	Can amphipathic helices influence the CNS antinociceptive activity of glycopeptides related to beta-endorphin?	Glycopeptides	70-83	proopiomelanocortin	Homo sapiens	95-109
25635161-7	2014	RESULTS: MS/MS analysis of glycopeptides captured from BxPC-3 cells revealed 18 proteins predicted or known to be associated with the plasma membrane, including CD109, which has not been reported in pancreatic cancer.	Glycopeptides	27-40	CD109 molecule	Homo sapiens	161-166
24246952-0	2014	A straightforward protocol for the preparation of high performance microarray displaying synthetic MUC1 glycopeptides.	Glycopeptides	104-117	mucin 1, cell surface associated	Homo sapiens	99-103
24246952-4	2014	RESULTS: Selective imine-coupling between aminooxy-functionalized methacrylic copolymer with phosphorylcholine unit and synthetic MUC1 glycopeptides-capped by a ketone linker at N-terminus provided a facile and seamless protocol for the preparation of glycopeptides microarray platform.	Glycopeptides	135-148	mucin 1, cell surface associated	Homo sapiens	130-134
24246952-4	2014	RESULTS: Selective imine-coupling between aminooxy-functionalized methacrylic copolymer with phosphorylcholine unit and synthetic MUC1 glycopeptides-capped by a ketone linker at N-terminus provided a facile and seamless protocol for the preparation of glycopeptides microarray platform.	Glycopeptides	252-265	mucin 1, cell surface associated	Homo sapiens	130-134
24393138-0	2014	Glycan analysis of Prostate Specific Antigen (PSA) directly from the intact glycoprotein by HR-ESI/TOF-MS. Glycans are important modulators of the biological function of proteins and are normally characterized from proteolytic glycopeptides or from (N-)glycans released enzymatically by glycosidase treatment or chemically by hydrazinolysis.	Glycopeptides	227-240	kallikrein related peptidase 3	Homo sapiens	46-49
24239874-3	2014	In order to study how glycogenin-1 and -2 interactions may influence each other"s glucosylations we setup a cell-free expression system for in vitro production and glucosylation of glycogenin-1 and -2 in various combinations, and used a mass spectrometry based workflow for the characterization and quantitation of tryptic glycopeptides originating from glycogenin-1 and -2.	Glycopeptides	323-336	glycogenin 1	Homo sapiens	22-41
24164404-5	2013	Here, we show the feasibility of formerly N-glycopeptide identification and quantification at MS1 level using genomic N-glycosite prediction (GenoGlyco) coupled with stable isotopic labeling and accurate mass matching.	Glycopeptides	44-56	MS	Homo sapiens	94-97
24307362-0	2013	A unified strategy for the synthesis of mucin cores 1-4 saccharides and the assembled multivalent glycopeptides.	Glycopeptides	98-111	LOC100508689	Homo sapiens	40-45
24123641-6	2013	A site-specific glycoform profile variation was obtained by comparing the glycoform profile of CH2 and 13 CD2 glycopeptides.	Glycopeptides	110-123	CD2 molecule	Homo sapiens	106-109
23909558-7	2013	By implementing the rules into an algorithm to score potential assignments against ETD-MS/MS data, we applied the method to glycopeptides generated from various O-glycosylated proteins including mucin, erythropoietin, fetuin, and an HIV envelope protein, 1086.C gp120.	Glycopeptides	124-137	LOC100508689	Homo sapiens	195-200
24160308-2	2013	These glycosylamino acids can be employed directly in the solid-phase synthesis of glycopeptides, as demonstrated by the efficient preparation of tumor-associated MUC1 glycopeptide fragments.	Glycopeptides	83-96	mucin 1, cell surface associated	Homo sapiens	163-167
24097394-7	2013	LC/ETD was also performed on ions from the smaller glycopeptides obtained from erythropoietin.	Glycopeptides	51-64	erythropoietin	Homo sapiens	79-93
23912193-6	2013	Fmoc-solid phase peptide synthesis was carried out using COMU as the coupling reagent for the introduction of [Hyp(L-Araf0-3)] derivatives as well as further elongation to the CLV3 glycopeptides.	Glycopeptides	181-194	CLAVATA3	Arabidopsis thaliana	176-180
23909558-7	2013	By implementing the rules into an algorithm to score potential assignments against ETD-MS/MS data, we applied the method to glycopeptides generated from various O-glycosylated proteins including mucin, erythropoietin, fetuin, and an HIV envelope protein, 1086.C gp120.	Glycopeptides	124-137	erythropoietin	Homo sapiens	202-216
23909558-7	2013	By implementing the rules into an algorithm to score potential assignments against ETD-MS/MS data, we applied the method to glycopeptides generated from various O-glycosylated proteins including mucin, erythropoietin, fetuin, and an HIV envelope protein, 1086.C gp120.	Glycopeptides	124-137	inter-alpha-trypsin inhibitor heavy chain 4	Homo sapiens	262-267
23535562-0	2013	One-pot multi-enzyme (OPME) chemoenzymatic synthesis of sialyl-Tn-MUC1 and sialyl-T-MUC1 glycopeptides containing natural or non-natural sialic acid.	Glycopeptides	89-102	mucin 1, cell surface associated	Homo sapiens	84-88
23535562-1	2013	A series of STn-MUC1 and ST-MUC1 glycopeptides containing naturally occurring and non-natural sialic acids have been chemoenzymatically synthesized from Tn-MUC1 glycopeptide using one-pot multienzyme (OPME) approaches.	Glycopeptides	33-46	eukaryotic translation elongation factor 1 alpha 2	Homo sapiens	12-15
23535562-1	2013	A series of STn-MUC1 and ST-MUC1 glycopeptides containing naturally occurring and non-natural sialic acids have been chemoenzymatically synthesized from Tn-MUC1 glycopeptide using one-pot multienzyme (OPME) approaches.	Glycopeptides	33-46	mucin 1, cell surface associated	Homo sapiens	28-32
23535562-1	2013	A series of STn-MUC1 and ST-MUC1 glycopeptides containing naturally occurring and non-natural sialic acids have been chemoenzymatically synthesized from Tn-MUC1 glycopeptide using one-pot multienzyme (OPME) approaches.	Glycopeptides	33-46	mucin 1, cell surface associated	Homo sapiens	28-32
23535562-1	2013	A series of STn-MUC1 and ST-MUC1 glycopeptides containing naturally occurring and non-natural sialic acids have been chemoenzymatically synthesized from Tn-MUC1 glycopeptide using one-pot multienzyme (OPME) approaches.	Glycopeptides	33-45	eukaryotic translation elongation factor 1 alpha 2	Homo sapiens	12-15
23535562-1	2013	A series of STn-MUC1 and ST-MUC1 glycopeptides containing naturally occurring and non-natural sialic acids have been chemoenzymatically synthesized from Tn-MUC1 glycopeptide using one-pot multienzyme (OPME) approaches.	Glycopeptides	33-45	mucin 1, cell surface associated	Homo sapiens	28-32
23535562-1	2013	A series of STn-MUC1 and ST-MUC1 glycopeptides containing naturally occurring and non-natural sialic acids have been chemoenzymatically synthesized from Tn-MUC1 glycopeptide using one-pot multienzyme (OPME) approaches.	Glycopeptides	33-45	mucin 1, cell surface associated	Homo sapiens	28-32
23732560-0	2013	Convergent synthesis of MUC1 glycopeptides via serine ligation.	Glycopeptides	29-42	mucin 1, cell surface associated	Homo sapiens	24-28
23829323-9	2013	We further demonstrate the effectiveness of this approach by analyzing plasma-derived haptoglobin, identifying 136 N-linked glycopeptide spectra at a false discovery rate of 0.4%, representing 15 distinct glycopeptides on at least three of the four N-linked glycosylation sites.	Glycopeptides	205-218	haptoglobin	Homo sapiens	86-97
23831758-3	2013	We report here the design, synthesis and antigenic evaluation of new cyclic V1V2 glycopeptides carrying defined N-linked glycans at the conserved glycosylation sites (Asn160 and Asn156 or Asn173) derived from gp120 of two HIV-1 isolates.	Glycopeptides	81-94	inter-alpha-trypsin inhibitor heavy chain 4	Homo sapiens	209-214
23732560-1	2013	Syntheses of MUC1 glycopeptides (40-mer and 80-mer) are described.	Glycopeptides	18-31	mucin 1, cell surface associated	Homo sapiens	13-17
23616304-0	2013	Self-adjuvanting synthetic antitumor vaccines from MUC1 glycopeptides conjugated to T-cell epitopes from tetanus toxoid.	Glycopeptides	56-69	mucin 1, cell surface associated	Homo sapiens	51-55
23676437-2	2013	A cluster of genes homologous to enterococcal glycopeptides resistance vanG genes was found in the genome of C. difficile 630, although this strain remains sensitive to vancomycin.	Glycopeptides	46-59	D-alanine--D-serine ligase VanG-Cd	Clostridioides difficile 630	71-75
23380952-6	2013	In this study, 3-AQ/CHCA LM was applied to tryptic digests of HER2 to reveal its N-glycosylation state and to evaluate the utility of this LM in characterizing glycopeptides.	Glycopeptides	160-173	erb-b2 receptor tyrosine kinase 2	Homo sapiens	62-66
23652307-2	2013	As we have found autoantibodies to MUC1 glycopeptides to be elevated in early-stage breast cancer patients, in this study we analysed these autoantibodies in large population cohorts of sera taken before cancer diagnosis.	Glycopeptides	40-53	mucin 1, cell surface associated	Homo sapiens	35-39
23256149-6	2013	Comparison of mono-, di- and triarabinosylated CLV3 glycopeptides revealed that the biological activity increased progressively as the arabinose chain length increased.	Glycopeptides	52-65	CLAVATA3	Arabidopsis thaliana	47-51
23389048-9	2013	The exoglycosidase-assisted LC-MS-MRM workflow, optimized for the quantification of fucosylated glycoforms of haptoglobin, can be used for quantification of these glycoforms on other glycopeptides with appropriate analytical behavior.	Glycopeptides	183-196	haptoglobin	Homo sapiens	110-121
22381366-2	2012	Synthetic cluster glycopeptides (e.g., triGalNAc) bind with high affinity to ASGP-R and, when conjugated to a therapeutic agent, can drive receptor-mediated uptake in liver.	Glycopeptides	18-31	mucin 4, cell surface associated	Rattus norvegicus	77-81
23280874-3	2013	A new thioether-ligation method for the synthesis of two- and three-component vaccines that contain MUC1 glycopeptides as the B-cell epitopes, a T-cell epitope peptide, and the Pam(3)CSK(4) lipopeptide is described.	Glycopeptides	105-118	mucin 1, transmembrane	Mus musculus	100-104
23934307-0	2013	Root-derived CLE glycopeptides control nodulation by direct binding to HAR1 receptor kinase.	Glycopeptides	17-30	CM0216.560.nc	Lotus japonicus	71-75
23023583-6	2012	The immunogenicity of synthetic MUC1 glycopeptides bearing Tn or sialyl-Tn antigens have been studied in mouse models, while authentic glyco-epitopes expressed by tumor cells remain unclear.	Glycopeptides	37-50	mucin 1, transmembrane	Mus musculus	32-36
23023583-8	2012	Antibody responses to individual glyco-epitopes were determined by chemically synthesized candidate MUC1 glycopeptides predicted through computational glycomics.	Glycopeptides	105-118	mucin 1, transmembrane	Mus musculus	100-104
22559037-0	2012	HIV inhibition by CD4 and CCR5-derived glycopeptides.	Glycopeptides	39-52	C-C motif chemokine receptor 5	Homo sapiens	26-30
22559037-10	2012	Notably, the combination of CD4 and CCR5 glycopeptides enhanced the neutralization potential as compared to the single peptides.	Glycopeptides	41-54	C-C motif chemokine receptor 5	Homo sapiens	36-40
22265686-9	2012	GENERAL SIGNIFICANCE: Novel glycomics designated for investigating proteoglycan biosynthesis, namely real-time GAGomics using synthetic glycopeptides as PGIs, should facilitate greatly dynamic profiling of GAGs in the living cells.	Glycopeptides	136-149	prostaglandin I2 synthase	Homo sapiens	153-157
22393263-1	2012	Improved enrichment methods for mucin core-1 type glycopeptides.	Glycopeptides	50-63	LOC100508689	Homo sapiens	32-37
22393263-3	2012	Bovine serum samples were subjected to lectin affinity-chromatography both at the protein- and peptide-level in order to selectively isolate glycopeptides with the most common, mucin core-1 sugar.	Glycopeptides	141-154	LOC100508689	Homo sapiens	177-182
22678432-2	2012	This protocol describes workflows for the characterization of glycopeptides and their site-specific heterogeneity, showing examples of the analysis of recombinant human erythropoietin (rHuEPO), alpha1-proteinase inhibitor (A1PI) and immunoglobulin (IgG).	Glycopeptides	62-75	erythropoietin	Homo sapiens	169-183
23113753-8	2013	In a subset of patients who received initial treatment with glycopeptides, only the patients whose isolates were hVISA(+)/BIVR(+) displayed a significantly higher mortality rate in comparison to those with non-hVISA(+)/BIVR(+) (80.0% vs 31.3%, p = 0.004).	Glycopeptides	60-73	mitochondrial antiviral signaling protein	Homo sapiens	113-118
23113753-8	2013	In a subset of patients who received initial treatment with glycopeptides, only the patients whose isolates were hVISA(+)/BIVR(+) displayed a significantly higher mortality rate in comparison to those with non-hVISA(+)/BIVR(+) (80.0% vs 31.3%, p = 0.004).	Glycopeptides	60-73	mitochondrial antiviral signaling protein	Homo sapiens	210-215
23259747-0	2013	Site-specific conformational alteration induced by sialylation of MUC1 tandem repeating glycopeptides at an epitope region for the anti-KL-6 monoclonal antibody.	Glycopeptides	88-101	mucin 1, cell surface associated	Homo sapiens	66-70
23259747-3	2013	Systematic nuclear magnetic resonance (NMR) study revealed that sialylation of the MUC1 tandem repeating glycopeptide, Pro-Pro-Ala-His-Gly-Val-Thr-Ser-Ala-Pro-Asp-Thr-Arg-Pro-Ala-Pro-Gly-Ser-Thr-Ala with core 2-type O-glycans at five potential glycosylation sites, afforded a specific conformational change at one of the most important cancer-relevant epitopes (Pro-Asp-Thr-Arg).	Glycopeptides	105-117	mucin 1, cell surface associated	Homo sapiens	83-87
23943488-3	2013	This will be exemplified for mucin-type glycopeptides and the construction of glycopeptide microarrays.	Glycopeptides	40-53	LOC100508689	Homo sapiens	29-34
22444368-6	2012	Features of the native mucin motifs impact their relative immunogenicity and are accurately encoded in the antibody binding site, with the conformational integrity being preserved in isolated glycopeptides, as reflected in the antibody binding profile to array components.	Glycopeptides	192-205	LOC100508689	Homo sapiens	23-28
21822974-7	2012	The few cases of MR-hVISA infections evaluated in our study demonstrated that 5 out of 9 patients (55%) receiving a glycopeptide, died.	Glycopeptides	116-128	mitochondrial antiviral signaling protein	Homo sapiens	20-25
21780104-9	2012	In particular, fucosylation at Asn 241 of beta-Hp in sera of colon cancer patients was clearly higher than in the other groups, and the ratio of fucosylated glycopeptides containing Asn 241 decreased greatly after treatment with alpha1-3/4 fucosidase.	Glycopeptides	157-170	adrenoceptor alpha 1D	Homo sapiens	229-237
22042768-0	2012	Elucidation of the sugar recognition ability of the lectin domain of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3 by using unnatural glycopeptide substrates.	Glycopeptides	147-159	polypeptide N-acetylgalactosaminyltransferase 3	Homo sapiens	69-127
22329400-8	2012	(iii) Studies of [14C] sialylated human sera showed larger mucin glycopeptides and >2-fold larger mucin-type chains in human serum compared to [14C]sialyl labeled glycans of fetuin.	Glycopeptides	65-78	LOC100508689	Homo sapiens	59-64
22042768-4	2012	Here, we report a new strategy to give insight on the sugar recognition ability and the function of the GalNAc-T3 lectin domain using chemically synthesized natural-type (alpha-GalNAc-O-Thr) and unnatural-type [beta-GalNAc-O-Thr, alpha-Fuc-O-Thr and beta-GlcNAc-O-Thr] MUC5AC glycopeptides.	Glycopeptides	276-289	polypeptide N-acetylgalactosaminyltransferase 3	Homo sapiens	104-113
21768105-6	2011	Using a glycopeptide array with a library of synthetic and recombinant glycopeptides based on sequences of mucins MUC1, MUC2, MUC4, MUC5AC, MUC6, and MUC7 as well as a random glycopeptide bead library, we examined the binding properties of four different lectin domains.	Glycopeptides	71-84	mucin 1, cell surface associated	Homo sapiens	114-118
22539431-7	2012	The rKLK6 glycoform composition of each peak was assessed by lectin affinity and MS/MS based glycopeptide quantification by product ion monitoring.	Glycopeptides	93-105	kallikrein related-peptidase 6	Rattus norvegicus	4-9
22365600-3	2012	We report the molecular details of the interaction of a bacterial O-GlcNAcase homolog with three different synthetic glycopeptides derived from characterized O-GlcNAc sites in the human proteome.	Glycopeptides	117-130	O-GlcNAcase	Homo sapiens	66-77
22365600-3	2012	We report the molecular details of the interaction of a bacterial O-GlcNAcase homolog with three different synthetic glycopeptides derived from characterized O-GlcNAc sites in the human proteome.	Glycopeptides	117-130	O-linked N-acetylglucosamine (GlcNAc) transferase	Homo sapiens	66-74
22122935-0	2012	Analysis of recombinant human erythropoietin glycopeptides by capillary electrophoresis electrospray-time of flight-mass spectrometry.	Glycopeptides	45-58	erythropoietin	Homo sapiens	30-44
22122935-3	2012	Neuraminidase was first used to enhance the detection of the glycopeptides and detect all possible glycoforms contained in each glycosylation site.	Glycopeptides	61-74	neuraminidase 1	Homo sapiens	0-13
22081384-5	2012	All five glycopeptides contained the hydroxy-amino acids serine and threonine, suggesting that Acm2 is O-glycosylated.	Glycopeptides	9-22	cell wall hydrolase	Lactobacillus plantarum WCFS1	95-99
23272204-8	2012	Tryptic glycopeptides of Hpt were also analyzed by mass spectrometry, and a decreased amount of sialylated glycan chains was found in glycopeptides of skin Hpt, as compared with Hpt from plasma.	Glycopeptides	134-147	haptoglobin	Homo sapiens	156-159
23272204-8	2012	Tryptic glycopeptides of Hpt were also analyzed by mass spectrometry, and a decreased amount of sialylated glycan chains was found in glycopeptides of skin Hpt, as compared with Hpt from plasma.	Glycopeptides	134-147	haptoglobin	Homo sapiens	156-159
22253738-1	2012	Glycopeptides are still the gold standard to treat MRSA (Methicillin Resistant Staphylococcus aureus) infections, but their widespread use has led to vancomycin-reduced susceptibility [heterogeneous Vancomycin-Intermediate-Staphylococcus aureus (hVISA) and Vancomycin-Intermediate-Staphylococcus aureus (VISA)], in which different genetic loci (regulatory, autolytic, cell-wall turnover and cell-envelope positive charge genes) are involved.	Glycopeptides	0-13	mitochondrial antiviral signaling protein	Homo sapiens	246-251
22253738-1	2012	Glycopeptides are still the gold standard to treat MRSA (Methicillin Resistant Staphylococcus aureus) infections, but their widespread use has led to vancomycin-reduced susceptibility [heterogeneous Vancomycin-Intermediate-Staphylococcus aureus (hVISA) and Vancomycin-Intermediate-Staphylococcus aureus (VISA)], in which different genetic loci (regulatory, autolytic, cell-wall turnover and cell-envelope positive charge genes) are involved.	Glycopeptides	0-13	mitochondrial antiviral signaling protein	Homo sapiens	247-251
22180206-8	2011	This study demonstrates the capabilities of ETD MS/MS for site-specific characterisation of mucin-type glycopeptides containing high-density O-linked glycan clusters, using accessible and relative low-resolution/low-mass accuracy IT MS instrumentation.	Glycopeptides	103-116	LOC100508689	Homo sapiens	92-97
21898809-3	2011	A new method was developed to selectively enrich glycopeptides from complex sample by coupling C18 fractionation with titanium dioxide (TiO(2)) enrichment.	Glycopeptides	49-62	Bardet-Biedl syndrome 9	Homo sapiens	95-98
21959619-6	2011	CONCLUSIONS: The thickened nerve fiber layer was probably caused by accumulation of metabolic products such as sialylated oligosaccharides and glycopeptides, suggesting that SD- OCT, due to its enhanced resolution, can be a useful tool for diagnosis of rare neurological conditions.	Glycopeptides	143-156	plexin A2	Homo sapiens	178-181
21880669-2	2012	KL-6/mAb is thought to recognize the specific glycopeptides sequence of MUC1, but the precise glycan structure of the epitope is unclear.	Glycopeptides	46-59	mucin 1, cell surface associated	Homo sapiens	0-8
21880669-2	2012	KL-6/mAb is thought to recognize the specific glycopeptides sequence of MUC1, but the precise glycan structure of the epitope is unclear.	Glycopeptides	46-59	mucin 1, cell surface associated	Homo sapiens	72-76
22970605-3	2012	Copeptin is a glycopeptide of 39 amino acid residues that is cleaved from a precursor of ADH and secreted to the circulation in an equimolar manner with ADH.	Glycopeptides	14-26	arginine vasopressin	Homo sapiens	0-8
22970605-3	2012	Copeptin is a glycopeptide of 39 amino acid residues that is cleaved from a precursor of ADH and secreted to the circulation in an equimolar manner with ADH.	Glycopeptides	14-26	arginine vasopressin	Homo sapiens	89-92
22970605-3	2012	Copeptin is a glycopeptide of 39 amino acid residues that is cleaved from a precursor of ADH and secreted to the circulation in an equimolar manner with ADH.	Glycopeptides	14-26	arginine vasopressin	Homo sapiens	153-156
22259131-1	2012	The characterization of mucin-type O-glycosylation is fraught with extreme difficulty at almost every level of analysis: from difficulties in obtaining glycopeptides suitable for study, their structural heterogeneity, lack of broad acting glycosidase tools capable of simplifying the glycans, and finally the vast complexity of performing analysis on multiply glycosylated glycopeptides.	Glycopeptides	152-165	LOC100508689	Homo sapiens	24-29
22259131-1	2012	The characterization of mucin-type O-glycosylation is fraught with extreme difficulty at almost every level of analysis: from difficulties in obtaining glycopeptides suitable for study, their structural heterogeneity, lack of broad acting glycosidase tools capable of simplifying the glycans, and finally the vast complexity of performing analysis on multiply glycosylated glycopeptides.	Glycopeptides	373-386	LOC100508689	Homo sapiens	24-29
23272204-8	2012	Tryptic glycopeptides of Hpt were also analyzed by mass spectrometry, and a decreased amount of sialylated glycan chains was found in glycopeptides of skin Hpt, as compared with Hpt from plasma.	Glycopeptides	134-147	haptoglobin	Homo sapiens	25-28
21768105-6	2011	Using a glycopeptide array with a library of synthetic and recombinant glycopeptides based on sequences of mucins MUC1, MUC2, MUC4, MUC5AC, MUC6, and MUC7 as well as a random glycopeptide bead library, we examined the binding properties of four different lectin domains.	Glycopeptides	71-84	mucin 4, cell surface associated	Homo sapiens	126-130
21768105-6	2011	Using a glycopeptide array with a library of synthetic and recombinant glycopeptides based on sequences of mucins MUC1, MUC2, MUC4, MUC5AC, MUC6, and MUC7 as well as a random glycopeptide bead library, we examined the binding properties of four different lectin domains.	Glycopeptides	71-84	mucin 5AC, oligomeric mucus/gel-forming	Homo sapiens	132-138
21768105-7	2011	The lectin domains of GalNAc-T1, -T2, -T3, and -T4 bound different subsets of small glycopeptides.	Glycopeptides	84-97	polypeptide N-acetylgalactosaminyltransferase 1	Homo sapiens	22-31
21563953-7	2011	vanA-Enterococcus faecium isolates were recovered from 4 of 103 tested samples, and they showed glycopeptide and erythromycin resistances.	Glycopeptides	96-108	Vancomycin Teicoplanin A-type resistance protein VanA / D-alanine--D-alanine ligase	Enterococcus faecium	0-4
21712440-4	2011	In addition to 33 unglycosylated APP/Abeta peptides, we identified 37 APP/Abeta glycopeptides with sialylated core 1 like O-glycans attached to Thr(-39, -21, -20, and -13), in a series of APP/AbetaX-15 glycopeptides, where X was -63, -57, -52, and -45, in relation to Asp1 of the Abeta sequence.	Glycopeptides	202-215	amyloid beta precursor protein	Homo sapiens	74-79
21819298-8	2011	The profiling of sera immunoreactivity of colon cancer patients allowed the identification of cancer-associated autoantibodies to various mucin (MUC)1 and MUC4 glycopeptides carrying aberrant glycosylation.	Glycopeptides	160-173	mucin 4, cell surface associated	Homo sapiens	155-159
21712440-4	2011	In addition to 33 unglycosylated APP/Abeta peptides, we identified 37 APP/Abeta glycopeptides with sialylated core 1 like O-glycans attached to Thr(-39, -21, -20, and -13), in a series of APP/AbetaX-15 glycopeptides, where X was -63, -57, -52, and -45, in relation to Asp1 of the Abeta sequence.	Glycopeptides	80-93	amyloid beta precursor protein	Homo sapiens	74-79
21712440-4	2011	In addition to 33 unglycosylated APP/Abeta peptides, we identified 37 APP/Abeta glycopeptides with sialylated core 1 like O-glycans attached to Thr(-39, -21, -20, and -13), in a series of APP/AbetaX-15 glycopeptides, where X was -63, -57, -52, and -45, in relation to Asp1 of the Abeta sequence.	Glycopeptides	80-93	beta-secretase 2	Homo sapiens	268-272
21712440-4	2011	In addition to 33 unglycosylated APP/Abeta peptides, we identified 37 APP/Abeta glycopeptides with sialylated core 1 like O-glycans attached to Thr(-39, -21, -20, and -13), in a series of APP/AbetaX-15 glycopeptides, where X was -63, -57, -52, and -45, in relation to Asp1 of the Abeta sequence.	Glycopeptides	202-215	amyloid beta precursor protein	Homo sapiens	74-79
21712440-4	2011	In addition to 33 unglycosylated APP/Abeta peptides, we identified 37 APP/Abeta glycopeptides with sialylated core 1 like O-glycans attached to Thr(-39, -21, -20, and -13), in a series of APP/AbetaX-15 glycopeptides, where X was -63, -57, -52, and -45, in relation to Asp1 of the Abeta sequence.	Glycopeptides	80-93	amyloid beta precursor protein	Homo sapiens	74-79
21712440-5	2011	Unexpectedly, we also identified a series of 27 glycopeptides, the Abeta1-X series, where X was 20 (DAEFRHDSGYEVHHQKLVFF), 19, 18, 17, 16, and 15, which were all uniquely glycosylated on Tyr10.	Glycopeptides	48-61	AA1	Homo sapiens	67-73
21613225-5	2011	Surprisingly, mass spectrometric analysis of LIF glycopeptides enriched on the CI-MPR column revealed that all six N-glycan sites could be Man-6-P-modified.	Glycopeptides	49-62	LIF interleukin 6 family cytokine	Homo sapiens	45-48
21613225-5	2011	Surprisingly, mass spectrometric analysis of LIF glycopeptides enriched on the CI-MPR column revealed that all six N-glycan sites could be Man-6-P-modified.	Glycopeptides	49-62	insulin like growth factor 2 receptor	Homo sapiens	79-85
19477606-9	2011	The two patients with E. faecium VanA had been previously given glycopeptides for 10 days.	Glycopeptides	64-77	Vancomycin Teicoplanin A-type resistance protein VanA / D-alanine--D-alanine ligase	Enterococcus faecium	33-37
21455712-0	2011	Glycopeptide and daptomycin resistance in community-associated MRSA in the UK.	Glycopeptides	0-12	solute carrier family 9 member A6	Homo sapiens	63-67
21451866-2	2011	This derivative exhibits a similar affinity for a natural lectin as for the natural Tn and retains the bioactive conformation observed in the Tn-containing glycopeptides with anti-MUC1 antibodies.	Glycopeptides	156-169	mucin 1, cell surface associated	Homo sapiens	180-184
21538615-0	2011	Towards a fully synthetic MUC1-based anticancer vaccine: efficient conjugation of glycopeptides with mono-, di-, and tetravalent lipopeptides using click chemistry.	Glycopeptides	82-95	mucin 1, cell surface associated	Homo sapiens	26-30
21538615-4	2011	These fully synthetic vaccine candidates were prepared by solid-phase synthesis of the MUC1 glycopeptides.	Glycopeptides	92-105	mucin 1, cell surface associated	Homo sapiens	87-91
21469647-4	2011	The strategy described herein involves the analysis of a complex mixture of glycopeptides generated from immobilized-Pronase digestion of a cocktail of glycoproteins consisting of bovine lactoferrin, kappa casein, and bovine fetuin using nanoflow liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (nano-LC-Q-TOF MS).	Glycopeptides	76-89	lactotransferrin	Bos taurus	187-198
20598637-1	2010	Methicillin-resistant Staphylococcus aureus (MRSA) with decreased susceptibility to glycopeptides can be categorized as first, heteroresistant to vancomycin (hVISA); second, with intermediate susceptibility to vancomycin (VISA); and third, fully resistant to vancomycin (VRSA).	Glycopeptides	84-97	mitochondrial antiviral signaling protein	Homo sapiens	158-163
21443200-0	2011	Elucidation of glycoprotein structures by unspecific proteolysis and direct nanoESI mass spectrometric analysis of ZIC-HILIC-enriched glycopeptides.	Glycopeptides	134-147	Zic family member 1	Homo sapiens	115-118
21443200-5	2011	This method has now been refined for two aspects: (1) separation of glycopeptides by use of ZIC-HILIC SPE and (2) the use of unspecific proteases like thermolysin, elastase, or a trypsin/chymotrypsin mixture leading per se to a mass-based separation, that is, small nonglycosylated peptides and almost exclusively glycopeptides at higher m/z values.	Glycopeptides	68-81	Zic family member 1	Homo sapiens	92-95
21423632-6	2011	Synthesis and biological evaluation of the designed glycopeptides provided novel structure-activity relationship (SAR) understanding of binding to A(q) and DR4.	Glycopeptides	52-65	major histocompatibility complex, class II, DR beta 4	Homo sapiens	156-159
21264968-0	2011	An efficient approach for the characterization of mucin-type glycopeptides: the effect of O-glycosylation on the conformation of synthetic mucin peptides.	Glycopeptides	61-74	LOC100508689	Homo sapiens	50-55
21264968-0	2011	An efficient approach for the characterization of mucin-type glycopeptides: the effect of O-glycosylation on the conformation of synthetic mucin peptides.	Glycopeptides	61-74	LOC100508689	Homo sapiens	139-144
20878823-0	2010	Synthetic antitumor vaccines from tetanus toxoid conjugates of MUC1 glycopeptides with the Thomsen-Friedenreich antigen and a fluorine-substituted analogue.	Glycopeptides	68-81	mucin 1, cell surface associated	Homo sapiens	63-67
20823119-6	2010	To address this problem, we analyzed all glycoforms of the HR glycopeptides of a Gal-deficient IgA1 myeloma protein, mimicking the aberrant IgA1 in patients with IgAN, by use of a combination of IgA-specific proteases + trypsin and AI-ECD Fourier transform ion cyclotron resonance (FT-ICR) tandem mass spectrometry (MS/MS).	Glycopeptides	62-75	immunoglobulin heavy constant alpha 1	Homo sapiens	95-99
21344374-6	2011	Seromic profiling of patients with colorectal cancer identified cancer-associated autoantibodies to a set of aberrant glycopeptides derived from MUC1 and MUC4.	Glycopeptides	118-131	mucin 1, cell surface associated	Homo sapiens	145-149
21344374-6	2011	Seromic profiling of patients with colorectal cancer identified cancer-associated autoantibodies to a set of aberrant glycopeptides derived from MUC1 and MUC4.	Glycopeptides	118-131	mucin 4, cell surface associated	Homo sapiens	154-158
20598637-1	2010	Methicillin-resistant Staphylococcus aureus (MRSA) with decreased susceptibility to glycopeptides can be categorized as first, heteroresistant to vancomycin (hVISA); second, with intermediate susceptibility to vancomycin (VISA); and third, fully resistant to vancomycin (VRSA).	Glycopeptides	84-97	mitochondrial antiviral signaling protein	Homo sapiens	159-163
20563275-4	2010	By incorporation of T(N)-Fmoc-beta3hThr conjugate into the 20 amino acid tandem repeat sequence of MUC1 using sequential solid-phase glycopeptide synthesis, a first example of a mixed alpha/beta-hybrid glycopeptide building block was obtained.	Glycopeptides	133-145	mucin 1, cell surface associated	Homo sapiens	99-103
20726594-6	2010	As proof-of-concept, we have demonstrated that MUC1 glycopeptides could be assembled and used to detect autoantibodies in vaccine-induced disease-free breast cancer patients and in patients with confirmed disease at time of diagnosis.	Glycopeptides	52-65	mucin 1, cell surface associated	Homo sapiens	47-51
20574591-1	2010	MUC1 glycopeptide was efficiently coupled to glycosylphosphatidylinositol (GPI) derivatives by sortase A (SrtA), verifying that SrtA can accept sterically hindered glycopeptide as substrate for ligation with GPIs.	Glycopeptides	5-17	mucin 1, cell surface associated	Homo sapiens	0-4
20429820-12	2010	CONCLUSION: The results of this meta-analysis suggest higher success rates for linezolid and the new glycopeptides (dalbavancin and telavancin) in MRSA-confirmed cSSTIs.	Glycopeptides	101-114	solute carrier family 9 member A6	Homo sapiens	147-151
20335177-8	2010	Liquid chromatography/multiple-stage mass spectrometry analysis of Glu-C glycopeptides of each VN determined the site-specific glycosylation.	Glycopeptides	73-86	vitronectin	Rattus norvegicus	95-97
20563275-4	2010	By incorporation of T(N)-Fmoc-beta3hThr conjugate into the 20 amino acid tandem repeat sequence of MUC1 using sequential solid-phase glycopeptide synthesis, a first example of a mixed alpha/beta-hybrid glycopeptide building block was obtained.	Glycopeptides	202-214	mucin 1, cell surface associated	Homo sapiens	99-103
19819901-6	2010	The recombinant tomato PNGase showed optimum activity at pH 4.5 and 40 degrees C. It did not require any metal ions for full enzymatic activity and could release the complex-type N-glycan from glycopeptides.	Glycopeptides	193-206	peptide N-glycanase	Solanum lycopersicum	23-29
20209506-0	2010	Characterization of sialylated and fucosylated glycopeptides of beta2-glycoprotein I by a combination of HILIC LC and MALDI MS/MS.	Glycopeptides	47-60	apolipoprotein H	Homo sapiens	64-84
20415687-1	2010	AIM: To design, manufacture and test a second generation leptin receptor (ObR) agonist glycopeptide derivative.	Glycopeptides	87-99	leptin	Mus musculus	57-63
20816477-4	2010	Additionally, we have developed an in vivo production system for mammalian mucin-type glycopeptides using a genetically engineered yeast strain.	Glycopeptides	86-99	LOC100508689	Homo sapiens	75-80
20043307-2	2010	After investigation and optimization of various surface materials, surface chemistries and reaction parameters, microstructures and microarrays of biotin, oligonucleotides, peptides, and MUC1 tandem repeat glycopeptides were prepared with this photoimmobilization method.	Glycopeptides	206-219	mucin 1, transmembrane	Mus musculus	187-191
20091489-2	2010	To pursue this diagnostic approach, we used mass spectrometric analysis to search for specific structures in IgA1 hinge glycopeptides in 30 IgAN patients contrasted with 30 healthy controls.	Glycopeptides	120-133	immunoglobulin heavy constant alpha 1	Homo sapiens	109-113
20091489-2	2010	To pursue this diagnostic approach, we used mass spectrometric analysis to search for specific structures in IgA1 hinge glycopeptides in 30 IgAN patients contrasted with 30 healthy controls.	Glycopeptides	120-133	IGAN1	Homo sapiens	140-144
20091489-11	2010	These results open the possibility for preparation of lectin and/or antibodies binding to specific glycopeptides in IgAN.	Glycopeptides	99-112	IGAN1	Homo sapiens	116-120
20816484-13	2010	Here, we present examples of fluorescence-based solid-phase assays to study P- and L-selectin and galectin-1 binding to immobilized glycopeptides, oligosaccharides, and cells.	Glycopeptides	132-145	selectin L	Homo sapiens	83-93
20816484-13	2010	Here, we present examples of fluorescence-based solid-phase assays to study P- and L-selectin and galectin-1 binding to immobilized glycopeptides, oligosaccharides, and cells.	Glycopeptides	132-145	galectin 1	Homo sapiens	98-108
19007994-2	2009	The latter results in appearance of new antigenic tumor specific glycopeptides not found on normal glycoforms of the mucin.	Glycopeptides	65-78	LOC100508689	Homo sapiens	117-122
19852465-1	2009	An efficient protocol for the construction of MUC1-related glycopeptide analogues having complex O-glycan and N-glycan chains was established by integrating chemical and enzymatic approaches on the functional polymer platforms.	Glycopeptides	59-71	mucin 1, cell surface associated	Homo sapiens	46-50
20161377-3	2009	Here we describe new methods for the synthesis of glycopeptides that have emerged from the erythropoietin adventure, including the development of unique C-terminal acyl donors, novel amide bond forming methods, and new ligation and coupling strategies.	Glycopeptides	50-63	erythropoietin	Homo sapiens	91-105
19899793-4	2009	In the present study, a novel compound library of synthetic MUC1 glycopeptides allowed the first rapid and precise evaluation of the specific epitope structure of anti-KL-6 MAb by combined use of a tailored glycopeptides library and common ELISA protocol.	Glycopeptides	65-78	mucin 1, cell surface associated	Homo sapiens	60-64
19899793-4	2009	In the present study, a novel compound library of synthetic MUC1 glycopeptides allowed the first rapid and precise evaluation of the specific epitope structure of anti-KL-6 MAb by combined use of a tailored glycopeptides library and common ELISA protocol.	Glycopeptides	65-78	mucin 1, cell surface associated	Homo sapiens	168-172
19899793-4	2009	In the present study, a novel compound library of synthetic MUC1 glycopeptides allowed the first rapid and precise evaluation of the specific epitope structure of anti-KL-6 MAb by combined use of a tailored glycopeptides library and common ELISA protocol.	Glycopeptides	207-220	mucin 1, cell surface associated	Homo sapiens	60-64
19899793-4	2009	In the present study, a novel compound library of synthetic MUC1 glycopeptides allowed the first rapid and precise evaluation of the specific epitope structure of anti-KL-6 MAb by combined use of a tailored glycopeptides library and common ELISA protocol.	Glycopeptides	207-220	mucin 1, cell surface associated	Homo sapiens	168-172
19899793-10	2009	In other words, combined use of anti-KL-6 MAb and some probes that can differentiate the sugars substituted at the O-6 position of the GalNAc residue in MUC1 glycopeptides including the PDTRPAP sequence might be a promising diagnostic protocol for individual disease-specific biomarkers.	Glycopeptides	158-171	mucin 1, cell surface associated	Homo sapiens	37-41
19899793-10	2009	In other words, combined use of anti-KL-6 MAb and some probes that can differentiate the sugars substituted at the O-6 position of the GalNAc residue in MUC1 glycopeptides including the PDTRPAP sequence might be a promising diagnostic protocol for individual disease-specific biomarkers.	Glycopeptides	158-171	mucin 1, cell surface associated	Homo sapiens	153-157
19007994-4	2009	No study has yet reported presentation of MUC1 glycopeptides on MHC class I molecules as stimulators of cytotoxic T-cells.	Glycopeptides	47-60	mucin 1, cell surface associated	Homo sapiens	42-46
19674964-0	2009	Affinity enrichment and characterization of mucin core-1 type glycopeptides from bovine serum.	Glycopeptides	62-75	LOC100508689	Homo sapiens	44-49
19007994-5	2009	In this study we show that human immunoproteasomes and cathepsin-L can generate octa to undecameric glycopeptides from the MUC1 repeat domain in vitro.	Glycopeptides	100-113	cathepsin L	Homo sapiens	55-66
19007994-5	2009	In this study we show that human immunoproteasomes and cathepsin-L can generate octa to undecameric glycopeptides from the MUC1 repeat domain in vitro.	Glycopeptides	100-113	mucin 1, cell surface associated	Homo sapiens	123-127
19524017-0	2009	Site directed processing: role of amino acid sequences and glycosylation of acceptor glycopeptides in the assembly of extended mucin type O-glycan core 2.	Glycopeptides	85-98	LOC100508689	Homo sapiens	127-132
19453144-7	2009	The resulting fucosylated glycopeptides were subjected to two different runs of LC-MSn using a Fourier- transform ion cyclotron resonance mass spectrometer (FTICR-MS) and an ion trap-type mass spectrometer.	Glycopeptides	26-39	moesin	Mus musculus	83-86
19387707-2	2009	Compared with vancomycin-susceptible S. aureus (n = 30), hVISA and VISA infections (n = 10) are found to be associated with a longer period of prior glycopeptide use (P = 0.01), bone/joint (P < 0.01) and prosthetic infections (P = 0.04), as well as treatment failure, as evidenced by longer bacteremic (P < 0.01) and culture positivity (P < 0.01) periods.	Glycopeptides	149-161	mitochondrial antiviral signaling protein	Homo sapiens	57-62
19387707-2	2009	Compared with vancomycin-susceptible S. aureus (n = 30), hVISA and VISA infections (n = 10) are found to be associated with a longer period of prior glycopeptide use (P = 0.01), bone/joint (P < 0.01) and prosthetic infections (P = 0.04), as well as treatment failure, as evidenced by longer bacteremic (P < 0.01) and culture positivity (P < 0.01) periods.	Glycopeptides	149-161	mitochondrial antiviral signaling protein	Homo sapiens	58-62
19426130-7	2009	We conclude that MUC1 glycopeptides induce stronger immunity in MUC1-Tg mice because they are recognized as "foreign" rather than ;self" and because they are cross-presented preferentially by DCs.	Glycopeptides	22-35	mucin 1, transmembrane	Mus musculus	17-21
19426130-7	2009	We conclude that MUC1 glycopeptides induce stronger immunity in MUC1-Tg mice because they are recognized as "foreign" rather than ;self" and because they are cross-presented preferentially by DCs.	Glycopeptides	22-35	mucin 1, transmembrane	Mus musculus	64-68
19129245-6	2009	More interestingly, a comparison of the N-glycans released from the MBP-binding and non-MBP-binding glycopeptides suggested that complex-type N-glycans carrying a minimum of 4 Le(a)/Le(b) epitopes arranged either as multimeric tandem repeats or terminal epitopes on multiantennary structures are critically important for the high affinity binding to MBP.	Glycopeptides	100-113	myelin basic protein	Homo sapiens	88-91
19203595-1	2009	Determination of O-glycosylation sites in glycopeptides was developed by using two model compounds designed from mucin2 tandem repeat motif and erythropoietin.	Glycopeptides	42-55	mucin 2, oligomeric mucus/gel-forming	Homo sapiens	113-119
19129245-6	2009	More interestingly, a comparison of the N-glycans released from the MBP-binding and non-MBP-binding glycopeptides suggested that complex-type N-glycans carrying a minimum of 4 Le(a)/Le(b) epitopes arranged either as multimeric tandem repeats or terminal epitopes on multiantennary structures are critically important for the high affinity binding to MBP.	Glycopeptides	100-113	myelin basic protein	Homo sapiens	88-91
19088067-7	2009	After transfection in COS7 cells, the three FUT10s and at least one FUT11, link alpha-l-fucose onto conalbumin glycopeptides and biantennary N-glycan acceptors but not onto short lactosaminyl acceptor substrates as do classical monoexonic alpha1,3-fucosyltransferases.	Glycopeptides	111-124	fucosyltransferase 11	Homo sapiens	68-73
19244429-1	2009	nov., a glycopeptide-resistant species isolated from human faeces.	Glycopeptides	8-20	cellular communication network factor 3	Homo sapiens	0-3
19236026-1	2009	This paper reports the synthesis of a 40-residue glycopeptide having two antigenic sialyl-T(N) (NeuAc-alpha-(2,6)-GalNAc-Thr) residues in the MUC1 sequence.	Glycopeptides	49-61	mucin 1, cell surface associated	Homo sapiens	142-146
19074376-2	2009	In their free-living state, S. meliloti and B. abortus mutants lacking BacA have reductions in their outer membrane lipid A very-long-chain fatty acid (VLCFA) contents and exhibit low-level resistance to the glycopeptide bleomycin in comparison to their respective parent strains.	Glycopeptides	208-220	putative udecaprenol kinase BacA	Escherichia coli	71-75
19180724-0	2008	The interaction of mannose binding lectin (MBL) with mannose containing glycopeptides and the resultant potential impact on invasive fungal infection.	Glycopeptides	72-85	mannose-binding lectin (protein C) 2	Mus musculus	43-46
19099505-2	2009	To assess the reliability of this method for determining the fucosylation levels of glycoproteins, we conducted mass spectrometry of fucosylated glycopeptides from transferrin and haptoglobin.	Glycopeptides	145-158	transferrin	Homo sapiens	164-175
19099505-3	2009	The biantennary glycans containing antenna alpha1,3/4 fucose or alpha1,6 core fucose showed different fragmentation behaviors in collision-induced dissociation of protonated glycopeptides.	Glycopeptides	174-187	adrenoceptor alpha 1D	Homo sapiens	43-51
19099505-3	2009	The biantennary glycans containing antenna alpha1,3/4 fucose or alpha1,6 core fucose showed different fragmentation behaviors in collision-induced dissociation of protonated glycopeptides.	Glycopeptides	174-187	adrenoceptor alpha 1D	Homo sapiens	64-72
19099505-9	2009	The mass spectrometric profiling of glycopeptides from transferrin of congenital disorders of glycosylation (CDG-Ia and CDG-IIc) patients demonstrated that the elevation or reduction of fucosylation in pathological conditions can be reliably determined by MS of glycopeptides.	Glycopeptides	36-49	transferrin	Homo sapiens	55-66
18220508-6	2008	We also describe a new experimental vaccine model for the generation of CD8+ cytotoxic T cells (CTL) that involves designer TACA-containing glycopeptides with high affinity for class I molecules of the major histocompatibility complex (MHC).	Glycopeptides	140-153	CD8a molecule	Homo sapiens	72-75
18562306-4	2008	We demonstrate that the lectin domain of hT2 directs glycosylation site selection for glycopeptide substrates.	Glycopeptides	86-98	solute carrier family 25 member 5	Homo sapiens	41-44
18563860-7	2008	The technique described herein provides a mean to detect glycopeptides from commercially available pharmaceutical preparations of rhEPO with the sensitivity required to analyze pmol amounts of hEPO, which could ultimately lead to the identification of structural differences between the recombinant and the human forms of the hormone.	Glycopeptides	57-70	erythropoietin	Homo sapiens	131-135
18272656-6	2008	We verified this approach with the 150 serotransferrin glycopeptide spectra, where we automatically generated 10(5) putative interpretations from >10(9) theoretical glycopeptides.	Glycopeptides	168-181	transferrin	Homo sapiens	39-54
18683685-12	2008	Twelve vancomycin-resistant Enterococcus faecium isolates showed incongruence between phenotype and genotype for glycopeptides resistance (vanA genotype and vanB phenotype).	Glycopeptides	113-126	Vancomycin Teicoplanin A-type resistance protein VanA / D-alanine--D-alanine ligase	Enterococcus faecium	139-143
18178603-7	2008	Furthermore, we examined the O-glycan structure of IgA1 hinge glycopeptides by mass spectrometry (MS).	Glycopeptides	62-75	immunoglobulin heavy constant alpha 1	Homo sapiens	51-55
18178603-11	2008	MS showed that peak distribution of IgA1 hinge glycopeptides was shifted to smaller molecular weights in high HAA-IgA-binding IgAN patients.	Glycopeptides	47-60	immunoglobulin heavy constant alpha 1	Homo sapiens	36-40
18178603-11	2008	MS showed that peak distribution of IgA1 hinge glycopeptides was shifted to smaller molecular weights in high HAA-IgA-binding IgAN patients.	Glycopeptides	47-60	IGAN1	Homo sapiens	126-130
17592722-12	2007	It was shown that the presence of Fbs1 perturb the activity of PNGase toward high-mannose-type glycopeptides.	Glycopeptides	95-108	F-box protein 2	Homo sapiens	34-38
17766267-8	2007	The improved enzyme CgtB(OH4384)DeltaC-MalE was used to galactosylate a glyco-peptide acceptor based on the interferon alpha2b protein O-linked glycosylation site as confirmed by the CE-MS analysis of the reaction products.	Glycopeptides	72-85	interferon alpha 2	Homo sapiens	108-126
17960575-5	2007	Glycopeptides derived from all three N-glycosylation sites of FETUA were observed, and the corresponding CID spectra proved the respective glycans to be oligosaccharides of the triantennary complex type.	Glycopeptides	0-13	alpha 2-HS glycoprotein	Homo sapiens	62-67
17960575-7	2007	An in-solution tryptic/chymotryptic digest of human transferrin (TRFE) was analyzed directly for glycopeptides subsequent to the addition of methanol and formic acid.	Glycopeptides	97-110	transferrin	Homo sapiens	52-63
17960575-7	2007	An in-solution tryptic/chymotryptic digest of human transferrin (TRFE) was analyzed directly for glycopeptides subsequent to the addition of methanol and formic acid.	Glycopeptides	97-110	transferrin	Homo sapiens	65-69
17960575-8	2007	Disialylated diantennary glycans were observed in glycopeptides of both N-glycosylation sites of TRFE.	Glycopeptides	50-63	transferrin	Homo sapiens	97-101
17720138-3	2007	Inspection of the NMR data obtained by use of the isotopically labeled glycopeptide indicated that Fbs1 interacts with sugar-peptide junctions, which are shielded in native glycoprotein, in many cases, but become accessible to Fbs1 in unfolded glycoproteins.	Glycopeptides	71-83	fibrosin	Homo sapiens	99-103
17602511-6	2007	We showed by confocal microscopy and flow cytometry that fluorescent-labeled Melan-A glycoclusters containing either dimannoside or Lewis oligosaccharide were taken up by DC and concentrated in acidic vesicles; conversely lactoside glycopeptides were not at all taken up.	Glycopeptides	232-245	melan-A	Homo sapiens	77-84
17804752-4	2007	Glycopeptides corresponding to three tandem repeats of MUC1, enzymatically glycosylated with 9 or 15 mol of GalNAc, were shown to specifically bind and to be internalized by immature monocyte-derived DCs (iDCs).	Glycopeptides	0-13	mucin 1, cell surface associated	Homo sapiens	55-59
17804752-7	2007	Confocal analysis and ELISA done on subcellular fractions of iDCs showed that the Tn-MUC1 glycopeptides colocalized with HLA class I and II compartments after internalization.	Glycopeptides	90-103	mucin 1, cell surface associated	Homo sapiens	85-89
17956937-3	2008	In the present study, the glycan profiles of free and complexed forms of PSA from cancer patient serum and of seminal plasma PSA were compared by analyzing the glycopeptides obtained by lysylendopeptidase digestion of the electrophoretically separated PSA with mass spectrometry.	Glycopeptides	160-173	kallikrein related peptidase 3	Homo sapiens	73-76
17712550-5	2007	Here, we report the analysis of IgA1 O-glycan heterogeneity by use of FT-ICR MS and liquid chromatography FT-ICR MS to obtain unbiased accurate mass profiles of IgA1 HR glycopeptides from three different IgA1 myeloma proteins.	Glycopeptides	169-182	immunoglobulin heavy constant alpha 1	Homo sapiens	32-36
17712550-5	2007	Here, we report the analysis of IgA1 O-glycan heterogeneity by use of FT-ICR MS and liquid chromatography FT-ICR MS to obtain unbiased accurate mass profiles of IgA1 HR glycopeptides from three different IgA1 myeloma proteins.	Glycopeptides	169-182	immunoglobulin heavy constant alpha 1	Homo sapiens	161-165
17712550-5	2007	Here, we report the analysis of IgA1 O-glycan heterogeneity by use of FT-ICR MS and liquid chromatography FT-ICR MS to obtain unbiased accurate mass profiles of IgA1 HR glycopeptides from three different IgA1 myeloma proteins.	Glycopeptides	169-182	immunoglobulin heavy constant alpha 1	Homo sapiens	161-165
17513023-6	2007	At the same time, intermediate sensitive and resistant MRSA strains to glycopeptides appeared.	Glycopeptides	71-84	solute carrier family 9 member A6	Homo sapiens	55-59
17592722-12	2007	It was shown that the presence of Fbs1 perturb the activity of PNGase toward high-mannose-type glycopeptides.	Glycopeptides	95-108	N-glycanase 1	Homo sapiens	63-69
17295374-0	2007	Synthetic glycopeptides from the E-selectin ligand 1 with varied sialyl Lewis(x) structure as cell-adhesion inhibitors of E-selectin.	Glycopeptides	10-23	golgi glycoprotein 1	Homo sapiens	33-52
17623277-7	2007	Glycosylation site and oligosaccharide structures were elucidated from MS and MS/MS spectra of trypsin-digested DCE glycopeptides.	Glycopeptides	116-129	24-dehydrocholesterol reductase	Homo sapiens	112-115
17623277-13	2007	During mass spectrometric analysis of DCE glycopeptides, their CID patterns were highly intriguing, in that some glycopeptides underwent both C-terminal rearrangement and formation of dimeric structures during CID.	Glycopeptides	42-55	24-dehydrocholesterol reductase	Homo sapiens	38-41
17623277-13	2007	During mass spectrometric analysis of DCE glycopeptides, their CID patterns were highly intriguing, in that some glycopeptides underwent both C-terminal rearrangement and formation of dimeric structures during CID.	Glycopeptides	113-126	24-dehydrocholesterol reductase	Homo sapiens	38-41
17502600-4	2007	To better understand the bactericidal mechanism of PGRPs, we determined the crystal structure of the C-terminal PGN-binding domain of human PGRP-I beta in complex with NAG-NAM-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala, a synthetic glycopeptide comprising a complete PGN repeat.	Glycopeptides	225-237	SPG7 matrix AAA peptidase subunit, paraplegin	Homo sapiens	112-115
17502600-4	2007	To better understand the bactericidal mechanism of PGRPs, we determined the crystal structure of the C-terminal PGN-binding domain of human PGRP-I beta in complex with NAG-NAM-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala, a synthetic glycopeptide comprising a complete PGN repeat.	Glycopeptides	225-237	peptidoglycan recognition protein 4	Homo sapiens	140-151
17330941-11	2007	We show that analysis by cysteine-containing glycopeptides allows detection of low-abundance proteins such as the epidermal growth factor receptor, the Vitamin K-dependent protein Z, the hepatocyte growth factor activator, and the lymphatic endothelium-specific hyaluronan receptor as these proteins were not detected in the glycopeptide control analysis.	Glycopeptides	45-58	epidermal growth factor receptor	Mus musculus	114-146
17330941-11	2007	We show that analysis by cysteine-containing glycopeptides allows detection of low-abundance proteins such as the epidermal growth factor receptor, the Vitamin K-dependent protein Z, the hepatocyte growth factor activator, and the lymphatic endothelium-specific hyaluronan receptor as these proteins were not detected in the glycopeptide control analysis.	Glycopeptides	45-58	protein Z, vitamin K-dependent plasma glycoprotein	Mus musculus	152-181
17330941-11	2007	We show that analysis by cysteine-containing glycopeptides allows detection of low-abundance proteins such as the epidermal growth factor receptor, the Vitamin K-dependent protein Z, the hepatocyte growth factor activator, and the lymphatic endothelium-specific hyaluronan receptor as these proteins were not detected in the glycopeptide control analysis.	Glycopeptides	45-58	hepatocyte growth factor activator	Mus musculus	187-221
17400357-1	2007	In the present study the structures of two glycopeptides (G1 and G1"), isolated from FU RvH(1)-b and two glycopeptides (G2 and G3), isolated from the structural subunit RvH(1) of Rapana venosa hemocyanin, were determined.	Glycopeptides	43-56	proline rich protein BstNI subfamily 3	Homo sapiens	58-68
17283034-1	2007	OBJECTIVES AND METHODS: The transferability of vanA and vanB glycopeptide resistance determinants with a defined plasmid (n = 9) or chromosomal (n = 4) location between Enterococcus faecium strains of human and animal origins was compared using filter mating (in vitro) and germ-free mice (in vivo) as experimental models.	Glycopeptides	61-73	D-alanine--D-lactate ligase	Enterococcus faecium	56-60
17050588-4	2007	Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance.	Glycopeptides	54-67	mucin 1, transmembrane	Mus musculus	49-53
17050588-4	2007	Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance.	Glycopeptides	54-67	mucin 1, transmembrane	Mus musculus	96-100
17050588-8	2007	In the present study, we define the immunodominant epitope on Tn/STn-MUC1 glycopeptides to the region including the amino acids GSTA of the MUC1 20-amino acid tandem repeat (HGVTSAPDTRPAPGSTAPPA).	Glycopeptides	74-87	mucin 1, transmembrane	Mus musculus	69-73
17050588-8	2007	In the present study, we define the immunodominant epitope on Tn/STn-MUC1 glycopeptides to the region including the amino acids GSTA of the MUC1 20-amino acid tandem repeat (HGVTSAPDTRPAPGSTAPPA).	Glycopeptides	74-87	mucin 1, transmembrane	Mus musculus	140-144
17194161-5	2007	On-line digestion allowed extensive cleavage of the model protein (ribonuclease B), yielding to glycopeptides with peptide moieties up to eight amino acids, carrying the Man5-Man9 N-glycans each, selectively resolved on an Amide-80 column.	Glycopeptides	96-109	mannosidase alpha class 1A member 1	Homo sapiens	175-179
17295374-0	2007	Synthetic glycopeptides from the E-selectin ligand 1 with varied sialyl Lewis(x) structure as cell-adhesion inhibitors of E-selectin.	Glycopeptides	10-23	selectin E	Homo sapiens	33-43
16940100-9	2006	In summary, hVISA/VISA arises from fully VSSA during persistent infection that fails to respond to glycopeptide therapy and is associated with significant phenotypic changes, including a marked reduction in biofilm-forming ability.	Glycopeptides	99-111	mitochondrial antiviral signaling protein	Homo sapiens	12-17
17604678-5	2007	MUC16 from NHBE cells was a high-molecular-mass, monomeric mucin which gave rise to large glycopeptides after proteolysis.	Glycopeptides	90-103	mucin 16, cell surface associated	Homo sapiens	0-5
17604678-5	2007	MUC16 from NHBE cells was a high-molecular-mass, monomeric mucin which gave rise to large glycopeptides after proteolysis.	Glycopeptides	90-103	LOC100508689	Homo sapiens	59-64
16940100-9	2006	In summary, hVISA/VISA arises from fully VSSA during persistent infection that fails to respond to glycopeptide therapy and is associated with significant phenotypic changes, including a marked reduction in biofilm-forming ability.	Glycopeptides	99-111	mitochondrial antiviral signaling protein	Homo sapiens	13-17
16470771-1	2006	An array of sugar oxazolines was synthesized and tested as donor substrates for the Arthrobacter endo-beta-N-acetylglucosaminidase (Endo-A)-catalyzed glycopeptide synthesis.	Glycopeptides	150-162	endo-beta-N-acetylglucosaminidase	Homo sapiens	97-130
17017874-0	2006	Synthetic glycopeptides from the mucin family as potential tools in cancer immunotherapy.	Glycopeptides	10-23	LOC100508689	Homo sapiens	33-38
17017874-9	2006	In this review, methodologies for the synthesis of mucin-type glycopeptides containing complex tumor-associated antigen structures are described.	Glycopeptides	62-75	LOC100508689	Homo sapiens	51-56
16642533-8	2006	Taken together, the joined sequence GVTSAPDTR represents the largest structural model of MUC1 derived glycopeptides analyzed so far.	Glycopeptides	102-115	mucin 1, cell surface associated	Homo sapiens	89-93
16599599-0	2006	Construction of highly glycosylated mucin-type glycopeptides based on microwave-assisted solid-phase syntheses and enzymatic modifications.	Glycopeptides	47-60	LOC100508689	Homo sapiens	36-41
16467946-0	2006	Formation of lactones from sialylated MUC1 glycopeptides.	Glycopeptides	43-56	mucin 1, cell surface associated	Homo sapiens	38-42
16506767-6	2006	Beautifully, 5 exhibited antimicrobial activity (MIC = 31 microg/mL) against a VanA-resistant organism that remodels its D-Ala-D-Ala cell wall precursor to d-Ala-d-Lac upon glycopeptide antibiotic challenge, displaying a potency that reflects these binding characteristics.	Glycopeptides	173-185	lactase	Homo sapiens	164-167
16207894-0	2006	Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance.	Glycopeptides	54-67	eukaryotic translation elongation factor 1 alpha 2	Homo sapiens	45-48
16207894-0	2006	Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance.	Glycopeptides	54-67	mucin 1, cell surface associated	Homo sapiens	49-53
16207894-0	2006	Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance.	Glycopeptides	54-67	mucin 1, cell surface associated	Homo sapiens	96-100
16207894-3	2006	In this study, we have developed chemoenzymatic synthesis of extended MUC1 TR glycopeptides with cancer-associated O-glycosylation using a panel of recombinant human glycosyltransferases.	Glycopeptides	78-91	mucin 1, cell surface associated	Homo sapiens	70-74
16207894-5	2006	Glycopeptides with complete O-glycan occupancy (five sites per repeat) elicited the strongest antibody response reacting with MUC1 expressed in breast cancer cell lines in both Balb/c and MUC1.Tg mice.	Glycopeptides	0-13	mucin 1, transmembrane	Mus musculus	126-130
16207894-5	2006	Glycopeptides with complete O-glycan occupancy (five sites per repeat) elicited the strongest antibody response reacting with MUC1 expressed in breast cancer cell lines in both Balb/c and MUC1.Tg mice.	Glycopeptides	0-13	mucin 1, transmembrane	Mus musculus	188-192
16204891-1	2005	The NNA7 Fab antibody fragment recognizes the human N-type blood-group antigen comprised of the N-terminal glycopeptide of glycophorin A (GPA).	Glycopeptides	107-119	FA complementation group B	Homo sapiens	9-12
16177266-3	2006	In this study, we prepared a series of mucin-type glycopeptides using human glycosyltransferases, that is, ST6GalNAc1, Core1Gal-T1 and -T2, beta3Gn-T6, and Core2GnT1, and investigated their binding to immobilized Jacalin by frontal affinity chromatography (FAC).	Glycopeptides	50-63	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1	Homo sapiens	107-117
17091533-0	2006	Direct structural assignment of neutral and sialylated N-glycans of glycopeptides using collision-induced dissociation MSn spectral matching.	Glycopeptides	68-81	moesin	Gallus gallus	119-122
16456804-0	2006	Complementary structural information of positive- and negative-ion MSn spectra of glycopeptides with neutral and sialylated N-glycans.	Glycopeptides	82-95	moesin	Gallus gallus	67-70
16456804-1	2006	Positive- and negative-ion MSn spectra of chicken egg yolk glycopeptides binding a neutral and a sialylated N-glycan were acquired by using electrospray ionization linear ion trap time-of-flight mass spectrometry (ESI-LIT-TOFMS) and collision-induced dissociation (CID) with helium as collision gas.	Glycopeptides	59-72	moesin	Gallus gallus	27-30
16204891-1	2005	The NNA7 Fab antibody fragment recognizes the human N-type blood-group antigen comprised of the N-terminal glycopeptide of glycophorin A (GPA).	Glycopeptides	107-119	glycophorin A (MNS blood group)	Homo sapiens	123-136
15656939-4	2005	Genetic studies in yeast, and biochemical data from higher eukaryotes, indicate that glycopeptides utilise the Sec61 translocon.	Glycopeptides	85-98	translocon subunit SEC61	Saccharomyces cerevisiae S288C	111-116
16042579-3	2005	These natural responses to tumour-associated MUC1 glycoforms indicate that antibody reactivities are more directed to glycopeptide than to non-glycosylated peptide epitopes.	Glycopeptides	118-130	mucin 1, cell surface associated	Homo sapiens	45-49
15814824-6	2005	We also examined the conformational changes of MUC1 glycopeptides induced by the concerted DT to ES replacements and revealed a higher conformational flexibility of ES/P peptides compared to DT/P peptides.	Glycopeptides	52-65	mucin 1, cell surface associated	Homo sapiens	47-51
16104759-0	2005	Combinatorial synthesis of MUC1 glycopeptides: polymer blotting facilitates chemical and enzymatic synthesis of highly complicated mucin glycopeptides.	Glycopeptides	32-45	mucin 1, cell surface associated	Homo sapiens	27-31
16104759-0	2005	Combinatorial synthesis of MUC1 glycopeptides: polymer blotting facilitates chemical and enzymatic synthesis of highly complicated mucin glycopeptides.	Glycopeptides	32-45	LOC100508689	Homo sapiens	131-136
16104759-0	2005	Combinatorial synthesis of MUC1 glycopeptides: polymer blotting facilitates chemical and enzymatic synthesis of highly complicated mucin glycopeptides.	Glycopeptides	137-150	mucin 1, cell surface associated	Homo sapiens	27-31
16104759-0	2005	Combinatorial synthesis of MUC1 glycopeptides: polymer blotting facilitates chemical and enzymatic synthesis of highly complicated mucin glycopeptides.	Glycopeptides	137-150	LOC100508689	Homo sapiens	131-136
16104759-5	2005	We report here a high-throughput synthetic system for the various types of MUC1 glycopeptides exhibiting a variety of sugar moieties.	Glycopeptides	80-93	mucin 1, cell surface associated	Homo sapiens	75-79
16116288-2	2005	The building blocks were utilized in the solid-phase synthesis of a glycopeptide carrying two O-glycans with the consensus sequence of the tandem-repeat domain of MUC5AC.	Glycopeptides	68-80	mucin 5AC, oligomeric mucus/gel-forming	Homo sapiens	163-169
15826181-0	2005	Glycopeptides related to beta-endorphin adopt helical amphipathic conformations in the presence of lipid bilayers.	Glycopeptides	0-13	proopiomelanocortin	Homo sapiens	25-39
15640183-8	2005	In conclusion, our observations suggest that the molecular unit of persistence of glycopeptide resistance is a common mobile plasmid-mediated vanA-containing element within a polyclonal GREF population that changes over time.	Glycopeptides	82-94	Vancomycin Teicoplanin A-type resistance protein VanA / D-alanine--D-alanine ligase	Enterococcus faecium	142-146
16400877-10	2005	All the MRSA isolates were multidrug resistant but sensitive to glycopeptides.	Glycopeptides	64-77	solute carrier family 9 member A6	Homo sapiens	8-12
15519221-1	2004	Previously, we have characterized the HIV-I(SF2) gp120 glycopeptides using matrix-assisted laser desorption/ionization mass spectrometry (MALDI/MS) and nanospray electrospray ionization (ESI).	Glycopeptides	55-68	serine and arginine rich splicing factor 1	Homo sapiens	44-47
15519221-1	2004	Previously, we have characterized the HIV-I(SF2) gp120 glycopeptides using matrix-assisted laser desorption/ionization mass spectrometry (MALDI/MS) and nanospray electrospray ionization (ESI).	Glycopeptides	55-68	inter-alpha-trypsin inhibitor heavy chain 4	Homo sapiens	49-54
15491501-17	2004	G-CSF treatment is very expensive, likewise glycopeptides.	Glycopeptides	44-57	colony stimulating factor 3 (granulocyte)	Mus musculus	0-5
15292166-7	2004	Extensive Pronase E digestion of unlabeled Muclin was used to produce glycopeptides, which competed for binding of [35S]sulfate-labeled Muclin to zymogens.	Glycopeptides	70-83	deleted in malignant brain tumors 1	Homo sapiens	43-49
15466199-4	2004	The recombinant ST6GalNAc-I and ST6GalNAc-II showed similar substrate specificity toward glycoproteins and GalNAcalpha-O-Ser/Thr glycopeptides, such as glycopeptides derived from the MUC2 mucin and the HIVgp120.	Glycopeptides	129-142	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1	Homo sapiens	16-27
15466199-4	2004	The recombinant ST6GalNAc-I and ST6GalNAc-II showed similar substrate specificity toward glycoproteins and GalNAcalpha-O-Ser/Thr glycopeptides, such as glycopeptides derived from the MUC2 mucin and the HIVgp120.	Glycopeptides	129-142	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2	Homo sapiens	32-44
15292166-7	2004	Extensive Pronase E digestion of unlabeled Muclin was used to produce glycopeptides, which competed for binding of [35S]sulfate-labeled Muclin to zymogens.	Glycopeptides	70-83	deleted in malignant brain tumors 1	Homo sapiens	136-142
15320440-1	2004	DISTURBING EPIDEMIOLOGICAL DATA: Over the past decade there has been a continuous progression in the percentage of Staphylococcus aureus strains resistant to methicillin (MRSA), a slight progression in coagulase-negative staphylococci strains resistant to methicillin and a spectacular progression of enterococci resistant to glycopeptides, not only in hospitals but also in intensive care settings.	Glycopeptides	326-339	solute carrier family 9 member A6	Homo sapiens	171-175
15283567-5	2004	MALDI/PSD analysis of glycopeptides converted to their acetyl phosphonium derivatives is an effective alternative to electron capture dissociation, as illustrated by the positioning of up to three GalNac residues along the full tandem repeat peptide sequence derived from the MUC 5AC mucin.	Glycopeptides	22-35	mucin 5AC, oligomeric mucus/gel-forming	Homo sapiens	276-283
15182249-5	2004	Internalized Db- and Kb-binding glycopeptides, detected with high specificity using an anti-galabiose (Gal2) monoclonal antibody, were found to appear on the cell surface of BFA-treated cells after intracellular MHC-I-binding.	Glycopeptides	32-45	galectin 2	Homo sapiens	103-107
15045167-9	2004	Comparison with US ICARE (Intensive Care Antimicrobial Resistance Epidemiology)/AUR (Antimicrobial Use and Resistance) data revealed a higher AD for glycopeptides and 3rd generation cephalosporins in ICARE/AUR ICUs, but a higher AD for carbapenems in German SARI ICUs regardless of the type of ICU.	Glycopeptides	149-162	basic leucine zipper ATF-like transcription factor 2	Homo sapiens	258-262
14993254-3	2004	Here we demonstrate that by using glycopeptides with high affinity for the major histocompatibility complex and glycosylated in a position corresponding to a critical T cell receptor (TcR) contact, it is possible to induce anti-TACA CTL in vivo.	Glycopeptides	34-47	T cell receptor beta variable 20/OR9-2 (non-functional)	Homo sapiens	167-182
14993254-3	2004	Here we demonstrate that by using glycopeptides with high affinity for the major histocompatibility complex and glycosylated in a position corresponding to a critical T cell receptor (TcR) contact, it is possible to induce anti-TACA CTL in vivo.	Glycopeptides	34-47	T cell receptor beta variable 20/OR9-2 (non-functional)	Homo sapiens	184-187
14993254-4	2004	In the current study we show that designer glycopeptides containing the Thomsen-Freidenreich (TF) antigen (beta-Gal-[1-->3]-alpha-GalNAc-O-serine) are immunogenic in vivo and generate TF-specific CTL capable of recognizing a variety of tumor cells in vitro including a MUC1-expressing tumor.	Glycopeptides	43-56	mucin 1, cell surface associated	Homo sapiens	272-276
12925576-0	2003	Conformational studies on the MUC1 tandem repeat glycopeptides: implication for the enzymatic O-glycosylation of the mucin protein core.	Glycopeptides	49-62	mucin 1, cell surface associated	Homo sapiens	30-34
14733546-0	2004	Chemical synthesis of normal and transformed PSA glycopeptides.	Glycopeptides	49-62	kallikrein related peptidase 3	Homo sapiens	45-48
14991920-4	2004	For the construction of immunostimulating antigens, glycopeptide partial structures from the mucins MUC1 and MUC4 carrying the tumor-associated sialyl-T(N), alpha2,6-sialyl-T and alpha2,3-sialyl-T antigens have been synthesized.	Glycopeptides	52-64	mucin 1, cell surface associated	Homo sapiens	100-104
14991920-4	2004	For the construction of immunostimulating antigens, glycopeptide partial structures from the mucins MUC1 and MUC4 carrying the tumor-associated sialyl-T(N), alpha2,6-sialyl-T and alpha2,3-sialyl-T antigens have been synthesized.	Glycopeptides	52-64	mucin 4, cell surface associated	Homo sapiens	109-113
14679514-3	2003	The advantages of the PTMSEL linker are demonstrated in the synthesis of glycopeptides from the liver intestine (LI)-cadherin and the mucin MUC1, bearing carbohydrate moieties such as N-linked chitobiose or O-linked sialyl-T(N)-residues.	Glycopeptides	73-86	cadherin 17	Homo sapiens	96-125
14558142-7	2003	Moreover, the interaction between IMP2 and GAL6/BLH1, a recently isolated gene involved in the regulation of GAL genes that shares with Imp2 the ability to protect cells from the glycopeptide bleomycin, was also analysed.	Glycopeptides	179-191	endopeptidase catalytic subunit	Saccharomyces cerevisiae S288C	34-38
14604374-0	2003	Chemical synthesis of CD52 glycopeptides containing the acid-labile fucosyl linkage.	Glycopeptides	27-40	CD52 molecule	Homo sapiens	22-26
14517945-2	2003	Mutations in the sialidase gene NEU1, located on chromosome 6p21.3, result in autosomal recessive disorder, sialidosis, which is characterized by the progressive lysosomal storage of sialylated glycopeptides and oligosaccharides.	Glycopeptides	194-207	neuraminidase 1	Homo sapiens	32-36
14552419-1	2003	Based on structural information reported for the tumour-associated epithelial mucin MUC1, glycopeptides have been synthesized which contain tumour-associated saccharide antigens.	Glycopeptides	90-103	mucin 1, cell surface associated	Homo sapiens	84-88
12847092-6	2003	Like P-selectin, A. phagocytophilum bound to purified human PSGL-1 and to glycopeptides modeled after the N terminus of human PSGL-1 that presented sLex on an O-glycan.	Glycopeptides	74-87	selectin P ligand	Homo sapiens	126-132
12945896-1	2003	Glycopeptides that bind to MHC molecules on antigen presenting cells may elicit carbohydrate selective T cells.	Glycopeptides	0-13	major histocompatibility complex, class I, C	Homo sapiens	27-30
12929179-5	2003	The phosphate group on site Ser12 of tryptic peptide 8-22 of most phosphorylated alpha(s1)-CN (11 phosphate groups) was localized and the oligosaccharide sequence of the main tryptic glycopeptides of two kappa-CN components was determined by means of MS/MS analysis.	Glycopeptides	183-196	proteasome 26S subunit, non-ATPase 1	Homo sapiens	81-93
12945896-6	2003	Our observation suggests an explanation for previous findings, which show that glycopeptides isolated from MHC molecules in nature usually carry small saccharides.	Glycopeptides	79-92	major histocompatibility complex, class I, C	Homo sapiens	107-110
12778480-1	2003	Multi-component glycopeptide libraries and single glycopeptides were used for immunization of mice with the aim of inducing strong T helper cell responses to the repetitive sequence of MUC1 expressed by human tumor cells.	Glycopeptides	50-63	mucin 1, transmembrane	Mus musculus	185-189
12778480-2	2003	The glycopeptides and glycopeptide libraries were modeled upon the native human MUC1 amino acid variable number of tandem repeats sequence by introduction of modifications in the MHC anchor positions to optimally fulfil the binding requirements of the A(d) MHC class II molecule in the BALB/c mouse.	Glycopeptides	4-17	mucin 1, cell surface associated	Homo sapiens	80-84
12778480-3	2003	The immunogenicity of the MUC1 glycopeptides in BALB/c mice was determined by immunization in complete Freund"s adjuvant and assaying lymph node T cells for a proliferative response to the glycopeptide used.	Glycopeptides	31-44	mucin 1, transmembrane	Mus musculus	26-30
12778480-3	2003	The immunogenicity of the MUC1 glycopeptides in BALB/c mice was determined by immunization in complete Freund"s adjuvant and assaying lymph node T cells for a proliferative response to the glycopeptide used.	Glycopeptides	31-43	mucin 1, transmembrane	Mus musculus	26-30
14633362-6	2003	A 17-kb composite cluster was identified in a single hospital isolate linking determinants for glycopeptide (vanA), macrolide-lincosamide-streptogramin B [erm(B)], and aminoglycoside-streptothricin (aadE-sat4-aphA-3) resistances.	Glycopeptides	95-107	aminoglycoside phosphotransferase	Enterococcus faecium	209-215
12770769-4	2003	Protection against the action of PLG, PLP and sulfhydryl modifying reagents was offered by GDP-fucose, GDP, and the acceptor substrate, a transferrin-derived biantennary glycopeptide with terminal GlcNAc residues.	Glycopeptides	170-182	pyridoxal phosphatase	Homo sapiens	38-41
12527303-6	2003	The IgG-Fc is a homodimer of N-linked glycopeptide chains comprised of two immunoglobulin domains (Cgamma2, Cgamma3) that dimerise via inter-heavy chain disulphide bridges at the N-terminal region and non-covalent interactions between the C-terminal Cgamma3 domains.	Glycopeptides	38-50	immunoglobulin heavy constant gamma 3 (G3m marker)	Homo sapiens	108-115
12523830-0	2003	Glycopeptides as oligosaccharide mimics: high affinity sialopeptide ligands for sialoadhesin from combinatorial libraries.	Glycopeptides	0-13	sialic acid binding Ig like lectin 1	Homo sapiens	80-92
12770766-6	2003	During the synthesis three intermediate glycopeptides containing O-linked GalNAc, Gal(beta1-4)GlcNAc(beta1-6)[Gal(beta1-3)]GalNAc, and Neu5Ac(alpha2-3)Gal(beta1-4)GlcNAc(beta1-6)[Gal(beta1-3)]GalNAc, respectively, were isolated in mg quantities.	Glycopeptides	40-53	eukaryotic translation elongation factor 1 beta 2 pseudogene 2	Homo sapiens	86-93
12770766-6	2003	During the synthesis three intermediate glycopeptides containing O-linked GalNAc, Gal(beta1-4)GlcNAc(beta1-6)[Gal(beta1-3)]GalNAc, and Neu5Ac(alpha2-3)Gal(beta1-4)GlcNAc(beta1-6)[Gal(beta1-3)]GalNAc, respectively, were isolated in mg quantities.	Glycopeptides	40-53	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	Homo sapiens	101-108
12770766-6	2003	During the synthesis three intermediate glycopeptides containing O-linked GalNAc, Gal(beta1-4)GlcNAc(beta1-6)[Gal(beta1-3)]GalNAc, and Neu5Ac(alpha2-3)Gal(beta1-4)GlcNAc(beta1-6)[Gal(beta1-3)]GalNAc, respectively, were isolated in mg quantities.	Glycopeptides	40-53	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	Homo sapiens	114-121
12770766-6	2003	During the synthesis three intermediate glycopeptides containing O-linked GalNAc, Gal(beta1-4)GlcNAc(beta1-6)[Gal(beta1-3)]GalNAc, and Neu5Ac(alpha2-3)Gal(beta1-4)GlcNAc(beta1-6)[Gal(beta1-3)]GalNAc, respectively, were isolated in mg quantities.	Glycopeptides	40-53	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	Homo sapiens	170-177
12770766-6	2003	During the synthesis three intermediate glycopeptides containing O-linked GalNAc, Gal(beta1-4)GlcNAc(beta1-6)[Gal(beta1-3)]GalNAc, and Neu5Ac(alpha2-3)Gal(beta1-4)GlcNAc(beta1-6)[Gal(beta1-3)]GalNAc, respectively, were isolated in mg quantities.	Glycopeptides	40-53	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	Homo sapiens	183-190
12565922-0	2003	Chemoenzymatic synthesis of high-mannose type HIV-1 gp120 glycopeptides.	Glycopeptides	58-71	Envelope surface glycoprotein gp160, precursor	Human immunodeficiency virus 1	52-57
12565922-2	2003	Thus, the high-mannose type glycopeptides [gp120 (336-342)] containing Man(9), Man(6) and Man(5) moieties, respectively, were synthesized in satisfactory yields via transglycosylation to the acetylglucosaminyl peptide, using the recombinant Arthrobacter Endo-beta-N-acetyl-glucosaminidase (Endo-A) as the key enzyme.	Glycopeptides	28-41	inter-alpha-trypsin inhibitor heavy chain 4	Homo sapiens	43-48
12565922-2	2003	Thus, the high-mannose type glycopeptides [gp120 (336-342)] containing Man(9), Man(6) and Man(5) moieties, respectively, were synthesized in satisfactory yields via transglycosylation to the acetylglucosaminyl peptide, using the recombinant Arthrobacter Endo-beta-N-acetyl-glucosaminidase (Endo-A) as the key enzyme.	Glycopeptides	28-41	endo-beta-N-acetylglucosaminidase	Homo sapiens	254-288
12565922-2	2003	Thus, the high-mannose type glycopeptides [gp120 (336-342)] containing Man(9), Man(6) and Man(5) moieties, respectively, were synthesized in satisfactory yields via transglycosylation to the acetylglucosaminyl peptide, using the recombinant Arthrobacter Endo-beta-N-acetyl-glucosaminidase (Endo-A) as the key enzyme.	Glycopeptides	28-41	endo-beta-N-acetylglucosaminidase	Homo sapiens	290-296
12461079-5	2002	We show that DCs endocytose MUC1 glycopeptides, transport them to acidic compartments, process them into smaller peptides, and present them on major histocompatability complex (MHC) class II molecules without removing the carbohydrates.	Glycopeptides	33-46	mucin 1, cell surface associated	Homo sapiens	28-32
11697954-7	2001	The outlined chemoenzymatic approach was applied to glycopeptides from the tandem repeat domain of the mucin MUC1, as well as to neoglycosylated derivatives of a T cell stimulating viral peptide.	Glycopeptides	52-65	mucin 1, cell surface associated	Homo sapiens	109-113
12473113-6	2002	All pp-GalNAc-T isozymes tested exhibited distinct specificities toward glycopeptides.	Glycopeptides	72-85	beta-1,4-N-acetyl-galactosaminyltransferase 1	Homo sapiens	7-15
11867604-11	2002	LC-ESMS analysis of tryptic peptides indicated that PEDF A and B exhibit differences in glycopeptides containing N-acetylneuraminic acid (NeuAc) and N-acetylhexosamine (HexNAc).	Glycopeptides	88-101	serpin family F member 1	Homo sapiens	52-56
12175243-0	2002	Principles of mucin architecture: structural studies on synthetic glycopeptides bearing clustered mono-, di-, tri-, and hexasaccharide glycodomains.	Glycopeptides	66-79	LOC100508689	Homo sapiens	14-19
11907045-4	2002	We now report that monoclonal antibodies-induced L-selectin dimerization enhances L-selectin leukocyte tethering to purified physiological L-selectin ligands and glycopeptides.	Glycopeptides	162-175	selectin L	Homo sapiens	49-59
11907045-4	2002	We now report that monoclonal antibodies-induced L-selectin dimerization enhances L-selectin leukocyte tethering to purified physiological L-selectin ligands and glycopeptides.	Glycopeptides	162-175	selectin L	Homo sapiens	82-92
11907045-4	2002	We now report that monoclonal antibodies-induced L-selectin dimerization enhances L-selectin leukocyte tethering to purified physiological L-selectin ligands and glycopeptides.	Glycopeptides	162-175	selectin L	Homo sapiens	82-92
11939716-5	2002	The radioscanning of the samples prepared from the culture medium and the apical epithelial membranes subjected to SDS-PAGE and western blotting disclosed that the released, water soluble 97kDa MBP glycopeptide was labeled with proline and palmitate.	Glycopeptides	198-210	myelin basic protein	Rattus norvegicus	194-197
29712138-2	2001	It is important for the inhibition of cell adhesion that the arabino sialyl Lewisx glycopeptide 1, which contains the Gly 672 -Asp 681 sequence of the E-selectin Ligand 1 (ESL-1), binds ten times more strongly than sialyl Lewisx to E-selectin, although it is monovalent and does not contain L-fucose, which is considered essential.	Glycopeptides	83-95	golgi glycoprotein 1	Homo sapiens	151-170
11710528-2	2001	The radiolabeled hTR glycopeptides were prepared and fractionated by a lectin chromatography of Concanavalin A-Sepharose.	Glycopeptides	21-34	telomerase RNA component	Homo sapiens	17-20
11710528-3	2001	The composition analysis of hTR glycopeptides revealed that Con A-I contains both mannose and fucose, whereas Con A-III has mannose exclusively.	Glycopeptides	32-45	telomerase RNA component	Homo sapiens	28-31
29712138-2	2001	It is important for the inhibition of cell adhesion that the arabino sialyl Lewisx glycopeptide 1, which contains the Gly 672 -Asp 681 sequence of the E-selectin Ligand 1 (ESL-1), binds ten times more strongly than sialyl Lewisx to E-selectin, although it is monovalent and does not contain L-fucose, which is considered essential.	Glycopeptides	83-95	golgi glycoprotein 1	Homo sapiens	172-177
29712138-2	2001	It is important for the inhibition of cell adhesion that the arabino sialyl Lewisx glycopeptide 1, which contains the Gly 672 -Asp 681 sequence of the E-selectin Ligand 1 (ESL-1), binds ten times more strongly than sialyl Lewisx to E-selectin, although it is monovalent and does not contain L-fucose, which is considered essential.	Glycopeptides	83-95	selectin E	Homo sapiens	151-161
12240213-1	2001	The protease-catalyzed synthesis of amino acid est-carbohydrate conjugates as glycopeptide analogues has been achieved in a highly regioselective and carbohydrate-specific manner using amino acid vinyl ester acyl donors and minimally or completely unprotected carbohydrate acyl acceptors, which together probed active sites of proteases to reveal yield efficiencies that are modulated by the carbohydrate C-2 substitutent, and that may be exploited to allow selective one-pot syntheses.	Glycopeptides	78-90	complement C2	Homo sapiens	405-408
11278534-7	2001	However, when incubated with MUC5AC and EA2 glycopeptides (obtained by the prior action of ppGaNTase-T1), additional incorporation of GalNAc was achieved, resulting in new hydroxyamino acid modification.	Glycopeptides	44-57	calcium voltage-gated channel subunit alpha1 A	Homo sapiens	40-43
11675980-8	2001	However, there is also reason for concern about the recent emergence of MRSA resistant to glycopeptides, such as vancomycin.	Glycopeptides	90-103	solute carrier family 9 member A6	Homo sapiens	72-76
11555617-0	2001	Evidence for glycosylation-dependent activities of polypeptide N-acetylgalactosaminyltransferases rGalNAc-T2 and -T4 on mucin glycopeptides.	Glycopeptides	126-139	chondroitin sulfate N-acetylgalactosaminyltransferase 2	Rattus norvegicus	98-108
11555617-0	2001	Evidence for glycosylation-dependent activities of polypeptide N-acetylgalactosaminyltransferases rGalNAc-T2 and -T4 on mucin glycopeptides.	Glycopeptides	126-139	LOC100508689	Homo sapiens	120-125
11384997-7	2001	The CRDs of DC-SIGN and DC-SIGNR bind Man(9)GlcNAc(2) oligosaccharide 130- and 17-fold more tightly than mannose, and affinity for a glycopeptide bearing two such oligosaccharides is increased by a further factor of 5- to 25-fold.	Glycopeptides	133-145	C-type lectin domain family 4 member M	Homo sapiens	24-32
11445553-2	2001	In vitro metabolic labeling of cells with either [(3)H] glucosamine or [(3)H] threonine, together with tomato lectin staining, revealed that nerve growth factor (NGF) stimulation caused a decrease in the poly-N-acetyllactosamine synthesis of high-molecular-weight glycopeptides from PC12 cells.	Glycopeptides	264-277	nerve growth factor	Rattus norvegicus	162-165
11240145-0	2001	Structure determination and by-product profile of the NK(2) receptor antagonist nepadutant, a bicyclic glycopeptide.	Glycopeptides	103-115	tachykinin receptor 2	Homo sapiens	54-68
11263562-1	2001	Selective glycopeptide mapping of recombinant human erythropoietin (rhEPO) used as a model glycoprotein was successfully carried out by on-line high-performance liquid chromatography-electrospray ionization mass spectrometry (LC-ESI-MS) using a Vydac C18 column eluted in acetonitrile-1 mM ammonium acetate, pH 6.8. rhEPO expressed in a Chinese hamster ovary clone was exhaustively digested into four glycopeptides and nine peptides with endoproteinase Glu-C.	Glycopeptides	401-414	erythropoietin	Homo sapiens	52-66
16557681-0	2001	Two Structurally Distinct VanA Resistance Elements at Different Locations in a Glycopeptide-Resistant Strain of Enterococcus faecalis.	Glycopeptides	79-91	VanA	Enterococcus faecalis	26-30
11231363-4	2001	The variety of O-glycan glycoform was determined by estimating the precise molecular weights of the IgA1 hinge glycopeptides using matrix-assisted laser desorption ionization time of flight mass spectrometry.	Glycopeptides	111-124	immunoglobulin heavy constant alpha 1	Homo sapiens	100-104
11231363-5	2001	RESULTS: The peak distribution of IgA1 hinge glycopeptides clearly shifted to lesser molecular weights in both glomerular and serum IgA1 in IgAN compared with the serum IgA1 of controls.	Glycopeptides	45-58	immunoglobulin heavy constant alpha 1	Homo sapiens	34-38
11231363-5	2001	RESULTS: The peak distribution of IgA1 hinge glycopeptides clearly shifted to lesser molecular weights in both glomerular and serum IgA1 in IgAN compared with the serum IgA1 of controls.	Glycopeptides	45-58	immunoglobulin heavy constant alpha 1	Homo sapiens	132-136
11231363-5	2001	RESULTS: The peak distribution of IgA1 hinge glycopeptides clearly shifted to lesser molecular weights in both glomerular and serum IgA1 in IgAN compared with the serum IgA1 of controls.	Glycopeptides	45-58	IGAN1	Homo sapiens	140-144
11231363-5	2001	RESULTS: The peak distribution of IgA1 hinge glycopeptides clearly shifted to lesser molecular weights in both glomerular and serum IgA1 in IgAN compared with the serum IgA1 of controls.	Glycopeptides	45-58	immunoglobulin heavy constant alpha 1	Homo sapiens	132-136
11231363-8	2001	These results indicate that the decreased sialylation and galactosylation of the IgA1 hinge glycopeptides play a crucial role in its glomerular deposition in IgAN.	Glycopeptides	92-105	immunoglobulin heavy constant alpha 1	Homo sapiens	81-85
11231363-8	2001	These results indicate that the decreased sialylation and galactosylation of the IgA1 hinge glycopeptides play a crucial role in its glomerular deposition in IgAN.	Glycopeptides	92-105	IGAN1	Homo sapiens	158-162
11290314-8	2001	Although the frequency of enterococcal infections is very low in most Latin America countries, the finding of glycopeptide (VanA) resistance in E. faecalis increases concern about apreading antimicrobial resistance in this region.	Glycopeptides	110-122	VanA	Enterococcus faecalis	124-128
11141302-7	2001	An analytical method for the microheterogeneity of the IgA1 hinge glycopeptide (HGP33) was developed to determine the difference between these IgA1 fractions by capillary electrophoresis (CE).	Glycopeptides	66-78	immunoglobulin heavy constant alpha 1	Homo sapiens	55-59
11221889-6	2001	When the MUC2 tandem repeat peptide was glycosylated with a mixture of the normal mucosa extract and recombinant N-acetylgalactosaminyltransferase-3, larger amounts of glycopeptides with higher contents of GalNAc residues were produced.	Glycopeptides	168-181	mucin 2, oligomeric mucus/gel-forming	Homo sapiens	9-13
11221889-6	2001	When the MUC2 tandem repeat peptide was glycosylated with a mixture of the normal mucosa extract and recombinant N-acetylgalactosaminyltransferase-3, larger amounts of glycopeptides with higher contents of GalNAc residues were produced.	Glycopeptides	168-181	chondroitin sulfate synthase 3	Homo sapiens	113-148
11141302-7	2001	An analytical method for the microheterogeneity of the IgA1 hinge glycopeptide (HGP33) was developed to determine the difference between these IgA1 fractions by capillary electrophoresis (CE).	Glycopeptides	66-78	immunoglobulin heavy constant alpha 1	Homo sapiens	143-147
11399322-1	2000	Matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry was applied to studies of the molecular heterogeneity of desialylated human IgA1 hinge region glycopeptides released with two IgA1 proteases.	Glycopeptides	183-196	immunoglobulin heavy constant alpha 1	Homo sapiens	165-169
11114588-5	2001	Three glycopeptides, having one Asn residue to which the carbohydrate chain is linked, are obtained by lysylendopeptidase digestion of the heat-solubilized zonae containing intact ZPB, and lysylendopeptidase and chymotryptic digestions of endo-beta-galactosidase-digested ZPB.	Glycopeptides	6-19	zona pellucida glycoprotein 4	Sus scrofa	180-183
11114588-5	2001	Three glycopeptides, having one Asn residue to which the carbohydrate chain is linked, are obtained by lysylendopeptidase digestion of the heat-solubilized zonae containing intact ZPB, and lysylendopeptidase and chymotryptic digestions of endo-beta-galactosidase-digested ZPB.	Glycopeptides	6-19	zona pellucida glycoprotein 4	Sus scrofa	272-275
11399322-1	2000	Matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry was applied to studies of the molecular heterogeneity of desialylated human IgA1 hinge region glycopeptides released with two IgA1 proteases.	Glycopeptides	183-196	immunoglobulin heavy constant alpha 1	Homo sapiens	215-219
11249650-4	2000	In this review, we will discuss such crystal structures, as well as structures of glycopeptides and alternative T-cell antigens presented by MHC molecules.	Glycopeptides	82-95	major histocompatibility complex, class I, C	Homo sapiens	141-144
10952577-7	2000	The vanB2 resistance element appears to be widespread among VanB glycopeptide-resistant E. faecium strains isolated in Scottish hospitals.	Glycopeptides	65-77	D-alanine--D-lactate ligase	Enterococcus faecalis	4-9
10952577-7	2000	The vanB2 resistance element appears to be widespread among VanB glycopeptide-resistant E. faecium strains isolated in Scottish hospitals.	Glycopeptides	65-77	D-alanine--D-lactate ligase	Enterococcus faecium	60-64
10963678-8	2000	Overall, the data are consistent with a mode of lipoglycan recognition similar to that proposed for glycopeptides, in which the TCR alpha and beta chains survey a surface composed of both mCD1.1 and the carbohydrate portion of alpha-GalCer.	Glycopeptides	100-113	T cell receptor alpha chain	Mus musculus	128-137
10963678-8	2000	Overall, the data are consistent with a mode of lipoglycan recognition similar to that proposed for glycopeptides, in which the TCR alpha and beta chains survey a surface composed of both mCD1.1 and the carbohydrate portion of alpha-GalCer.	Glycopeptides	100-113	CD1d1 antigen	Mus musculus	188-194
11019912-8	2000	Together, these data provide further evidence for the natural presentation by human class I MHC of glycopeptides carrying terminal O-GlcNAc residues in vivo.	Glycopeptides	99-112	O-linked N-acetylglucosamine (GlcNAc) transferase	Homo sapiens	131-139
10882013-3	2000	To further characterize this system, the synthesis of glycopeptides from PSGL-1 was undertaken.	Glycopeptides	54-67	selectin P ligand	Homo sapiens	73-79
10660465-1	2000	We have developed an assay system for endo-beta-N-acetylglucosaminidase and glycoamidase (PNGase), using Eu(3+)-labeled Man(9)GlcNAc(2) glycopeptides as substrates in combination with lectin capture.	Glycopeptides	136-149	O-GlcNAcase	Homo sapiens	43-71
11085411-7	2000	The analysis of phospholipase A2 from the venom of individual bees indicated that the variation and relative abundances of different glycopeptides were similar between the younger and the older bees.	Glycopeptides	133-146	phospholipase A2	Apis mellifera	16-32
10784033-5	2000	As demonstrated by both ELISA and FACS analysis, the glycopeptides induced high titers of anti-Tn antibodies in mice, in the absence of a carrier molecule.	Glycopeptides	53-66	acyl-CoA synthetase long-chain family member 1	Mus musculus	34-38
10425209-14	1999	The binding was non-covalent and not strong because the asialo-, agalacto-hinge glycopeptide was eluted slightly slower than the native one from the column and the bound IgA1 was dissociated in the presence of 1 M NaCl.	Glycopeptides	80-92	immunoglobulin heavy constant alpha 1	Homo sapiens	170-174
10588068-5	1999	The glycopeptides [beta-D-Glc-(1-->6)-alpha-D-Man-(1-->6)-D-Man]-O-Ser2-Pro2 (No.	Glycopeptides	4-17	jagged canonical Notch ligand 2	Homo sapiens	73-77
10532235-0	1999	NMR analysis of human salivary mucin (MUC7) derived O-linked model glycopeptides: comparison of structural features and carbohydrate-peptide interactions.	Glycopeptides	67-80	LOC100508689	Homo sapiens	31-36
10532235-0	1999	NMR analysis of human salivary mucin (MUC7) derived O-linked model glycopeptides: comparison of structural features and carbohydrate-peptide interactions.	Glycopeptides	67-80	mucin 7, secreted	Homo sapiens	38-42
10094775-6	1999	Examples are shown with mannosyl- and mucin-type glycopeptides.	Glycopeptides	49-62	LOC100508689	Homo sapiens	38-43
10341169-3	1999	Accumulating evidence now indicates that the use of the glycopeptide avoparcin as a growth promoter has created in food animals a major reservoir of Enterococcus faecium, which contains the high level glycopeptide resistance determinant vanA, located on the Tn1546 transposon.	Glycopeptides	56-68	Vancomycin Teicoplanin A-type resistance protein VanA / D-alanine--D-alanine ligase	Enterococcus faecium	237-241
10200322-2	1999	Bleomycin (BLM), a clinically used glycopeptide anticancer agent, is deaminated in vitro by Blmh.	Glycopeptides	35-47	bleomycin hydrolase	Mus musculus	92-96
10417422-0	1999	Crystallization and preliminary X-ray characterization of VanA from Enterococcus faecium BM4147: towards the molecular basis of bacterial resistance to the glycopeptide antibiotic vancomycin.	Glycopeptides	156-168	Vancomycin Teicoplanin A-type resistance protein VanA / D-alanine--D-alanine ligase	Enterococcus faecium	58-62
10348770-6	1999	Furthermore, the msbB mutant was resistant to glycopeptides (vancomycin, teicoplanin), whereas the rfa, lpxA, and lpxD mutants were susceptible.	Glycopeptides	46-59	lipid A biosynthesis (KDO)2-(lauroyl)-lipid IVA acyltransferase	Escherichia coli	17-21
10226365-0	1999	Characterization of O-glycosylation sites in MUC2 glycopeptides by nanoelectrospray QTOF mass spectrometry.	Glycopeptides	50-63	mucin 2, oligomeric mucus/gel-forming	Homo sapiens	45-49
10230695-5	1999	In addition, two methods were developed to detect the different genotypes of glycopeptide resistance described in enterococci: a multiplex PCR assay for detection of vanA, vanB, vanC-1, vanC-2/3 ligase genes including 16S rRNA gene control primers and a sandwich hybridization assay to confirm vanA and vanB PCR-positive strains.	Glycopeptides	77-89	D-alanine--D-lactate ligase	Enterococcus faecium	172-176
10230695-5	1999	In addition, two methods were developed to detect the different genotypes of glycopeptide resistance described in enterococci: a multiplex PCR assay for detection of vanA, vanB, vanC-1, vanC-2/3 ligase genes including 16S rRNA gene control primers and a sandwich hybridization assay to confirm vanA and vanB PCR-positive strains.	Glycopeptides	77-89	D-alanine--D-lactate ligase	Enterococcus faecium	303-307
10230695-7	1999	Four strains were found with acquired resistance to glycopeptides: one E. faecium and one E. gallinarum were vanA positive, and two E. faecium isolates were vanB positive.	Glycopeptides	52-65	D-alanine--D-lactate ligase	Enterococcus faecium	157-161
10021921-1	1999	Glycopeptides of hMOG(30-50) containing a glucosyl moiety on the side-chains of Asn, Ser or Hyp at position 31 were synthesised.	Glycopeptides	0-13	myelin oligodendrocyte glycoprotein	Homo sapiens	17-21
10021921-1	1999	Glycopeptides of hMOG(30-50) containing a glucosyl moiety on the side-chains of Asn, Ser or Hyp at position 31 were synthesised.	Glycopeptides	0-13	phosphate regulating endopeptidase homolog X-linked	Homo sapiens	92-95
10021921-3	1999	Anti-hMOG(30-50) antibodies were detected only using the glycopeptide [Asn31(N-Glc)]hMOG(30-50).	Glycopeptides	57-69	myelin oligodendrocyte glycoprotein	Homo sapiens	5-9
10021921-3	1999	Anti-hMOG(30-50) antibodies were detected only using the glycopeptide [Asn31(N-Glc)]hMOG(30-50).	Glycopeptides	57-69	myelin oligodendrocyte glycoprotein	Homo sapiens	84-88
9824507-1	1998	The CAMPATH-1H (CD52) antigen is a 21 000-28 000 MW glycopeptide antigen that is highly expressed on T and B lymphocytes and is coupled to the membrane by a glycosylphosphatidylinositol (GPI) anchoring structure.	Glycopeptides	52-64	CD52 molecule	Homo sapiens	16-20
10217327-0	1999	Structure/activity studies of the anti-MUC1 monoclonal antibody C595 and synthetic MUC1 mucin-core-related peptides and glycopeptides.	Glycopeptides	120-133	mucin 1, cell surface associated	Homo sapiens	39-43
10217327-0	1999	Structure/activity studies of the anti-MUC1 monoclonal antibody C595 and synthetic MUC1 mucin-core-related peptides and glycopeptides.	Glycopeptides	120-133	mucin 1, cell surface associated	Homo sapiens	83-87
10023770-2	1999	Immunization with an H-2Kb-restricted glycopeptide RGY8-6H-Gal2 generates a population of cytotoxic T cells that express both alpha/beta TCR, specific for glycopeptide, and gamma/delta TCR, specific for the disaccharide, even on glycolipids.	Glycopeptides	38-50	T cell receptor beta variable 20/OR9-2 (non-functional)	Homo sapiens	137-140
10023770-2	1999	Immunization with an H-2Kb-restricted glycopeptide RGY8-6H-Gal2 generates a population of cytotoxic T cells that express both alpha/beta TCR, specific for glycopeptide, and gamma/delta TCR, specific for the disaccharide, even on glycolipids.	Glycopeptides	38-50	T cell receptor beta variable 20/OR9-2 (non-functional)	Homo sapiens	155-188
9873537-1	1998	Application of the Ugi four-component condensation to rapidly synthesize a library of glycopeptide mimics of the tetrasaccharide SLe(x) as inhibitors of E- and P-selectin, and to study the effect of varied functionality in mimics on the inhibition is described.	Glycopeptides	86-98	selectin P	Homo sapiens	160-170
10211705-1	1998	Glycopeptides containing the N-linked oligosaccharide from human serum IgA1 were analyzed by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOFMS).	Glycopeptides	0-13	immunoglobulin heavy constant alpha 1	Homo sapiens	71-75
10211705-5	1998	On the other hand, the GP2 fraction corresponded to the glycopeptides having a fully galactosylated and fucosylated bianntena sugar chain partly bearing a bisecting GlcNAc residue.	Glycopeptides	56-69	glycoprotein 2	Homo sapiens	23-26
9788808-9	1998	However, these relatively new enterococcal resistances appear still to be evolving; there have now been reports of transferable VanB resistance associated with either large chromosomally borne transposons or plasmids, genetic linkage of glycopeptide resistance and genes conferring high-level resistance to aminoglycoside antibiotics, epidemic strains of glycopeptide-resistant Enterococcus faecium isolated from multiple patients in numerous hospitals, and of glycopeptide dependence (mutant enterococci that actually require these agents for growth).	Glycopeptides	237-249	D-alanine--D-lactate ligase	Enterococcus faecium	128-132
9788808-9	1998	However, these relatively new enterococcal resistances appear still to be evolving; there have now been reports of transferable VanB resistance associated with either large chromosomally borne transposons or plasmids, genetic linkage of glycopeptide resistance and genes conferring high-level resistance to aminoglycoside antibiotics, epidemic strains of glycopeptide-resistant Enterococcus faecium isolated from multiple patients in numerous hospitals, and of glycopeptide dependence (mutant enterococci that actually require these agents for growth).	Glycopeptides	355-367	D-alanine--D-lactate ligase	Enterococcus faecium	128-132
9705282-6	1998	Upon incubation of a glycosylatable peptide R-Asn-X-Thr-R" with permeabilized yeast spheroplasts, we detected formation of both glycosylated peptide and the peptide product expected from PNGase-mediated deglycosylation of this glycopeptide, namely, R-Asp-X-Thr-R".	Glycopeptides	227-239	N-glycanase 1	Homo sapiens	187-193
9801825-2	1998	The solution conformation of these MUC1-related synthetic glycopeptides and the control, non-glycosylated decapeptide AcPAPGSTAPPA have been investigated using NMR spectroscopy.	Glycopeptides	58-71	mucin 1, cell surface associated	Homo sapiens	35-39
9574545-1	1998	The M and N human blood group glycopeptide Ags are carried on RBCs by glycophorin A.	Glycopeptides	30-42	glycophorin A (MNS blood group)	Homo sapiens	70-83
9870359-0	1998	Different O-glycosylation of respiratory mucin glycopeptides from a patient with cystic fibrosis.	Glycopeptides	47-60	LOC100508689	Homo sapiens	41-46
9870359-1	1998	The O-linked oligosaccharides from three fractions of highly glycosylated mucin glycopeptides obtained from sputum of a patient with cystic fibrosis were characterized and compared regarding size, composition, sequence and when possible linkage positions.	Glycopeptides	80-93	LOC100508689	Homo sapiens	74-79
9705247-3	1998	We have previously demonstrated that tanapox virus (TPV) infected cells secrete an early 38 kDa glycopeptide that binds to human (h) interferon-gamma, hIL-2, and hIL-5.	Glycopeptides	96-108	interferon gamma	Homo sapiens	133-149
9705247-3	1998	We have previously demonstrated that tanapox virus (TPV) infected cells secrete an early 38 kDa glycopeptide that binds to human (h) interferon-gamma, hIL-2, and hIL-5.	Glycopeptides	96-108	interleukin 2	Homo sapiens	151-156
9705247-3	1998	We have previously demonstrated that tanapox virus (TPV) infected cells secrete an early 38 kDa glycopeptide that binds to human (h) interferon-gamma, hIL-2, and hIL-5.	Glycopeptides	96-108	interleukin 5	Homo sapiens	162-167
9705247-9	1998	Based on TNF-alpha affinity chromatography, this activity appears to be associated with a 38 kDa glycopeptide.	Glycopeptides	97-109	tumor necrosis factor	Homo sapiens	9-18
9881747-5	1998	CD studies of natural and synthetic diproline-rich peptides and glycopeptides indicated that polyproline type structures do play a significant role in the conformational dynamics of MUC7.	Glycopeptides	64-77	mucin 7, secreted	Homo sapiens	182-186
9555659-0	1998	Analyses of IgA1 hinge glycopeptides in IgA nephropathy by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.	Glycopeptides	23-36	immunoglobulin heavy constant alpha 1	Homo sapiens	12-16
9613824-2	1998	Glycopeptides from the ConA-bound fraction corresponding to the component PP3 were obtained by Pronase digestion and were separated by gel filtration into high and low-molecular-mass glycopeptides.	Glycopeptides	183-196	glycosylation dependent cell adhesion molecule 1	Bos taurus	74-77
9555659-9	1998	These results suggested the presence of a defect in the Gal and/or GalNAc residues in the IgA1 hinge glycopeptides in IgAN.	Glycopeptides	101-114	immunoglobulin heavy constant alpha 1	Homo sapiens	90-94
9555659-9	1998	These results suggested the presence of a defect in the Gal and/or GalNAc residues in the IgA1 hinge glycopeptides in IgAN.	Glycopeptides	101-114	IGAN1	Homo sapiens	118-122
9455924-1	1997	We previously demonstrated that gp120/160 (Env) of HIV-1 interact in a carbohydrate-specific manner with mannosyl/N-acetylglucosaminyl derivatives and that HIV-1LAI infection of monocytic U937 and lymphoid CEM cells was inhibited by CD4-free Concanavalin A-reactive glycopeptides from U937 cells.	Glycopeptides	266-279	Envelope surface glycoprotein gp160, precursor	Human immunodeficiency virus 1	32-41
9485374-1	1998	Bleomycin hydrolase (BH) is unusual among cysteine proteinases because it appears to form multihomomeric structures, inactivates the antitumor glycopeptide bleomycin, and contains a unique C-terminal amino acid sequence.	Glycopeptides	143-155	bleomycin hydrolase	Homo sapiens	0-19
9485374-1	1998	Bleomycin hydrolase (BH) is unusual among cysteine proteinases because it appears to form multihomomeric structures, inactivates the antitumor glycopeptide bleomycin, and contains a unique C-terminal amino acid sequence.	Glycopeptides	143-155	bleomycin hydrolase	Homo sapiens	21-23
9548367-5	1998	We show here that phosphorylation of L1 is reduced concomitant with reduced neurite outgrowth when the L1/NCAM interaction is inhibited by oligomannosidic glycopeptides.	Glycopeptides	155-168	neural cell adhesion molecule 1	Mus musculus	106-110
9579798-6	1998	To overcome these difficulties, without resynthesis, the STn(c) glycopeptide was modified by attachment of an MMCCH (4-(4-N-maieimidomethyl) cyclohexane-1-carboxyl hydrazide) spacer arm to the aldehyde derivative, and then conjugated with thiolated KLH.	Glycopeptides	64-76	eukaryotic translation elongation factor 1 alpha 2	Homo sapiens	57-60
9455924-1	1997	We previously demonstrated that gp120/160 (Env) of HIV-1 interact in a carbohydrate-specific manner with mannosyl/N-acetylglucosaminyl derivatives and that HIV-1LAI infection of monocytic U937 and lymphoid CEM cells was inhibited by CD4-free Concanavalin A-reactive glycopeptides from U937 cells.	Glycopeptides	266-279	Envelope surface glycoprotein gp160, precursor	Human immunodeficiency virus 1	43-46
9455924-6	1997	Mannan also inhibited Env binding to surface glycopeptides obtained after trypsin treatment of macrophages.	Glycopeptides	45-58	endogenous retrovirus group K member 20	Homo sapiens	22-25
9189858-2	1997	The competitive inhibition assays of the IgA1-IgA1 binding were performed using the following candidates for inhibitors: native IgA1 hinge glycopeptide (nHGP), IgA1, IgA2, and IgG.	Glycopeptides	139-151	immunoglobulin heavy constant alpha 1	Homo sapiens	41-45
18636497-3	1997	Sialylation profiles were quantitated by reversed-phase HPLC separations of the site-specific pools of tryptic glycopeptides representing IFN-gamma"s two potential N-linked glycosylation sites (i.e., Asn(25) and Asn(97)).	Glycopeptides	111-124	interferon gamma	Homo sapiens	138-147
9189858-2	1997	The competitive inhibition assays of the IgA1-IgA1 binding were performed using the following candidates for inhibitors: native IgA1 hinge glycopeptide (nHGP), IgA1, IgA2, and IgG.	Glycopeptides	139-151	immunoglobulin heavy constant alpha 1	Homo sapiens	46-50
9189858-2	1997	The competitive inhibition assays of the IgA1-IgA1 binding were performed using the following candidates for inhibitors: native IgA1 hinge glycopeptide (nHGP), IgA1, IgA2, and IgG.	Glycopeptides	139-151	immunoglobulin heavy constant alpha 1	Homo sapiens	46-50
9189858-2	1997	The competitive inhibition assays of the IgA1-IgA1 binding were performed using the following candidates for inhibitors: native IgA1 hinge glycopeptide (nHGP), IgA1, IgA2, and IgG.	Glycopeptides	139-151	immunoglobulin heavy constant alpha 1	Homo sapiens	46-50
9065790-4	1997	Our investigations indicated that a peptide:N-glycanase (PNGase) is present in ER membranes that has the capacity to release from radiolabelled glycopeptides glucosylated as well as non-glucosylated polymannose oligosaccharides terminating at their reducing end in a di-N-acetylchitobiose sequence (OS-GlcNAc2).	Glycopeptides	144-157	N-glycanase 1	Rattus norvegicus	36-55
9109096-7	1997	Both glycopeptides with little or no antimicrobial activity and semisynthetic glycopeptides active against VanA resistant enterococci were inducers.	Glycopeptides	78-91	VanA	Enterococcus faecalis	107-111
9259029-6	1997	If the incidence of MRSA increases, drugs such as the glycopeptides will be of more importance.	Glycopeptides	54-67	solute carrier family 9 member A6	Homo sapiens	20-24
9065790-4	1997	Our investigations indicated that a peptide:N-glycanase (PNGase) is present in ER membranes that has the capacity to release from radiolabelled glycopeptides glucosylated as well as non-glucosylated polymannose oligosaccharides terminating at their reducing end in a di-N-acetylchitobiose sequence (OS-GlcNAc2).	Glycopeptides	144-157	N-glycanase 1	Rattus norvegicus	57-63
8756692-5	1996	Tryptic cleavage of pig AE2 in the Z-loop produced C-terminal glycopeptides and was unaffected by deglycosylation, whereas the smaller rabbit AE2 C-terminal tryptic peptide lacked oligosaccharide, consistent with the respective amino acid sequences.	Glycopeptides	62-75	solute carrier family 4 member 2	Sus scrofa	24-27
9013598-3	1997	The mass spectra of the glycopeptides exhibit characteristic clusters of peaks which indicate the N-linked glycans in tACE to be mostly of the biantennary, fucosylated complex type.	Glycopeptides	24-37	ADAM metallopeptidase domain 17	Homo sapiens	118-122
9299760-2	1997	In order to establish detailed fragmentation patterns and to dissect fragment ions with and without carbohydrate content, the same O-linked MUC1-derived glycopeptides with acetylated and non-acetylated sugars were analysed and compared.	Glycopeptides	153-166	mucin 1, cell surface associated	Homo sapiens	140-144
8910378-1	1996	GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1-->6fucosyltransferase (alpha1-6FucT; EC 2.4.1.68), which catalyzes the transfer of fucose from GDP-Fuc to N-linked type complex glycopeptides, was purified from a Triton X-100 extract of porcine brain microsomes.	Glycopeptides	178-191	fucosyltransferase 8	Rattus norvegicus	40-71
8910378-1	1996	GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1-->6fucosyltransferase (alpha1-6FucT; EC 2.4.1.68), which catalyzes the transfer of fucose from GDP-Fuc to N-linked type complex glycopeptides, was purified from a Triton X-100 extract of porcine brain microsomes.	Glycopeptides	178-191	fucosyltransferase 8	Rattus norvegicus	73-85
9133635-1	1997	GDP-L-Fuc:N-acetyl-beta-D-glucosaminide:alpha1-6 fucosyltransferase (alpha1-6 FucT), which catalyzes the transfer of fucose from GDP-Fuc to N-linked type complex glycopeptides, was purified from a culture supernatant of human gastric cancer cell line MKN45.	Glycopeptides	162-175	fucosyltransferase 8	Homo sapiens	0-67
9133635-1	1997	GDP-L-Fuc:N-acetyl-beta-D-glucosaminide:alpha1-6 fucosyltransferase (alpha1-6 FucT), which catalyzes the transfer of fucose from GDP-Fuc to N-linked type complex glycopeptides, was purified from a culture supernatant of human gastric cancer cell line MKN45.	Glycopeptides	162-175	fucosyltransferase 8	Homo sapiens	69-82
8981985-4	1997	Transcription of cat and vanX was inducible by glycopeptides in partial diploids harboring vanS and vanS(omega)cat but was constitutive in strains containing only vanS(omega)cat.	Glycopeptides	47-60	VanX protein	Enterococcus faecium	25-29
8981985-4	1997	Transcription of cat and vanX was inducible by glycopeptides in partial diploids harboring vanS and vanS(omega)cat but was constitutive in strains containing only vanS(omega)cat.	Glycopeptides	47-60	VanS protein	Enterococcus faecium	91-95
8981985-4	1997	Transcription of cat and vanX was inducible by glycopeptides in partial diploids harboring vanS and vanS(omega)cat but was constitutive in strains containing only vanS(omega)cat.	Glycopeptides	47-60	VanS protein	Enterococcus faecium	100-104
8981985-4	1997	Transcription of cat and vanX was inducible by glycopeptides in partial diploids harboring vanS and vanS(omega)cat but was constitutive in strains containing only vanS(omega)cat.	Glycopeptides	47-60	VanS protein	Enterococcus faecium	100-104
8828507-3	1996	Exposure of the cells to a culture temperature of 37 C, compared to 33 C, had a fast and irreversibly suppressive effect on the levels of an abundant epididymal messenger RNA (mRNA), CE5, which represents the canine counterpart of the human CD52/HE5 mRNA, encoding a major glycosylphoshatidylinnositol (GPI)-anchored sperm membrane glycopeptide.	Glycopeptides	332-344	CD52 molecule	Canis lupus familiaris	183-186
8756692-9	1996	Chymotryptic cleavage in the pig AE2 Z-loop produced C-terminal glycopeptides.	Glycopeptides	64-77	solute carrier family 4 member 2	Sus scrofa	33-36
8889826-0	1996	Estimation of the number of O-linked oligosaccharides per heavy chain of human serum IgA1 by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOFMS) analysis of the hinge glycopeptide.	Glycopeptides	206-218	immunoglobulin heavy constant alpha 1	Homo sapiens	85-89
8889826-4	1996	In order to determine the number of linked sugar chains, we applied matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOFMS) to the hinge glycopeptide prepared from human serum IgA1.	Glycopeptides	172-184	immunoglobulin heavy constant alpha 1	Homo sapiens	211-215
8889826-12	1996	The reason why only four out of five sites on the hinge glycopeptide were fully glycosylated in the IgA1 from the IgA1 myeloma patient is not clear.	Glycopeptides	56-68	immunoglobulin heavy constant alpha 1	Homo sapiens	100-104
8889826-12	1996	The reason why only four out of five sites on the hinge glycopeptide were fully glycosylated in the IgA1 from the IgA1 myeloma patient is not clear.	Glycopeptides	56-68	immunoglobulin heavy constant alpha 1	Homo sapiens	114-118
8626722-7	1996	The immobilized calreticulin proved to be a highly effective tool for sorting out monoglucosylated polymannose oligosaccharides or glycopeptides from complex mixtures of processing intermediates.	Glycopeptides	131-144	calreticulin	Homo sapiens	16-28
9387790-4	1996	These results suggest that the carbohydrate moiety of hCG participate in the signal transduction among receptor, G-protein and adenylatecyclase which is inhibited by Asn-linked oligosaccharide chains from ovalbumin glycopeptides.	Glycopeptides	215-228	hypertrichosis 2 (generalised, congenital)	Homo sapiens	54-57
8869094-14	1996	Our preliminary clinical results suggest that a humoral immune response to PEM protects against disease progression, and further support the idea of using synthetic peptides or glycopeptides containing the immunogenic core of the mucin as cancer vaccines.	Glycopeptides	177-190	mucin 1, cell surface associated	Homo sapiens	75-78
8799292-1	1996	The fraction of sulphated oligosaccharide alditols isolated from mucin glycopeptides of porcine small intestine "insoluble" mucin complex was analysed by negative-ion fast atom bombardment (FAB) tandem mass spectrometry.	Glycopeptides	71-84	LOC100508689	Homo sapiens	65-70
8631778-10	1996	1H NMR spectroscopy and electrospray ionization-mass spectrometry showed that the LEC14 core glycopeptides contain a new GlcNAc residue that substitutes the core beta(1-4)-Man residue at O-2 to give the following novel, N-linked core structure.	Glycopeptides	93-106	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	Homo sapiens	162-170
8758482-1	1996	Glycopeptides which have excellent in vitro activity against the Gram-positive causal agents of meningitis unfortunately have a poor CSF penetration.	Glycopeptides	0-13	colony stimulating factor 2	Homo sapiens	133-136
11667093-1	1996	The selective C-terminal deprotection of O-glycopeptide (methoxyethoxy)ethyl esters is achieved under mild conditions (pH 6.6, 37 degrees C) by enzymatic hydrolysis using papain or lipase M from Mucor javanicus to give building blocks useful for chain-extending glycopeptide synthesis.	Glycopeptides	43-55	probable feruloyl esterase A	Triticum aestivum	181-187
11667093-2	1996	On the other hand, the selective removal of acetyl protecting groups from the saccharide portion of glycopeptides is accomplished by alternative enzymatic hydrolysis with lipase WG from wheat germ to furnish model substrates for enzymatic glycosyl transfer reactions in order to extend the carbohydrate side chain of these conjugates.	Glycopeptides	100-113	probable feruloyl esterase A	Triticum aestivum	171-177
8605919-6	1996	With two of these glycopeptides, with galabiose (Gal alpha 1-4Gal; Gal2) bound to a homocysteine (via an ethylene spacer arm) in position 4 or 6 in a vesicular stomatitis virus nucleoprotein-derived peptide (RGYVYQGL binding to Kb), CTL were generated which preferentially killed target cells treated with glycopeptide compared to those treated with the core peptide.	Glycopeptides	18-31	lectin, galactose-binding, soluble 2	Mus musculus	67-71
8850552-3	1996	These sequences are nearly identical to the two human fibrinogen glycopeptides, Val-Glu-Asn(CHO)-Lys (gamma-chain), and Met-Gly-Glu-Asn(CHO)-Arg (beta-chain).	Glycopeptides	65-78	fibrinogen beta chain	Homo sapiens	54-64
8605919-6	1996	With two of these glycopeptides, with galabiose (Gal alpha 1-4Gal; Gal2) bound to a homocysteine (via an ethylene spacer arm) in position 4 or 6 in a vesicular stomatitis virus nucleoprotein-derived peptide (RGYVYQGL binding to Kb), CTL were generated which preferentially killed target cells treated with glycopeptide compared to those treated with the core peptide.	Glycopeptides	18-30	lectin, galactose-binding, soluble 2	Mus musculus	67-71
8641764-3	1996	The agglutination reaction was specifically inhibited by glycopeptides derived from bovine lactoferrin or alpha-methyl-D-mannoside.	Glycopeptides	57-70	lactotransferrin	Bos taurus	91-102
8825618-0	1996	Inhibition of human immunodeficiency virus infection of CD4+ cells by CD4-free glycopeptides from monocytic U937 cells.	Glycopeptides	79-92	CD4 molecule	Homo sapiens	56-59
8742080-0	1996	Selective detection and site-analysis of O-GlcNAc-modified glycopeptides by beta-elimination and tandem electrospray mass spectrometry.	Glycopeptides	59-72	O-linked N-acetylglucosamine (GlcNAc) transferase	Homo sapiens	41-49
8742080-5	1996	In this report, synthetic glycopeptides were generated and used to demonstrate that O-GlcNAc-modified peptides can be rapidly identified in complex mixtures by HPLC-coupled electrospray mass spectrometry due to the partial loss of the O-linked glycan (204 amu) at a modest orifice potential.	Glycopeptides	26-39	O-linked N-acetylglucosamine (GlcNAc) transferase	Homo sapiens	84-92
8825618-0	1996	Inhibition of human immunodeficiency virus infection of CD4+ cells by CD4-free glycopeptides from monocytic U937 cells.	Glycopeptides	79-92	CD4 molecule	Homo sapiens	70-73
8825618-3	1996	CD4-free tryptic glycopeptides, prepared from the membrane of CD4+ monocytic U937 cells and partially purified by ConA-agarose affinity chromatography, could be eluted by mannan but not by methyl-alpha-mannose or methyl-alpha-glucose, which strongly suggests that they displayed oligomannosidic structures.	Glycopeptides	17-30	CD4 molecule	Homo sapiens	0-3
8825618-3	1996	CD4-free tryptic glycopeptides, prepared from the membrane of CD4+ monocytic U937 cells and partially purified by ConA-agarose affinity chromatography, could be eluted by mannan but not by methyl-alpha-mannose or methyl-alpha-glucose, which strongly suggests that they displayed oligomannosidic structures.	Glycopeptides	17-30	CD4 molecule	Homo sapiens	62-65
7559574-4	1995	The larger of these (17 kDa) begins at Gln-209 near the end of the carbonic anhydrase-like domain of phosphacan/RPTP zeta/beta, whereas a 13-kDa glycopeptide begins at His-361 located in the middle of the fibronectin type III-like domain.	Glycopeptides	145-157	protein tyrosine phosphatase receptor type Z1	Homo sapiens	101-111
8834812-7	1996	Glycopeptides obtained from [3H]galactose-labelled cells bind to VIP36 and can be eluted with N-acetyl-D-galactosamine.	Glycopeptides	0-13	lectin, mannose binding 2	Canis lupus familiaris	65-70
8556161-7	1995	By reversed-phase HPLC of tryptic digested neuraminidase treated rFVIIa the glycopeptides containing the heavy chain N-glycosylated site elute as two peaks compared to the four peaks corresponding to glycopeptides with 0 to 3 N-acetyl-neuraminic acids seen for untreated rFVIIa.	Glycopeptides	76-89	neuraminidase 1	Homo sapiens	43-56
8770386-5	1995	It is suggested that dimeric SLex glycopeptides of the mucin type would be effective ligands for E-selectin.	Glycopeptides	34-47	selectin E	Homo sapiens	97-107
7559574-6	1995	Based on the amino acid sequence of phosphacan, it can be concluded that each of the tryptic peptides contains one potential N-glycosylation site (at Asn-232 and Asn-381), and analyses of the isolated glycopeptides demonstrated the presence of sialylated complex-type oligosaccharides.	Glycopeptides	201-214	protein tyrosine phosphatase receptor type Z1	Homo sapiens	36-46
8595249-9	1995	Immune responses generated by these synthetic glycopeptides are highly specific in recognizing the native cancer associated mucin.	Glycopeptides	46-59	LOC100508689	Homo sapiens	124-129
9158786-3	1995	In 5 of 13 samples of raw minced meat of pigs originating from 13 different butcher"s shops, glycopeptide-resistant E. faecium (VanA type) could be detected after overnight broth cultivation of these samples.	Glycopeptides	93-105	Vancomycin Teicoplanin A-type resistance protein VanA / D-alanine--D-alanine ligase	Enterococcus faecium	128-132
7626668-4	1995	Glycopeptides prepared from the N-terminal region of glycophorin A containing most of the sialosaccharide chains of the molecule inhibited the binding of ox-LDL although the potency was lower than that of glycophorin A.	Glycopeptides	0-13	glycophorin A	Mus musculus	53-66
7545084-6	1995	Binding of BW835 to glycopeptide 17 or to MUC1 was competitively inhibited by peanut agglutinin and by the synthetic glycopeptides TF alpha Ser or TF alpha Thr but not by their beta-anomers.	Glycopeptides	117-130	mucin 1, cell surface associated	Homo sapiens	42-46
7626668-4	1995	Glycopeptides prepared from the N-terminal region of glycophorin A containing most of the sialosaccharide chains of the molecule inhibited the binding of ox-LDL although the potency was lower than that of glycophorin A.	Glycopeptides	0-13	glycophorin A	Mus musculus	205-218
7795415-1	1995	A method for the separation of O-linked oligosaccharides into neutral, sialic acid-containing and sulfated species was applied to oligosaccharides released by alkaline borohydride from mucin glycopeptides from porcine small intestine.	Glycopeptides	191-204	LOC100508689	Homo sapiens	185-190
8572267-5	1995	Next, RCA I was used to isolate glycopeptides from the O-GlcNAc-bearing basic phosphoprotein (BPP) of human cytomegalovirus.	Glycopeptides	32-45	O-linked N-acetylglucosamine (GlcNAc) transferase	Homo sapiens	55-63
7786020-2	1995	PNGase activities were determined using 14C-labeled fetuin glycopeptide I as a substrate by a newly improved enzyme assay based on the paper chromatographic and paper electrophoretic analyses.	Glycopeptides	59-71	N-glycanase 1	Mus musculus	0-6
7496141-5	1995	A galactose-terminated triantennary N-glycoside, having one N-acetyl-lactosamine unit on the 6 branch and two N-acetyl-lactosamine units on the 3 branch of the trimannosyl core structure, showed affinity enhancement of approximately 10(5) over a monovalent ligand for HHL, while the same glycopeptide showed enhancement of about 2000-fold for rM-ASGP-BP.	Glycopeptides	288-300	C-type lectin domain containing 10A	Rattus norvegicus	343-353
7613477-2	1995	A recently described mass spectrometric technique involving monitoring of carbohydrate-specific fragment ions during HPLC/ESIMS was employed to locate eight different groups of glycopeptides in a digest of a human LCAT protein preparation.	Glycopeptides	177-190	lecithin-cholesterol acyltransferase	Homo sapiens	214-218
7613477-3	1995	In addition to the four expected N-linked glycopeptides of LCAT, a di-O-linked glycopeptide was detected, as well as three additional glycopeptides.	Glycopeptides	42-55	lecithin-cholesterol acyltransferase	Homo sapiens	59-63
7768507-3	1995	Both native mucin and glycopeptides bound to mature HAP crystals, but the glycopeptides were much more readily displaced by phosphate ions.	Glycopeptides	74-87	LOC100508689	Homo sapiens	12-17
7872492-5	1995	It is believed that cathepsin D plays a main role in the degradation of rod outer segments and rhodopsin into glycopeptides.	Glycopeptides	110-123	rhodopsin	Rattus norvegicus	95-104
7710067-3	1995	Desialylation and beta-galactosidase digestion conditions were developed to produce asialo- and asialo-agalacto glycopeptides.	Glycopeptides	112-125	galactosidase beta 1	Bos taurus	18-36
7733455-3	1995	The method was applied on a mixture of neutral oligosaccharides released from mucin glycopeptides of rat small intestine by alkaline borohydride.	Glycopeptides	84-97	solute carrier family 13 member 2	Rattus norvegicus	78-83
9346848-5	1995	While alpha-linked glycopeptides can bind to MHC without major alterations in the spatial arrangements and hydrogen bonding pattern of class II-peptide binding, the binding of beta-linked glycopeptides is considerably less favorable due to steric and columbic conflicts.	Glycopeptides	19-32	major histocompatibility complex, class I, C	Homo sapiens	45-48
7872492-5	1995	It is believed that cathepsin D plays a main role in the degradation of rod outer segments and rhodopsin into glycopeptides.	Glycopeptides	110-123	cathepsin D	Rattus norvegicus	20-31
9346848-0	1995	Computer design of T-cell agonist or antagonist glycopeptides: the effect of sugar identity and anomeric configuration on MHC binding.	Glycopeptides	48-61	major histocompatibility complex, class I, C	Homo sapiens	122-125
7966627-7	1994	Furthermore, the major sites of O-GlcNAc attachment to the rBPP were mapped on high-performance liquid chromatography-purified glycopeptides by gas phase microsequencing, manual Edman degradation, and electrospray-mass spectrometry.	Glycopeptides	127-140	O-linked N-acetylglucosamine (GlcNAc) transferase	Homo sapiens	32-40
7551253-2	1995	This provides the basis for our development of synthetic carbohydrate, peptide, and glycopeptide-based ASI agents corresponding to the cancer-associated mucin epitopes.	Glycopeptides	84-96	LOC100508689	Homo sapiens	153-158
7757427-6	1994	Glycopeptides containing N-glycans derived from lamp-1 were fractionated by sequential lectin affinity chromatography.	Glycopeptides	0-13	lysosome-associated membrane glycoprotein 1	Cricetulus griseus	48-54
7864366-0	1994	Analysis by electrospray mass spectrometry of glycopeptides from the in vitro O-glycosylation reaction using human mucin motif peptide.	Glycopeptides	46-59	LOC100508689	Homo sapiens	115-120
7873664-12	1994	These data demonstrate that the YEE(GalNAcAH)3 synthetic glycopeptide can be used as a ligand in targeted delivery of DNA to the liver-specific ASGPr.	Glycopeptides	57-69	asialoglycoprotein receptor 1	Homo sapiens	144-149
7854121-7	1994	These results establish that VanX is required for production of a D,D-dipeptidase that hydrolyses D-Ala-D-Ala, thereby preventing pentapeptide synthesis and subsequent binding of glycopeptides to D-Ala-D-Ala-containing peptidoglycan precursors at the cell surface.	Glycopeptides	179-192	VanX	Enterococcus faecalis	29-33
7854121-1	1994	Cloning and nucleotide sequencing indicated that transposon Tn1546 from Enterococcus faecium BM4147 encodes a 23,365 Da protein, VanX, required for glycopeptide resistance.	Glycopeptides	148-160	VanX protein	Enterococcus faecium	129-133
8181460-3	1994	Most glycopeptides were excellent substrates for core 1 beta 3-Gal-T compared to benzyl alpha-D-galactosamine as indicated by their relatively high Vmax/Km.	Glycopeptides	5-18	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	Rattus norvegicus	49-68
7921174-5	1994	A 1-h gas-phase hydrolysis time seems to be appropriate for the majority of glycopeptides and 1.5 h is suitable for the majority of phosphopeptides.	Glycopeptides	76-89	BCL2 related protein A1	Homo sapiens	0-3
8034696-5	1994	The O-GlcNAcase also shows substantially stronger relative activity against O-GlcNAc-synthetic glycopeptides than other hexosaminidases.	Glycopeptides	95-108	O-GlcNAcase	Rattus norvegicus	4-15
8067523-8	1994	In the mapping of the CHO IL-4 glycoprotein, detection of the trypsin-generated glycopeptides was only possible by MALDI, where their detection was greatly improved by using the super-DHB (sDHB) matrix, a 9:1 mixture of 2,5-dihydroxybenzoic acid (DHB) with 2-hydroxy-5-methoxybenzoic acid.	Glycopeptides	80-93	interleukin 4	Homo sapiens	26-30
8181460-2	1994	Series of glycopeptides have been synthesized by solid-phase synthesis, protected with an acetyl group on the amino terminal and an amide group on the carboxy terminal, based on variations of the repeat sequences of human intestinal mucin.	Glycopeptides	10-23	LOC100508689	Homo sapiens	233-238
8344946-5	1993	The predominant sites of O-GlcNAc attachment on NF-L and NF-M are identified using proteolysis, purification of the glycopeptides, and subsequent analysis by automated gas-phase sequencing, manual Edman degradation, and laser desorption mass spectrometry.	Glycopeptides	116-129	O-linked N-acetylglucosamine (GlcNAc) transferase	Homo sapiens	25-33
7507111-6	1994	Thus O-glycosylation is likely to play an important role in controlling the fate of the NH2-terminal portion of pro-opiomelanocortin, thereby affecting the biological events that are influenced by peptides and glycopeptides derived from this domain.	Glycopeptides	210-223	proopiomelanocortin	Bos taurus	112-132
8373354-2	1993	A rat intestinal lambda ZAP II cDNA library was screened using a polyclonal antiserum which was prepared against deglycosylated high-molecular-mass glycopeptides of the purified mucin.	Glycopeptides	148-161	solute carrier family 13 member 2	Rattus norvegicus	178-183
8168955-9	1994	These bands were partially or completely displaced by nonradiolabeled respiratory mucin glycopeptides but not by tetramethylurea, suggesting that they recognized carbohydrate sites.	Glycopeptides	88-101	LOC100508689	Homo sapiens	82-87
8360471-0	1993	Glycopeptides bind MHC molecules and elicit specific T cell responses.	Glycopeptides	0-13	major histocompatibility complex, class I, C	Homo sapiens	19-22
8360471-9	1993	T cells directed to Gal2-52-61 recognized glycopeptides having significant variation in the disaccharide structure, such as HEL(52-61) glycopeptides carrying lactose, cellobiose, or hepta-o-acetylated galabiose.	Glycopeptides	42-55	galectin 2	Homo sapiens	20-24
8360471-9	1993	T cells directed to Gal2-52-61 recognized glycopeptides having significant variation in the disaccharide structure, such as HEL(52-61) glycopeptides carrying lactose, cellobiose, or hepta-o-acetylated galabiose.	Glycopeptides	135-148	galectin 2	Homo sapiens	20-24
8344946-5	1993	The predominant sites of O-GlcNAc attachment on NF-L and NF-M are identified using proteolysis, purification of the glycopeptides, and subsequent analysis by automated gas-phase sequencing, manual Edman degradation, and laser desorption mass spectrometry.	Glycopeptides	116-129	neurofilament light chain	Homo sapiens	48-52
8344946-5	1993	The predominant sites of O-GlcNAc attachment on NF-L and NF-M are identified using proteolysis, purification of the glycopeptides, and subsequent analysis by automated gas-phase sequencing, manual Edman degradation, and laser desorption mass spectrometry.	Glycopeptides	116-129	neurofilament medium chain	Homo sapiens	57-61
1456441-10	1992	The SNA-bound glycopeptides were further fractionated by LPHA affinity chromatography.	Glycopeptides	14-27	secretoglobin family 1D member 1	Homo sapiens	57-61
8419650-7	1993	Fragmentation of the gp120-derived 35SO4-labeled glycopeptides by treatment with hydrazine and nitrous acid and subsequent reduction generated galactosyl-anhydromannitol-6-35SO4, which is the expected reaction product from GlcNAc-6-sulfate within a sulfated lactosamine moiety.	Glycopeptides	49-62	inter-alpha-trypsin inhibitor heavy chain 4	Homo sapiens	21-26
8419650-8	1993	Charge analysis of the [3H]galactose- and [3H]glucosamine-labeled glycopeptides from gp120 and gp160 indicates that approximately 14% of the complex-type N-linked oligosaccharides are sulfated.	Glycopeptides	66-79	inter-alpha-trypsin inhibitor heavy chain 4	Homo sapiens	85-90
8400551-3	1993	The amino acid sequence data demonstrated that the glycopeptides were derived from rhodopsin and confirmed the presence of two N-glycosylation sites, at residues Asn2 and Asn15.	Glycopeptides	51-64	rhodopsin	Homo sapiens	83-92
7685744-6	1993	Computer modeling of the MUC-1 immunoreactive glycopeptide containing the H type-3 trisaccharide alpha Fuc 1-2 beta Gal 1-3 alpha GalNAc- bound to the threonine of the PDTRP-pentapeptide shows that the peptide epitope might be masked when the fucose is positioned over the arginine.	Glycopeptides	46-58	mucin 1, cell surface associated	Homo sapiens	25-30
8448122-0	1993	Structure and dynamics of mucin-like glycopeptides.	Glycopeptides	37-50	LOC100508689	Homo sapiens	26-31
8448122-12	1993	These changes are consistent with the extrapolations of the mucin chain dimension data to glycopeptides of this size.	Glycopeptides	90-103	LOC100508689	Homo sapiens	60-65
1445223-9	1992	In addition, the N-terminal amino acid sequence of the larger glycopeptide was found to be part of one of the selected MG2 cDNA clones.	Glycopeptides	62-74	mucin 7, secreted	Homo sapiens	119-122
1418987-7	1992	Purified O-glycopeptides were characterized with respect to amino acid and carbohydrate compositions and sequenced by automated Edman degradation; alpha OGP was a 41-residue glycopeptide with three O-linked sugar chains.	Glycopeptides	11-23	oviductal glycoprotein 1	Mus musculus	153-156
1419961-1	1992	study of interaction between sugar and peptide moieties in mucin-type model glycopeptides.	Glycopeptides	76-89	LOC100508689	Homo sapiens	59-64
1418987-8	1992	Sequence comparisons revealed a 75% identity between alpha OGP and a corresponding segment of rabbit rec55 zona protein; beta OGP was a 25-residue glycopeptide characterized by the presence of one N-linked and five O-linked sugar chains and a trypsin-resistant internal arginine residue.	Glycopeptides	147-159	oviductal glycoprotein 1	Mus musculus	126-129
1346959-0	1992	Interaction between secretory leucocyte proteinase inhibitor and bronchial mucins or glycopeptides.	Glycopeptides	85-98	endogenous retrovirus group K member 25	Homo sapiens	40-50
1346959-2	1992	The interaction of secretory leucocyte proteinase inhibitor with bronchial mucins and glycopeptides was studied by means of c.d.	Glycopeptides	86-99	endogenous retrovirus group K member 25	Homo sapiens	39-49
1346959-8	1992	Glycopeptides treated with neuraminidase gave similar profiles of difference spectra in three different mixtures, indicating that the interaction was smaller.	Glycopeptides	0-13	neuraminidase 1	Homo sapiens	27-40
1822238-1	1991	In this paper we report the first application of fast atom bombardment mass spectrometry (FAB-MS) to O-linked N-acetylglucosamine (O-GlcNAc)-bearing glycopeptides.	Glycopeptides	149-162	FA complementation group B	Homo sapiens	90-93
1587263-5	1992	The staining procedure is also used following isoelectric focusing of mucin-derived glycopeptides to visualize their charge differences and the increase of their isoelectric point after neuraminidase treatment.	Glycopeptides	84-97	LOC100508689	Homo sapiens	70-75
1587263-5	1992	The staining procedure is also used following isoelectric focusing of mucin-derived glycopeptides to visualize their charge differences and the increase of their isoelectric point after neuraminidase treatment.	Glycopeptides	84-97	neuraminidase 1	Homo sapiens	186-199
1822238-1	1991	In this paper we report the first application of fast atom bombardment mass spectrometry (FAB-MS) to O-linked N-acetylglucosamine (O-GlcNAc)-bearing glycopeptides.	Glycopeptides	149-162	O-linked N-acetylglucosamine (GlcNAc) transferase	Homo sapiens	131-139
1822238-8	1991	The propionylation/FAB-MS procedure has been combined with gas-phase sequencing strategies and shows promise for defining the sites of glycosylation of O-GlcNAc glycopeptides that are available in limited quantities.	Glycopeptides	161-174	FA complementation group B	Homo sapiens	19-22
1822238-8	1991	The propionylation/FAB-MS procedure has been combined with gas-phase sequencing strategies and shows promise for defining the sites of glycosylation of O-GlcNAc glycopeptides that are available in limited quantities.	Glycopeptides	161-174	O-linked N-acetylglucosamine (GlcNAc) transferase	Homo sapiens	152-160
1822238-2	1991	Using N-acetylgalactosamine (GalNAc)- and Gal-GalNAc-containing glycopeptides (isolated from Tn glycophorin and desialylated normal glycophorin, respectively) as readily available model compounds, rapid and sensitive derivatization/FAB-MS strategies applicable to serine/threonine-rich glycopeptides have been devised.	Glycopeptides	64-77	FA complementation group B	Homo sapiens	232-235
1822238-3	1991	Peptides and glycopeptides were propionylated in a 1 min reaction using a mixture of trifluoroacetic anhydride and propionic acid, and the product mixtures were analysed directly by FAB-MS. Glycopeptides and peptides rich in hydroxylated residues afforded characteristic clusters of molecular ions at high sensitivity.	Glycopeptides	190-203	FA complementation group B	Homo sapiens	182-185
1822238-5	1991	These methods were used in a study of O-GlcNAc glycopeptides produced by purified O-GlcNAc transferase addition of GlcNAc to the synthetic peptides YSDSPSTST and YSGSPSTST in which Y is tyrosine, S is serine, D is aspartic acid, P is proline, T is threonine and G is glycine.	Glycopeptides	47-60	O-linked N-acetylglucosamine (GlcNAc) transferase	Homo sapiens	38-46
1823621-1	1991	The fibronectin fragment VTHPGY and the corresponding glycopeptides V(Gal beta 3GalNAc alpha)THPGY and V(Gal beta 3GalNAc beta)THPGY were synthesized by the FMOC/solid phase approach.	Glycopeptides	54-67	fibronectin 1	Homo sapiens	4-15
1822238-5	1991	These methods were used in a study of O-GlcNAc glycopeptides produced by purified O-GlcNAc transferase addition of GlcNAc to the synthetic peptides YSDSPSTST and YSGSPSTST in which Y is tyrosine, S is serine, D is aspartic acid, P is proline, T is threonine and G is glycine.	Glycopeptides	47-60	O-linked N-acetylglucosamine (GlcNAc) transferase	Homo sapiens	82-90
2045542-9	1991	Although these extended regions do not contain a glycosylation site, they show striking similarity with the glycopeptide moiety (copeptin) of toad vasotocin and mammalian vasopressin precursors.	Glycopeptides	108-120	arginine vasopressin	Homo sapiens	171-182
1712019-4	1991	On treatment with V8 protease, GP-I was converted to two glycopeptides, one with poor reactivity and the other with intermediate reactivity.	Glycopeptides	57-70	glucose-6-phosphate isomerase	Homo sapiens	31-35
2052617-10	1991	We conclude that in newborn rat kidney (i) podocalyxin contains both O- and N-linked oligosaccharides [high mannose or hybrid type, biantennary, and complex (sialylated) type], (ii) podocalyxin is sulfated, and (iii) sulfate is located on both O-linked oligosaccharides and on glycopeptides carrying tri- or tetrantennary N-linked structures.	Glycopeptides	277-290	podocalyxin-like	Rattus norvegicus	182-193
1723282-6	1991	In the CH-eluted fraction, 50 and 52 kDa glycopeptides were revealed by ConA and WGA, whereas in the CE-immunopurified fraction no band was visualized.	Glycopeptides	41-54	CONA	Bos taurus	72-76
2243102-5	1990	The poly-N-acetyllactosaminyl structures of isolated glycopeptides were confirmed by the susceptibility of their released oligosaccharides to endo-beta-galactosidase.	Glycopeptides	53-66	galactosidase beta 1	Homo sapiens	147-165
2224891-3	1990	Ester groups were removed from the carbohydrate moieties with methanolic hydrazine, to give the TN and T antigen glycopeptides which were coupled to bovine serum albumin (BSA) via a carbodi-imide procedure and without any spacer groups.	Glycopeptides	113-126	albumin	Homo sapiens	156-169
2150408-4	1990	Calcium ionophore-induced degranulation of beta-glucuronidase and elastase were slightly impaired (Student two-tailed; P less than 0.1) by both glycopeptides (beta-glucuronidase) and teicoplanin only (elastase).	Glycopeptides	144-157	glucuronidase beta	Homo sapiens	43-61
2211711-6	1990	The inhibitory potency of a variety of complex glycopeptides against radiolabeled ligand binding to both rat hepatocytes and soluble lectin are in agreement with photoaffinity results that galactose 8 of triantennary glycopeptide is of unique importance by binding solely to the minor subunits (RHL2/3) of the asialoglycoprotein receptor on hepatocytes.	Glycopeptides	47-60	asialoglycoprotein receptor 2	Rattus norvegicus	295-299
2211711-6	1990	The inhibitory potency of a variety of complex glycopeptides against radiolabeled ligand binding to both rat hepatocytes and soluble lectin are in agreement with photoaffinity results that galactose 8 of triantennary glycopeptide is of unique importance by binding solely to the minor subunits (RHL2/3) of the asialoglycoprotein receptor on hepatocytes.	Glycopeptides	47-59	asialoglycoprotein receptor 2	Rattus norvegicus	295-299
2223825-10	1990	The lectin profiles obtained for the complex N-glycans of the transferrin receptor glycopeptides were similar to those for the total cellular glycopeptides of NS-1 cells.	Glycopeptides	83-96	transferrin	Mus musculus	62-73
2223825-11	1990	Reverse-phase HPLC analysis of tryptic glycopeptides of the isolated [3H]mannose-labelled transferrin receptor gave three 3H-labelled peaks, indicating that all three potential N-glycosylation sites on the receptor are utilised.	Glycopeptides	39-52	transferrin	Mus musculus	90-101
2148751-0	1990	Vasopressin in the brain of the golden hamster: the distribution of vasopressin binding sites and of immunoreactivity to the vasopressin-related glycopeptide.	Glycopeptides	145-157	arginine vasopressin	Rattus norvegicus	0-11
2148751-0	1990	Vasopressin in the brain of the golden hamster: the distribution of vasopressin binding sites and of immunoreactivity to the vasopressin-related glycopeptide.	Glycopeptides	145-157	arginine vasopressin	Rattus norvegicus	125-136
2291654-11	1990	The vanA gene was not detected in the glycopeptide-producing strains of Amycolatopsis orientalis (vancomycin) and Actinoplanes teichomyceticus (teicoplanin) or in various gram-positive bacteria intrinsically resistant to glycopeptides.	Glycopeptides	221-234	Vancomycin Teicoplanin A-type resistance protein VanA / D-alanine--D-alanine ligase	Enterococcus faecium	4-8
2400992-0	1990	Evidence that high mannose glycopeptides are able to functionally interact with recombinant tumor necrosis factor and recombinant interleukin 1.	Glycopeptides	27-40	tumor necrosis factor	Mus musculus	92-113
2400992-0	1990	Evidence that high mannose glycopeptides are able to functionally interact with recombinant tumor necrosis factor and recombinant interleukin 1.	Glycopeptides	27-40	interleukin 1 complex	Mus musculus	130-143
2395332-8	1990	Digestion of the glycopeptides with endo-beta-galactosidase, which specifically cleaves polylactosaminoglycans, showed the presence of material containing N-acetyllactosamine repeating units in Gaucher liver glycopeptide fractions, but not in control and Niemann-Pick type C derived glycopeptide fractions.	Glycopeptides	17-29	galactosidase beta 1	Homo sapiens	41-59
2395332-8	1990	Digestion of the glycopeptides with endo-beta-galactosidase, which specifically cleaves polylactosaminoglycans, showed the presence of material containing N-acetyllactosamine repeating units in Gaucher liver glycopeptide fractions, but not in control and Niemann-Pick type C derived glycopeptide fractions.	Glycopeptides	17-29	protein interacting with PRKCA 1	Homo sapiens	263-267
2395332-8	1990	Digestion of the glycopeptides with endo-beta-galactosidase, which specifically cleaves polylactosaminoglycans, showed the presence of material containing N-acetyllactosamine repeating units in Gaucher liver glycopeptide fractions, but not in control and Niemann-Pick type C derived glycopeptide fractions.	Glycopeptides	208-220	galactosidase beta 1	Homo sapiens	41-59
2113054-9	1990	The disulfide bonds of sCD4 were determined to be within domains 1, 2, and 4 and isolation of glycopeptides showed that both N-linked sites were glycosylated.	Glycopeptides	94-107	stearoyl-coenzyme A desaturase 4	Rattus norvegicus	23-27
2194988-2	1990	In retinal pigment epithelium, cathepsin D degrades rod outer segments and rhodopsin into glycopeptides.	Glycopeptides	90-103	cathepsin D	Bos taurus	31-42
2194988-2	1990	In retinal pigment epithelium, cathepsin D degrades rod outer segments and rhodopsin into glycopeptides.	Glycopeptides	90-103	rhodopsin	Bos taurus	75-84
6652065-3	1983	Exo- and endoglycosidase digestion, periodate oxidation, permethylation analysis, and lectin reactivity provided evidence for a tentative carbohydrate structure for the glycopeptide mixture.	Glycopeptides	169-181	5'-3' exoribonuclease 1	Mus musculus	0-3
1694506-7	1990	In the present study we have shown that glycopeptides and oligosaccharides prepared from hCG, transferrin, fetuin, alpha 1-acid glycoprotein and ovalbumin inhibit the binding of hCG to its receptor.	Glycopeptides	40-53	glycoprotein hormones, alpha polypeptide	Homo sapiens	89-92
1694506-7	1990	In the present study we have shown that glycopeptides and oligosaccharides prepared from hCG, transferrin, fetuin, alpha 1-acid glycoprotein and ovalbumin inhibit the binding of hCG to its receptor.	Glycopeptides	40-53	transferrin	Homo sapiens	94-105
1694506-7	1990	In the present study we have shown that glycopeptides and oligosaccharides prepared from hCG, transferrin, fetuin, alpha 1-acid glycoprotein and ovalbumin inhibit the binding of hCG to its receptor.	Glycopeptides	40-53	glycoprotein hormones, alpha polypeptide	Homo sapiens	178-181
2106488-0	1990	In vitro inhibition of IL-2 biosynthesis in activated human peripheral blood mononuclear cells by a trauma-induced glycopeptide.	Glycopeptides	115-127	interleukin 2	Homo sapiens	23-27
2335508-1	1990	Binding characteristics of human spleen soluble galactoside-binding protein (galaptin) were studied using simple galactosides, galactose-terminated disaccharides, cluster glycosides containing up to 6 terminal lactosyl residues, bovine serum albumin derivatives containing 7 to 40 lactosyl residues, desialylated serum glycoproteins, and glycopeptides derived thereof as inhibitors in a newly developed binding assay.	Glycopeptides	338-351	galectin 1	Homo sapiens	77-85
2387072-5	1990	Glycopeptides derived from a glycoprotein, fibronectin, secreted from CF fibroblasts were also examined by 1H-NMR spectroscopy and showed no evidence of fucosyl residues linked alpha 1----3 to branch N-acetylglucosamine and a lesser percentage of core fucose than found in the peripheral membrane glycopeptides.	Glycopeptides	0-13	fibronectin 1	Homo sapiens	43-54
34652821-7	2021	Compared to controls, 24% of glycopeptides had reduced abundance in PMM2-deficient fibroblasts, 46% of which improved upon treatment.	Glycopeptides	29-42	phosphomannomutase 2	Homo sapiens	68-72
34840084-5	2022	As a result, GO@MPDA@Arg composites exhibited excellent enrichment performance for glycopeptides, containing good selectivity (IgG digests : BSA digests = 1:50, molar ratio), low detection limit for IgG digests (10 fmol muL-1), high loading capacity for IgG digests (200 mug mg-1), and good size exclusion (IgG digests : IgG : BSA = 1:100:100, mass ratio).	Glycopeptides	83-96	mitochondrial ubiquitin ligase activator of NFKB 1	Mus musculus	220-225
34152412-7	2021	The variation in O-glycoforms was evaluated by estimating the molecular weights of IgA1 hinge glycopeptides using reversed-phase liquid chromatography (LC) and tandem mass spectrometry under electron-transfer/higher-energy collision dissociation (EThcD) fragmentation mode.	Glycopeptides	94-107	immunoglobulin heavy constant alpha 1	Homo sapiens	83-87
34155551-0	2021	Simultaneous enrichment and separation of neutral and sialyl glycopeptides of SARS-CoV-2 spike protein enabled by dual-functionalized Ti-IMAC material.	Glycopeptides	61-74	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	89-94
34102146-4	2022	Results identified haptoglobin as the protein associated with HexNAc4-Hex5-NeuAc2, thus directly linking glycan imaging with intact glycopeptide identification.	Glycopeptides	132-144	haptoglobin	Canis lupus familiaris	19-30
34780171-0	2021	ZIC-cHILIC-Based StageTip for Simultaneous Glycopeptide Enrichment and Fractionation toward Large-Scale N-Sialoglycoproteomics.	Glycopeptides	43-55	Zic family member 1	Homo sapiens	0-3
34780171-3	2021	Here, we present the first implementation of zwitterionic hydrophilic interaction chromatography with the exposed choline group (ZIC-cHILIC) in StageTip for simultaneous enrichment and fractionation of intact glycopeptides.	Glycopeptides	209-222	Zic family member 1	Homo sapiens	129-132
34780171-6	2021	Most importantly, the ZIC-cHILIC stepwise strategy demonstrated good reproducibility (>80% in triplicate analysis) as well as superior coverage of 4.6- to 12.0-fold and 2.1- to 35.6-fold more glycopeptides and sialoglycopeptides compared to conventional TiO2 and ZIC-HILIC, respectively.	Glycopeptides	192-205	Zic family member 1	Homo sapiens	22-25
34364505-3	2021	Inspired by the prevalence of hydrophilic interaction chromatography for glycopeptide enrichment, a novel magnetic mesoporous silica nanomaterial (Fe3O4@mSiO2-TSG) with strongly hydrophilic property was developed through a one-pot method.	Glycopeptides	73-85	twisted gastrulation BMP signaling modulator 1	Homo sapiens	159-162
34711323-4	2021	Owing to the complexity of the intact protein, information about EPO glycosylation is commonly derived from released glycan and glycopeptide analysis using mass spectrometry (MS).	Glycopeptides	128-140	erythropoietin	Homo sapiens	65-68
34695439-6	2021	Glycopeptide analysis confirmed the presence of the glucose-beta1,3-fucose product of B3GLCT on TSP1 in wildtype (WT) cells and its absence in KO cells.	Glycopeptides	0-12	beta 3-glucosyltransferase	Homo sapiens	86-92
34695439-6	2021	Glycopeptide analysis confirmed the presence of the glucose-beta1,3-fucose product of B3GLCT on TSP1 in wildtype (WT) cells and its absence in KO cells.	Glycopeptides	0-12	thrombospondin 1	Homo sapiens	96-100
34192302-5	2021	In this study, we analyzed site-specific N-glycan structures of serum M2BP using Glyco-RIDGE (Glycan heterogeneity-based Relational IDentification of Glycopeptide signals on Elution profile) method.	Glycopeptides	150-162	galectin 3 binding protein	Homo sapiens	70-74
34812564-0	2021	The Development of Vaccines from Synthetic Tumor-Associated Mucin Glycopeptides and their Glycosylation-Dependent Immune Response.	Glycopeptides	66-79	LOC100508689	Homo sapiens	60-65
34578474-0	2021	ZIC-cHILIC Functionalized Magnetic Nanoparticle for Rapid and Sensitive Glycopeptide Enrichment from <1 microL Serum.	Glycopeptides	72-84	Zic family member 1	Homo sapiens	0-3
34092405-10	2021	Since the symptoms of ALG12-CDG are quite diverse, the combination of whole-exome sequencing and transferrin glycopeptide analysis with MS, can help diagnosis of ALG12-CDG.	Glycopeptides	109-121	ALG12 alpha-1,6-mannosyltransferase	Homo sapiens	22-27
34092405-10	2021	Since the symptoms of ALG12-CDG are quite diverse, the combination of whole-exome sequencing and transferrin glycopeptide analysis with MS, can help diagnosis of ALG12-CDG.	Glycopeptides	109-121	transferrin	Homo sapiens	97-108
34127537-6	2021	Methods: To gain insights into the complex O- and N-glycosylation of serum IgA1 and IgA2 in IgAN, we employed liquid chromatography-mass spectrometry (LC-MS) for the analysis of tryptic glycopeptides of serum IgA from 83 IgAN patients and 244 age and sex-matched healthy controls.	Glycopeptides	186-199	immunoglobulin heavy constant alpha 1	Homo sapiens	75-79
34127537-6	2021	Methods: To gain insights into the complex O- and N-glycosylation of serum IgA1 and IgA2 in IgAN, we employed liquid chromatography-mass spectrometry (LC-MS) for the analysis of tryptic glycopeptides of serum IgA from 83 IgAN patients and 244 age and sex-matched healthy controls.	Glycopeptides	186-199	CD79a molecule	Homo sapiens	84-88
34127537-6	2021	Methods: To gain insights into the complex O- and N-glycosylation of serum IgA1 and IgA2 in IgAN, we employed liquid chromatography-mass spectrometry (LC-MS) for the analysis of tryptic glycopeptides of serum IgA from 83 IgAN patients and 244 age and sex-matched healthy controls.	Glycopeptides	186-199	IGAN1	Homo sapiens	92-96
34127537-6	2021	Methods: To gain insights into the complex O- and N-glycosylation of serum IgA1 and IgA2 in IgAN, we employed liquid chromatography-mass spectrometry (LC-MS) for the analysis of tryptic glycopeptides of serum IgA from 83 IgAN patients and 244 age and sex-matched healthy controls.	Glycopeptides	186-199	CD79a molecule	Homo sapiens	209-212
34127537-10	2021	Finally, glycopeptides were a better predictor of IgAN and glomerular function than galactose-deficient IgA1 levels measured by lectin-based ELISA.	Glycopeptides	9-22	IGAN1	Homo sapiens	50-54
34482887-7	2021	Combining with the inherent properties of COF structure, the established platform achieved simultaneous enrichment of phosphopeptides and glycopeptides with excellent selectivity (1:1:1000 M ratio of alpha-casein/IgG/BSA), high sensitivity (0.05 fmol/muL alpha-casein; 0.05 fmol/muL IgG), and good size-exclusion effect (alpha-casein digests/IgG digests/BSA, 1:1:500).	Glycopeptides	138-151	tripartite motif containing 37	Homo sapiens	251-254
34482887-7	2021	Combining with the inherent properties of COF structure, the established platform achieved simultaneous enrichment of phosphopeptides and glycopeptides with excellent selectivity (1:1:1000 M ratio of alpha-casein/IgG/BSA), high sensitivity (0.05 fmol/muL alpha-casein; 0.05 fmol/muL IgG), and good size-exclusion effect (alpha-casein digests/IgG digests/BSA, 1:1:500).	Glycopeptides	138-151	tripartite motif containing 37	Homo sapiens	279-282
34778211-8	2021	A total of 7,127 unique N-linked glycosite-containing intact glycopeptides (IGPs), 928 glycosites, and 442 glycoproteins were identified from FUT8KO and WT CHO cells.	Glycopeptides	61-74	alpha-(1,6)-fucosyltransferase	Cricetulus griseus	142-148
34375180-4	2022	Here, we describe the design and in vivo biological evaluation of three vaccine candidates based on MUC1 glycopeptides that comprise unnatural elements in their structure.	Glycopeptides	105-118	mucin 1, transmembrane	Mus musculus	100-104
34375180-8	2022	According to our data, the development of effective MUC1-based vaccines should use surrogates that mimic the conformational space of aberrantly glycosylated MUC1 glycopeptides found in tumors.	Glycopeptides	162-175	mucin 1, transmembrane	Mus musculus	52-56
34375180-8	2022	According to our data, the development of effective MUC1-based vaccines should use surrogates that mimic the conformational space of aberrantly glycosylated MUC1 glycopeptides found in tumors.	Glycopeptides	162-175	mucin 1, transmembrane	Mus musculus	157-161
35388920-0	2022	New enantioselective liquid chromatography method development and validation of dipeptidyl peptidase IV inhibitors using a macrocyclic glycopeptide (vancomycin) chiral stationary phase under polar ionic mode condition.	Glycopeptides	135-147	dipeptidyl peptidase 4	Homo sapiens	80-103
34345007-0	2021	Identification, mapping and relative quantitation of SARS-CoV-2 Spike glycopeptides by Mass-Retention Time Fingerprinting.	Glycopeptides	70-83	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	64-69
34345007-1	2021	We describe an analytical method for the identification, mapping and relative quantitation of glycopeptides from SARS-CoV-2 Spike protein.	Glycopeptides	94-107	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	124-129
34345007-6	2021	In combination with MSMS and pseudo MS3, we have constructed a detailed mass-retention time database for Spike glycopeptides.	Glycopeptides	111-124	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	105-110
34345007-7	2021	This database allows any accurate mass LC-MS laboratory to reliably identify and quantify Spike glycopeptides from a single overnight elastase digest in less than 90 minutes.	Glycopeptides	96-109	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	90-95
34421504-1	2021	Sialidosis is a rare autosomal recessive disease that presents with progressive lysosomal storage of sialylated glycopeptides and oligosaccharides caused by homozygous or compound heterozygous sequence variants in the neuraminidase 1 (NEU1) gene.	Glycopeptides	112-125	neuraminidase 1	Homo sapiens	218-233
34421504-1	2021	Sialidosis is a rare autosomal recessive disease that presents with progressive lysosomal storage of sialylated glycopeptides and oligosaccharides caused by homozygous or compound heterozygous sequence variants in the neuraminidase 1 (NEU1) gene.	Glycopeptides	112-125	neuraminidase 1	Homo sapiens	235-239
34402270-5	2021	Then XIC peak shapes,standard deviation of peak area,and fold change were applied for further screening and 5 glycopeptides with significant differences in DCG and DHG were confirmed,which could serve as potential biomarkers for distinguishing DCG and DHG.	Glycopeptides	110-123	X chromosome inactivation center	Homo sapiens	5-8
34100586-0	2021	Dual-Functional Ti(IV)-IMAC Material Enables Simultaneous Enrichment and Separation of Diverse Glycopeptides and Phosphopeptides.	Glycopeptides	95-108	C-C motif chemokine ligand 26	Homo sapiens	23-27
34100586-2	2021	In this work, we report a new approach to enable simultaneous enrichment and separation of glycopeptides, phosphopeptides, and mannose-6-phosphate (M6P) glycopeptides by using a dual-functional Ti(IV)-IMAC material.	Glycopeptides	91-104	C-C motif chemokine ligand 26	Homo sapiens	201-205
34100586-6	2021	This is the first report on simultaneous enrichment and separation of neutral and sialyl glycopeptides, mono- and multi-phosphopeptides, and M6P glycopeptides via dual-functional Ti(IV)- IMAC, revealing novel insights into potential crosstalk among these important PTMs.	Glycopeptides	89-102	C-C motif chemokine ligand 26	Homo sapiens	187-191
34100586-6	2021	This is the first report on simultaneous enrichment and separation of neutral and sialyl glycopeptides, mono- and multi-phosphopeptides, and M6P glycopeptides via dual-functional Ti(IV)- IMAC, revealing novel insights into potential crosstalk among these important PTMs.	Glycopeptides	145-158	C-C motif chemokine ligand 26	Homo sapiens	187-191
34207451-5	2021	This platform utilizes an online purification of LC for sample desalting, and an in silico haptoglobin glycopeptide library constructed by combining peptides and N-glycans to readily identify glycopeptides.	Glycopeptides	103-115	haptoglobin	Homo sapiens	91-102
34207451-5	2021	This platform utilizes an online purification of LC for sample desalting, and an in silico haptoglobin glycopeptide library constructed by combining peptides and N-glycans to readily identify glycopeptides.	Glycopeptides	192-205	haptoglobin	Homo sapiens	91-102
34093861-5	2021	Through quantification analysis of intact glycopeptides, we found that the majority of core-fucosylated intact glycopeptides from folate receptor alpha (FOLR1) were up-regulated in the three HGF-treated cell lines.	Glycopeptides	42-55	folate receptor alpha	Homo sapiens	130-151
34093861-5	2021	Through quantification analysis of intact glycopeptides, we found that the majority of core-fucosylated intact glycopeptides from folate receptor alpha (FOLR1) were up-regulated in the three HGF-treated cell lines.	Glycopeptides	42-55	folate receptor alpha	Homo sapiens	153-158
34093861-5	2021	Through quantification analysis of intact glycopeptides, we found that the majority of core-fucosylated intact glycopeptides from folate receptor alpha (FOLR1) were up-regulated in the three HGF-treated cell lines.	Glycopeptides	42-55	hepatocyte growth factor	Homo sapiens	191-194
34093861-5	2021	Through quantification analysis of intact glycopeptides, we found that the majority of core-fucosylated intact glycopeptides from folate receptor alpha (FOLR1) were up-regulated in the three HGF-treated cell lines.	Glycopeptides	111-124	folate receptor alpha	Homo sapiens	130-151
34093861-5	2021	Through quantification analysis of intact glycopeptides, we found that the majority of core-fucosylated intact glycopeptides from folate receptor alpha (FOLR1) were up-regulated in the three HGF-treated cell lines.	Glycopeptides	111-124	folate receptor alpha	Homo sapiens	153-158
34093861-5	2021	Through quantification analysis of intact glycopeptides, we found that the majority of core-fucosylated intact glycopeptides from folate receptor alpha (FOLR1) were up-regulated in the three HGF-treated cell lines.	Glycopeptides	111-124	hepatocyte growth factor	Homo sapiens	191-194
34853246-5	2021	Here, we show that the DDRs observed as the phosphorylation of H2AX (gammaH2AX) and caspase-3-dependent apoptosis-induction are under critical control in the intestine of C57BL mice that were injected intraperitoneally with bleomycin, a natural glycopeptide used clinically as an antitumor agent.	Glycopeptides	245-257	H2A.X variant histone	Mus musculus	63-67
34853246-5	2021	Here, we show that the DDRs observed as the phosphorylation of H2AX (gammaH2AX) and caspase-3-dependent apoptosis-induction are under critical control in the intestine of C57BL mice that were injected intraperitoneally with bleomycin, a natural glycopeptide used clinically as an antitumor agent.	Glycopeptides	245-257	H2A.X variant histone	Mus musculus	69-78
34853246-5	2021	Here, we show that the DDRs observed as the phosphorylation of H2AX (gammaH2AX) and caspase-3-dependent apoptosis-induction are under critical control in the intestine of C57BL mice that were injected intraperitoneally with bleomycin, a natural glycopeptide used clinically as an antitumor agent.	Glycopeptides	245-257	caspase 3	Mus musculus	84-93
35388920-1	2022	The direct separation of dipeptidyl peptidase IV (DPP-4) inhibitors such as Sitagliptin (STG), Linagliptin (LIG), and Saxagliptin (SAG) enantiomers in normal phase conditions have been achieved on immobilized polysaccharide-based chiral stationary phases (CSPs), as well as on the macrocyclic glycopeptide vancomycin chiral stationary phase (Chirobiotic V2) under polar ionic mode.	Glycopeptides	293-305	dipeptidyl peptidase 4	Homo sapiens	25-48
35388920-1	2022	The direct separation of dipeptidyl peptidase IV (DPP-4) inhibitors such as Sitagliptin (STG), Linagliptin (LIG), and Saxagliptin (SAG) enantiomers in normal phase conditions have been achieved on immobilized polysaccharide-based chiral stationary phases (CSPs), as well as on the macrocyclic glycopeptide vancomycin chiral stationary phase (Chirobiotic V2) under polar ionic mode.	Glycopeptides	293-305	dipeptidyl peptidase 4	Homo sapiens	50-55
35093648-5	2022	According to electrospray ionization mass spectrometry (ESI-MS) analysis, there are two types of glycopeptides in the mixture, TGase and non-enzymatic glycated counterparts.	Glycopeptides	97-110	transglutaminase 1	Homo sapiens	127-132
35510762-3	2022	In this study, a novel hydrogel (denoted as ZIF-8/SAP) with a stable three-dimensional (3D) network structure and excellent hydrophilicity was successfully fabricated to capture glycopeptides with high efficiency.	Glycopeptides	178-191	SH2 domain containing 1A	Homo sapiens	50-53
35510762-5	2022	Inspired by the great enrichment performance of the as-prepared material toward glycopeptides, ZIF-8/SAP was further applied to capture glycopeptides from a real human serum sample.	Glycopeptides	80-93	SH2 domain containing 1A	Homo sapiens	101-104
35510762-5	2022	Inspired by the great enrichment performance of the as-prepared material toward glycopeptides, ZIF-8/SAP was further applied to capture glycopeptides from a real human serum sample.	Glycopeptides	136-149	SH2 domain containing 1A	Homo sapiens	101-104
35462306-0	2022	OGA activated glycopeptide-based nano-activator to activate PKM2 tetramerization for switching catabolic pathways and sensitizing chemotherapy resistance.	Glycopeptides	14-26	O-GlcNAcase	Homo sapiens	0-3
35420609-4	2022	In addition, Fe3O4@ILI-01@Ti4+ exhibits superior enrichment performance on synchronous enrichment of phosphopeptides/glycopeptides from beta-casein/HRP tryptic digests.	Glycopeptides	117-130	casein beta	Homo sapiens	136-147
35544340-6	2022	The general applicability and robustness of this approach are exemplified by efficient preparation of 16 well-defined SARS-CoV-2 O-glycopeptides, 4 complex MUC1 glycopeptides, and a 31-mer glycosylated glucagon-like peptide-1.	Glycopeptides	161-174	mucin 1, cell surface associated	Homo sapiens	156-160
35462306-0	2022	OGA activated glycopeptide-based nano-activator to activate PKM2 tetramerization for switching catabolic pathways and sensitizing chemotherapy resistance.	Glycopeptides	14-26	pyruvate kinase M1/2	Homo sapiens	60-64
35462306-3	2022	Herein, we developed a glycopeptide-based PKM2 nano-activator, which could induce the tetramerization of PKM2 based on serine bonding to Domain C of PKM2.	Glycopeptides	23-35	pyruvate kinase M1/2	Homo sapiens	42-46
35462306-3	2022	Herein, we developed a glycopeptide-based PKM2 nano-activator, which could induce the tetramerization of PKM2 based on serine bonding to Domain C of PKM2.	Glycopeptides	23-35	pyruvate kinase M1/2	Homo sapiens	105-109
35462306-3	2022	Herein, we developed a glycopeptide-based PKM2 nano-activator, which could induce the tetramerization of PKM2 based on serine bonding to Domain C of PKM2.	Glycopeptides	23-35	pyruvate kinase M1/2	Homo sapiens	149-153
35462306-5	2022	The glycopeptide assembled into nanoparticles under aqueous conditions and in the circulation, which in situ transformed into PKM2 nano-activator with nanofibrillar structure after specifically activated by O-GlcNAcase recognition upregulated in a wide range of human tumors.	Glycopeptides	4-16	pyruvate kinase M1/2	Homo sapiens	126-130
35462306-5	2022	The glycopeptide assembled into nanoparticles under aqueous conditions and in the circulation, which in situ transformed into PKM2 nano-activator with nanofibrillar structure after specifically activated by O-GlcNAcase recognition upregulated in a wide range of human tumors.	Glycopeptides	4-16	O-GlcNAcase	Homo sapiens	207-218
35462306-6	2022	Moreover, the glycopeptide-based PKM2 nano-activator successfully accumulated at the tumor sites and boosted the chemo-drug sensitivity against prostate and breast cancers.	Glycopeptides	14-26	pyruvate kinase M1/2	Homo sapiens	33-37
35462306-7	2022	Attributed to these intriguing results, the newly developed glycopeptide-based PKM2 nano-activator can be envisioned a promising candidate for the treatment of tumors by switching catabolic pathways.	Glycopeptides	60-72	pyruvate kinase M1/2	Homo sapiens	79-83
35182004-4	2022	This material manifests excellent property in glycopeptides enrichment, with high selectivity (1:5000), low detection limit (0.1 fmol muL-1 ), high recovery rate (99.4 +- 0.5%) and good repeatability.	Glycopeptides	46-59	mitochondrial E3 ubiquitin protein ligase 1	Homo sapiens	134-139
35572668-0	2022	Glycopeptide Antibiotic Teicoplanin Inhibits Cell Entry of SARS-CoV-2 by Suppressing the Proteolytic Activity of Cathepsin L.	Glycopeptides	0-12	cathepsin L	Homo sapiens	113-124
35572668-3	2022	We previously reported that teicoplanin, a glycopeptide antibiotic that has been commonly used in the clinic to treat bacterial infection, significantly restrained the cell entry of Ebola virus, SARS-CoV, and MERS-CoV by specifically inhibiting the activity of cathepsin L (CTSL).	Glycopeptides	43-55	cathepsin L	Homo sapiens	261-272
35572668-3	2022	We previously reported that teicoplanin, a glycopeptide antibiotic that has been commonly used in the clinic to treat bacterial infection, significantly restrained the cell entry of Ebola virus, SARS-CoV, and MERS-CoV by specifically inhibiting the activity of cathepsin L (CTSL).	Glycopeptides	43-55	cathepsin L	Homo sapiens	274-278
35495706-10	2022	Further in silico analyses revealed that an IS1216E-based composite transposon was generated in SC1762-D, and it disrupted the vanH gene, likely affecting the structure and expression of the vanA gene cluster and resulting in resensitization to glycopeptides.	Glycopeptides	245-258	VanH protein	Enterococcus faecium	127-131
35496372-7	2022	Individual glycopeptide analysis found separation between the AD patients and controls on complement proteins and apolipoprotein B.	Glycopeptides	11-23	apolipoprotein B	Homo sapiens	114-130
35573732-6	2022	Glycoproteomic analysis revealed the abundance of glycopeptides from LAMP2, NICA, and CEIP2 was significantly changed during NGI-1 treatment.	Glycopeptides	50-63	lysosomal associated membrane protein 2	Homo sapiens	69-74
35350332-9	2022	By cross-comparison with our previous urinary glycoproteomic dataset for aggressive prostate cancer, we reported a total of four glycopeptides from glycoproteins DSC2, MGAM, PIK3IP1, and CD55, commonly identified to be prostate cancer-specific.	Glycopeptides	129-142	desmocollin 2	Homo sapiens	162-166
35371101-6	2022	In addition, Alum adjuvant and built-in TLR7a synergistically enhanced MUC1 glycopeptide-specific memory CD8+ T-cell immune responses.	Glycopeptides	76-88	mucin 1, transmembrane	Mus musculus	71-75
35364384-3	2022	The stability of the new glycopeptide derivatives 10a,b is confirmed by assessing the physical character, HOMO-LUMO gap energy, ESP, and the corresponding correlation of 2D-NMR analysis.	Glycopeptides	25-37	protein tyrosine phosphatase receptor type V, pseudogene	Homo sapiens	128-131
35415375-5	2022	As compared to the parental cells, cells with mutations in exon 9 (E545K) or exon 20 (H1047R) of the PIK3CA gene exhibited site-specific glycosylation alterations in 464 of the 1999 glycopeptides quantified.	Glycopeptides	182-195	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha	Homo sapiens	101-107
35350332-9	2022	By cross-comparison with our previous urinary glycoproteomic dataset for aggressive prostate cancer, we reported a total of four glycopeptides from glycoproteins DSC2, MGAM, PIK3IP1, and CD55, commonly identified to be prostate cancer-specific.	Glycopeptides	129-142	maltase-glucoamylase	Homo sapiens	168-172
35350332-9	2022	By cross-comparison with our previous urinary glycoproteomic dataset for aggressive prostate cancer, we reported a total of four glycopeptides from glycoproteins DSC2, MGAM, PIK3IP1, and CD55, commonly identified to be prostate cancer-specific.	Glycopeptides	129-142	phosphoinositide-3-kinase interacting protein 1	Homo sapiens	174-181
35350332-9	2022	By cross-comparison with our previous urinary glycoproteomic dataset for aggressive prostate cancer, we reported a total of four glycopeptides from glycoproteins DSC2, MGAM, PIK3IP1, and CD55, commonly identified to be prostate cancer-specific.	Glycopeptides	129-142	CD55 molecule (Cromer blood group)	Homo sapiens	187-191
34991034-2	2022	Here, a co-assembled glycopeptide nanotransforrs (GPNTs) named MRP@DOX as a drug delivery system is reported.	Glycopeptides	21-33	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	Mus musculus	63-66
35122907-7	2022	CONCLUSIONS: A glycopeptide based diagnostic tool would be beneficial for patient stratification by providing information about the functionality of HNF1A.	Glycopeptides	15-27	HNF1 homeobox A	Homo sapiens	149-154
34991034-3	2022	The MRP@DOX co-assemble nanoparticles consisting of glycopeptide, cationic peptide, and doxorubicin (DOX).	Glycopeptides	52-64	ATP-binding cassette, sub-family C (CFTR/MRP), member 1	Mus musculus	4-7
35186526-2	2022	They are Gram-positive, catalase-negative cocci that are intrinsically resistant to glycopeptides, including vancomycin.	Glycopeptides	84-97	catalase	Homo sapiens	24-32